Close

Form N-CSRS BLACKROCK FUNDS For: Nov 30

February 1, 2023 2:37 PM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT

INVESTMENT COMPANIES

Investment Company Act file number: 811-05742

 

Name of Fund:   BlackRock FundsSM
       BlackRock Health Sciences Opportunities Portfolio
       BlackRock Infrastructure Sustainable Opportunities Fund
       BlackRock Mid-Cap Growth Equity Portfolio
       BlackRock Technology Opportunities Fund

 

Fund Address:   100 Bellevue Parkway, Wilmington, DE 19809

Name and address of agent for service: John M. Perlowski, Chief Executive Officer, BlackRock FundsSM, 55 East 52nd Street, New York, NY 10055

Registrant’s telephone number, including area code: (800) 441-7762

Date of fiscal year end: 05/31/2023

Date of reporting period: 11/30/2022


Item 1 –

Report to Stockholders

(a) The Report to Shareholders is attached herewith.


 

LOGO

  NOVEMBER 30, 2022

 

  

2022 Semi-Annual Report

(Unaudited)

 

BlackRock Capital Appreciation Fund, Inc.

BlackRock FundsSM

 

·  

BlackRock Health Sciences Opportunities Portfolio

 

·  

BlackRock Infrastructure Sustainable Opportunities Fund

 

·  

BlackRock Mid-Cap Growth Equity Portfolio

 

·  

BlackRock Technology Opportunities Fund

 

 

 

Not FDIC Insured • May Lose Value • No Bank Guarantee  


The Markets in Review

Dear Shareholder,

Significant economic headwinds emerged during the 12-month reporting period ended November 30, 2022, disrupting the economic recovery and strong financial markets of 2021. The U.S. economy shrank in the first half of 2022 before returning to moderate growth in the third quarter, marking a shift to a more challenging post-reopening economic environment. Changes in consumer spending patterns and a tight labor market led to elevated inflation, which reached a 40-year high before beginning to moderate. Moreover, while the foremost effect of Russia’s invasion of Ukraine has been a severe humanitarian crisis, the ongoing war continued to present challenges for both investors and policymakers.

Equity prices fell as interest rates rose, particularly weighing on relatively high-valuation growth stocks as inflation decreased the value of future cash flows and investors shifted focus to balance sheet resilience. Both large- and small-capitalization U.S. stocks fell, although declines for small-capitalization U.S. stocks were slightly steeper. Emerging market stocks and international equities from developed markets also declined significantly, pressured by rising interest rates and a strengthening U.S. dollar.

The 10-year U.S. Treasury yield rose notably during the reporting period, driving its price down, as investors reacted to higher inflation and attempted to anticipate its impact on future interest rate changes. The corporate bond market also faced inflationary headwinds, and increasing uncertainty led to higher corporate bond spreads (the difference in yield between U.S. Treasuries and similarly-dated corporate bonds).

The U.S. Federal Reserve (the “Fed”), acknowledging that inflation has been more persistent than expected, raised interest rates six times. Furthermore, the Fed wound down its bond-buying programs and is accelerating the reduction of its balance sheet. While the Fed suggested that additional rate hikes were likely, it also gave indications that the pace of increases would slow if inflation continued to subside.

The pandemic’s restructuring of the economy brought an ongoing mismatch between supply and demand, contributing to the current inflationary regime. While growth has slowed in 2022, we believe that taming inflation requires a more dramatic economic decline to bring demand back to a lower level that is more in line with the economy’s capacity. The Fed has been raising interest rates at the fastest pace in decades, and seems set to overtighten in its effort to get inflation back to target. With this in mind, we believe the possibility of a U.S. recession in the near-term is high, but this prospect has not yet been fully priced in by markets. Investors should expect a period of higher volatility as markets adjust to the new economic reality and policymakers attempt to adapt to rapidly changing conditions.

In this environment, while we favor an overweight to equities in the long-term, the market’s concerns over excessive rate hikes from central banks moderate our outlook. Rising input costs and a deteriorating economic backdrop are likely to challenge corporate earnings, so we are underweight equities overall in the near term. However, we see better opportunities in credit, where valuations are attractive and higher yields provide income opportunities. We believe that global investment-grade corporates, global inflation-linked bonds, and U.S. mortgage-backed securities offer strong opportunities for a six- to twelve-month horizon.

Overall, our view is that investors need to think globally, position themselves to be prepared for a decarbonizing economy, and be nimble as market conditions change. We encourage you to talk with your financial advisor and visit blackrock.com for further insight about investing in today’s markets.

Sincerely,

 

LOGO

Rob Kapito

President, BlackRock Advisors, LLC

LOGO

Rob Kaplito

President, BlackRock Advisors, LLC

 

Total Returns as of November 30, 2022
       6-Month       12-Month  

U.S. large cap equities (S&P 500® Index)

  (0.40)%   (9.21)%

U.S. small cap equities (Russell 2000® Index)

  1.98   (13.01)

International equities (MSCI Europe, Australasia, Far East Index)

  (3.59)   (10.14)

Emerging market equities (MSCI Emerging Markets Index)

  (8.15)   (17.43)

3-month Treasury bills (ICE BofA 3-Month U.S. Treasury Bill Index)

  0.98   1.11

U.S. Treasury securities (ICE BofA 10-Year U.S. Treasury Index)

  (5.33)   (15.69)

U.S. investment grade bonds (Bloomberg U.S. Aggregate Bond Index)

  (4.06)   (12.84)

Tax-exempt municipal bonds (Bloomberg Municipal Bond Index)

  (1.43)   (8.64)

U.S. high yield bonds (Bloomberg U.S. Corporate High Yield 2% Issuer Capped Index)

  (2.87)   (8.95)

Past performance is not an indication of future results. Index performance is shown for illustrative purposes only. You cannot invest directly in an index.

 

 

 

 

2

 

H I S   P A G E   I S   N O T   P A R T   O F   Y O U R   F U N D   R E P O R T


Table of Contents

 

      Page  

The Markets in Review

     2  

Semi-Annual Report:

  

Fund Summary

     4  

About Fund Performance

     15  

Disclosure of Expenses

     15  

Derivative Financial Instruments

     16  

Financial Statements:

  

Schedules of Investments

     17  

Statements of Assets and Liabilities

     36  

Statements of Operations

     40  

Statements of Changes in Net Assets

     42  

Financial Highlights

     45  

Notes to Financial Statements

     71  

Statement Regarding Liquidity Risk Management Program

     87  

Additional Information

     88  

Glossary of Terms Used in this Report

     90  

 

 

 

LOGO

 

 

  3


Fund Summary  as of November 30, 2022 

   BlackRock Capital Appreciation Fund, Inc.

 

Investment Objective

BlackRock Capital Appreciation Fund, Inc.’s (the “Fund”) investment objective is to seek long-term growth of capital.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2022, the Fund underperformed its benchmark, the Russell 1000® Growth Index. For the same period, all of the Fund’s share classes underperformed the broad-market S&P 500® Index. The following discussion of relative performance pertains to the Russell 1000® Growth Index.

What factors influenced performance?

The largest detractors from relative performance included investment decisions in the information technology (“IT”), energy and consumer staples sectors. Within IT, an underweight allocation to the technology hardware, storage and peripherals industry proved most costly, driven by a large underweight position in Apple Inc., while stock selection among IT services companies also weighed on relative return. In energy, a combination of stock selection and the timing of our overweight allocation to the oil & gas exploration & production sub-industry hurt relative results, including ownership of off-benchmark EQT Corp. and an overweight position in Pioneer Natural Resources Co. Lastly, in consumer staples, our decision to not invest in beverages and food & staples retailing companies dampened relative return, as did an overweight allocation to Olaplex Holdings, Inc. within the personal products industry.

The largest positive contributor to the Fund’s relative performance was positioning in the real estate sector. In particular, an underweight allocation to the equity REITs industry boosted relative return, most notably through avoiding positions in Crown Castle, Inc. and American Tower Corp. An overweight to the healthcare equipment and supplies industry, specifically to Intuitive Surgical, Inc., also proved additive. Finally, an overweight to LVMH, a luxury goods company within consumer discretionary, also contributed to relative performance during the period.

Describe recent portfolio activity.

During the period, exposure to healthcare increased with investment in the healthcare equipment and supplies sub-sector. Exposure to the IT sector increased as well. Conversely, exposure to communication services declined the most due to a decreased allocation to interactive media and services. Exposure to the energy sector also declined. The Fund’s cash position slightly decreased as well over the period.

Describe portfolio positioning at period end.

As of period end, the Fund’s largest overweight position relative to the Russell 1000® Growth Index was in the healthcare sector, followed by financials and IT. Conversely, the consumer staples sector was the largest underweight, followed by industrials and real estate.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

 

4  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2022 (continued)

   BlackRock Capital Appreciation Fund, Inc.

 

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (6.87 )%      (31.37 )%      N/A       9.36     N/A       12.44     N/A  

Investor A

    (7.01     (31.55     (35.15 )%      9.08       7.91     12.13       11.53

Investor C

    (7.38     (32.08     (32.65     8.22       8.22       11.41       11.41  

Class K

    (6.86     (31.33     N/A       9.47       N/A       12.55       N/A  

Class R

    (7.20     (31.83     N/A       8.73       N/A       11.81       N/A  

Russell 1000® Growth Index(c)

    (1.76     (21.64     N/A       12.92       N/A       15.01       N/A  

S&P 500® Index(d)

    (0.40     (9.21     N/A       10.98       N/A       13.34       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b)

The Fund invests primarily in a diversified portfolio consisting primarily of common stock of U.S. companies that Fund management believes have exhibited above-average growth rates in earnings over the long term.

 
(c) 

An index that measures the performance of the large-cap growth segment of the U.S. equity universe. It includes those Russell 1000® companies with higher price-to-book ratios and higher forecasted growth values.

 
(d)

An unmanaged index that covers 500 leading companies and captures approximately 80% coverage of available market capitalization.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

Expense Example

 

   

Actual

    Hypothetical 5% Return         
     Beginning
Account Value
(06/01/22)
     Ending   
Account Value   
(11/30/22)   
     Expenses
Paid During
the Period(a)
    Beginning
Account Value
(06/01/22)
    Ending
Account Value
(11/30/22)
     Expenses   
Paid During   
the Period(a)
     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 931.30         $ 3.49     $ 1,000.00     $ 1,021.46      $ 3.65           0.72

Investor A

    1,000.00        929.90           4.84       1,000.00       1,020.05        5.06           1.00  

Investor C

    1,000.00        926.20           8.86       1,000.00       1,015.87        9.25           1.83  

Class K

    1,000.00        931.40           3.12       1,000.00       1,021.83        3.29           0.65  

Class R

    1,000.00        928.00           6.60       1,000.00       1,018.23        6.88           1.36  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

TEN LARGEST HOLDINGS

 

Security(a)   Percent of
Net Assets
 

Apple Inc.

    8.7

Microsoft Corp.

    8.5  

Amazon.com, Inc.

    6.4  

Visa, Inc., Class A

    4.9  

Alphabet, Inc., Class A

    4.7  

Intuit, Inc.

    4.1  

UnitedHealth Group, Inc.

    3.5  

ASML Holding NV, Registered Shares

    3.4  

S&P Global, Inc.

    2.9  

Tesla, Inc.

    2.7  
SECTOR ALLOCATION

 

Sector(b)   Percent of
Net Assets
 

Information Technology

    44.7

Consumer Discretionary

    17.1  

Health Care

    16.9  

Communication Services

    7.3  

Financials

    5.4  

Industrials

    4.4  

Energy

    1.8  

Materials

    1.3  

Other (each representing less than 1%)

    0.6  

Short-Term Securities

    0.6  

Liabilities in Excess of Other Assets

    (0.1

 

 
  (a)

Excludes short-term securities.

 
  (b)

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

 

 

U N D   S U M M A R Y

  5


Fund Summary  as of November 30, 2022 

   BlackRock Health Sciences Opportunities Portfolio

 

Investment Objective

BlackRock Health Sciences Opportunities Portfolio’s (the “Fund”) investment objective is to provide long-term growth of capital.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2022, all of the Fund’s share classes outperformed its benchmark, the Russell 3000® Health Care Index, except for Investor C Shares, which underperformed, the benchmark.

What factors influenced performance?

Healthcare stocks posted a gain in the annual period and outperformed the broader U.S. equity market. The sector was helped by its relatively low sensitivity to the key issues weighing on market performance, particularly rising interest rates and slowing economic growth.

The Fund’s outperformance stemmed from both stock selection and industry allocations. In terms of specific holdings, an overweight position in Abiomed, Inc. was the top contributor to relative performance. The stock rose on news of Johnson & Johnson’s plans to acquire the medical device company for $16.6 billion. An underweight in Johnson & Johnson also contributed, as the stock declined on worries that the company would face challenges meeting its ambitious growth targets following its acquisition of Abiomed. An overweight in Imago Biosciences, Inc., which rallied after Merck announced a bid for the company, was an additional contributor of note.

On the other hand, an out-of-benchmark holding in Sanofi SA was the largest detractor amid ongoing concerns regarding Zantac litigation. The lack of a position in Humana, Inc. detracted after the company reported lackluster earnings and reduced membership guidance. The investment adviser subsequently sold the position, which prevented the Fund from capitalizing on the stock’s subsequent recovery. An overweight in Zoetis, Inc. also hurt performance. The stock declined as supply chain issues, labor shortages and adverse foreign-currency effects hindered the company’s earnings.

Describe recent portfolio activity.

The Fund’s weightings in the biotechnology and medical devices and supplies sub-sectors increased. Conversely, its allocations to the healthcare providers and services and pharmaceuticals sub-sectors decreased.

Describe portfolio positioning at period end.

The investment adviser was encouraged by the healthcare sector’s resilience in the midst of the extraordinary macroeconomic and geopolitical challenges that characterized the past six months. The investment adviser continued to identify investment opportunities in stable, cash-flow generating companies across the healthcare sector. In particular, it looked for selective growth opportunities stemming from innovation and technological developments, especially in the biotechnology, pharmaceuticals and medical devices industries. The investment adviser maintained an emphasis on diversification, risk management and fundamental analysis.

The investment adviser believed the long-term, secular drivers for the healthcare sector—including aging global demographics and innovation in medical technology—remain in place. It sees these trends, together with favorable valuations across the sector, as the foundation for a compelling long-term investment opportunity.

At the end of the period, the Fund was underweight in the pharmaceuticals industry and slightly overweight in biotechnology, healthcare providers and services and medical devices & supplies.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

 

6  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2022 (continued)   

BlackRock Health Sciences Opportunities Portfolio

 

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    6.55     3.13     N/A       11.68     N/A       15.78     N/A  

Service

    6.38       2.82       N/A       11.35       N/A       15.44       N/A  

Investor A

    6.41       2.87       (2.53 )%      11.39       10.19     15.47       14.85

Investor C

    6.00       2.10       1.22       10.57       10.57       14.80       14.80  

Class K

    6.60       3.23       N/A       11.79       N/A       15.74       N/A  

Class R

    6.21       2.48       N/A       11.01       N/A       15.09       N/A  

Russell 3000® Health Care Index(c)

    6.08       2.65       N/A       11.69       N/A       14.85       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b)

Under normal market conditions, the Fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries.

 
(c) 

An unmanaged index that features companies involved in medical services or health care in the Russell 3000® Index, which includes the largest 3,000 U.S. companies as determined by total market capitalization.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

Expense Example

 

     Actual   

Hypothetical 5% Return

    
      Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
   Expenses   
Paid During   
the Period(a)
   Beginning
Account Value
(06/01/22)
   Ending
Account Value
(11/30/22)
   Expenses   
Paid During   
the Period(a)
   Annualized
Expense
Ratio

Institutional

   $ 1,000.00      $ 1,065.50    $4.35       $ 1,000.00    $ 1,020.85    $4.26       0.84%

Service

     1,000.00      1,063.80    5.91       1,000.00    1,019.34    5.77       1.14

Investor A

     1,000.00      1,064.10    5.66       1,000.00    1,019.58    5.52       1.09

Investor C

     1,000.00      1,060.00    9.55       1,000.00    1,015.80    9.35       1.85

Class K

     1,000.00      1,066.00    3.86       1,000.00    1,021.33    3.80       0.75

Class R

     1,000.00      1,062.10    7.54       1,000.00    1,017.75    7.39       1.46

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

TEN LARGEST HOLDINGS

 

Security(a)   Percent of
Net Assets
 

UnitedHealth Group, Inc.

    8.7

Eli Lilly & Co.

    5.6  

Johnson & Johnson

    5.2  

Merck & Co., Inc.

    4.1  

Thermo Fisher Scientific, Inc.

    4.0  

Amgen, Inc.

    3.3  

Elevance Health, Inc.

    3.2  

Boston Scientific Corp.

    3.1  

Danaher Corp.

    3.1  

Abbott Laboratories

    2.9  

 

INDUSTRY ALLOCATION  
Industry(b)   Percent of
Net Assets
 

Pharmaceuticals

    23.5

Biotechnology

    21.7  

Health Care Providers & Services

    21.4  

Health Care Equipment & Supplies

    19.6  

Life Sciences Tools & Services

    11.5  

Other (each representing less than 1%)

    0.3  

Short-Term Securities

    3.4  

Liabilities in Excess of Other Assets

    (1.4

 

 
(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

 

U N D   S U M M A R Y

  7


Fund Summary  as of November 30, 2022    BlackRock Infrastructure Sustainable Opportunities Fund

 

Investment Objective

BlackRock Infrastructure Sustainable Opportunities Fund’s (the “Fund”) investment objective is to seek to maximize total return while seeking to invest in issuers which are helping to address certain United Nations Sustainable Development Goals (“SDGs”) through their products and services.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2022, the Fund underperformed its benchmark, the FTSE Developed Core Infrastructure 50/50 Net Tax Index.

What factors influenced performance?

An overweight allocation to the communication services sector, where many stocks were disproportionately hurt by rising interest rates, was the largest detractor from relative performance. Overweight positions in U.S. healthcare stocks also detracted, as did an overweight to Eurozone toll road operators.

Stock selection in U.S. electric utilities made the largest contribution to performance. An overweight in the nuclear power operator Constellation Energy Corp., which rallied on hopes that the renewable-energy incentives in the Inflation Reduction Act would support further growth for the renewables sector, was a top contributor. An underweight in Canadian midstream energy stocks also contributed to performance. An overweight in the Japanese railroad and Canadian electric utilities sectors contributed, as well.

Describe recent portfolio activity.

The Fund’s weightings in U.K. diversified utilities increased due to the addition of National Grid PLC, and its weighting in U.K. water utilities rose following the purchase of Severn Trent PLC. The purchases reflected the investment adviser’s view that both companies stood to benefit from their inflation-linked cash flows. The Fund’s weightings in Hong Kong electric utilities and U.S. railroads also increased.

The Fund reduced its allocation to U.S. electric utilities on the belief that the sector’s strong performance limited the amount of further upside potential. The Fund also lowered its weightings in Eurozone electric utilities and Australia toll road operators.

Describe portfolio positioning at period end.

The Fund’s cash weighting was higher than the investment adviser’s long-term target. Given the uncertainty in the markets, the investment adviser sought to have cash on hand to capitalize on additional volatility by purchasing stocks saw as having favorable risk-return profiles.

The strategy is benchmark-agnostic in its construction, and looks to avoid the inherent United States bias that is prevalent in the most widely used infrastructure index, the FTSE Developed Core Infrastructure 50/50 Net Tax Index. The Fund therefore finished the period overweight in the Europe/Middle East/Africa region, with a weighting approximately 30 percentage points above that of the benchmark. The investment adviser believed the region offers a compelling opportunity due to the combination of unique assets and the tailwinds from the structural megatrends of decarbonization and digitization. The Fund had a sizable overweight to European electric utilities—with a weighting 13 percentage points above the index—on the belief that the region is home to some of the most attractive opportunities in the renewable power industry. The Fund also had a six percentage-point overweight in the Europe communications sector.

The Fund had a significant, 31 percentage-point underweight in the Americas. While this was not necessarily an active decision to avoid the United States, this Fund seeks to provide true global exposure. It was underweight in U.S. electric utilities on the view that Europe electric utilities offered a more compelling opportunity.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

 

8  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2022 (continued)    BlackRock Infrastructure Sustainable Opportunities Fund

 

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     Since Inception(c)  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (8.67 )%      (8.62 )%      N/A       (7.12 )%      N/A  

Investor A

    (8.78     (8.79     (13.58 )%      (7.34     (11.53 )% 

Class K

    (8.65     (8.59     N/A       (7.09     N/A  

FTSE Developed Core Infrastructure 50/50 Net Tax Index(d)

    (6.00     3.71       N/A       3.29       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees.

 
(b) 

Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in the equity securities of infrastructure-related companies or derivatives with similar economic characteristics.

 
(c) 

The Fund commenced operations on September 30, 2021.

 
(d) 

Gives participants an industry-defined interpretation of infrastructure and adjusts the exposure to certain infrastructure sub-sectors. The constituent weights are adjusted as part of the semi-annual review according to three broad industry sectors: 50% utilities; 30% transportation, including capping of 7.5% for railroads/railways; and a 20% mix of other sectors, including pipelines, satellites and telecommunication towers.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

Expense Example

 

   

Actual

            Hypothetical 5% Return         
     Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
     Expenses
Paid During
the Period(a)
             Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
     Expenses
Paid During
the Period(a)
     Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 913.30      $ 4.76         $ 1,000.00      $ 1,020.09      $ 5.01        0.99

Investor A

    1,000.00        912.20        5.86           1,000.00        1,018.94        6.17        1.22  

Class K

    1,000.00        913.50        4.56                 1,000.00        1,020.30        4.81        0.95  

 

(a)   

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period shown).

 

  See

“Disclosure of Expenses” for further information on how expenses were calculated.

 

Portfolio Information

 

TEN LARGEST HOLDINGS

Security(a)   Percent of
Net Assets
 

Cellnex Telecom SA

    5.8

Enel SpA

    5.1  

Severn Trent PLC

    4.8  

SBA Communications Corp.

    4.6  

NEXTDC Ltd.

    4.4  

Public Service Enterprise Group, Inc.

    4.4  

Terna - Rete Elettrica Nazionale

    4.4  

Fraport AG Frankfurt Airport Services Worldwide

    4.1  

Smart Metering Systems PLC

    3.8  

American Tower Corp.

    3.5  

SECTOR ALLOCATION

Sector(b)   Percent of
Net Assets
 

Utilities

    41.6

Industrials

    20.0  

Real Estate

    15.6  

Communication Services

    8.3  

Information Technology

    4.5  

Energy

    1.5  

Short-Term Securities

    7.4  

Other Assets Less Liabilities

    1.1  
 

 

(a)   

Excludes short-term investments.

(b)   

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

 

U N D   S U M M A R Y

  9


Fund Summary  as of November 30, 2022    

BlackRock Mid-Cap Growth Equity Portfolio

 

Investment Objective

BlackRock Mid-Cap Growth Equity Portfolio’s (the “Fund”) investment objective is long-term capital appreciation.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2022, the Fund underperformed its benchmark, the Russell Midcap® Growth Index.

What factors influenced performance?

The largest detractors from relative performance included investment decisions in the healthcare, communication services, and energy sectors. In healthcare, within the life sciences tools and services industry, overweight positions in West Pharmaceutical Services, Inc. and Repligen Corp. weighed on relative results. Other detractors in the sector included an overweight allocation to pharmaceuticals and investment decisions among health care equipment & supplies companies. Following healthcare, a combination of stock selection and an overweight allocation to the communication services sector proved costly, primarily due to an overweight position in Match Group, Inc. within the interactive media and services industry. Lastly, an underweight allocation to the energy sector hurt relative performance, driven by a lack of exposure to Hess Corp. and Texas Pacific Land Corp. within the oil, gas & consumable fuels industry.

At the sector level, the largest positive contributors to the Fund’s relative performance were investment decisions in industrials and materials. In industrials, an overweight allocation to the commercial services & supplies industry proved beneficial, most notably due to a large overweight position in Copart, Inc., and stock selection among companies in the professional services and construction & engineering industries. In materials, the decision to avoid companies across the containers and packaging industry proved beneficial, specifically a lack of exposure to Ball Corp. and Crown Holdings Inc. Lastly, at the industry level, stock selection in the software industry contributed to relative return during the period.

Describe recent portfolio activity.

During the period, exposure to industrials increased with increased investment in the professional services sub-sector. Exposure to the consumer discretionary sector increased as well. Conversely, exposure to information technology (“IT”) declined the most due to a decreased allocation to IT services. Exposure to the communication services sector decreased as well.

Describe portfolio positioning at period end.

Relative to the Russell Midcap® Growth Index, at the end of the reporting period the Fund’s largest overweight was in the industrials sector, followed by financials and consumer discretionary. Conversely, the healthcare sector was the largest underweight, followed by consumer staples and materials.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

 

10  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2022 (continued)   

BlackRock Mid-Cap Growth Equity Portfolio

 

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years     10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (1.46 )%      (31.54 )%      N/A       9.41     N/A       14.02     N/A  

Service

    (1.60     (31.72     N/A       9.13       N/A       13.67       N/A  

Investor A

    (1.61     (31.72     (35.31 )%      9.12       7.95     13.70       13.09

Investor C

    (1.96     (32.21     (32.88     8.32       8.32       13.03       13.03  

Class K

    (1.43     (31.49     N/A       9.49       N/A       14.09       N/A  

Class R

    (1.72     (31.89     N/A       8.85       N/A       13.41       N/A  

Russell Midcap® Growth Index(c)

    4.54       (21.77     N/A       9.10       N/A       12.30       N/A  

 

(a)

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b)

The Fund normally invests at least 80% of its net assets in equity securities issued by U.S. mid-capitalization companies which Fund management believes have above-average earnings growth potential.

 
(c)

An index that measures the performance of the mid-cap growth segment of the U.S. equity universe. It includes those Russell Midcap® Index companies with higher price-to-book ratios and higher forecasted growth values.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

Expense Example

 

    Actual           Hypothetical 5% Return           
     Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
     Expenses   
Paid During   
the Period(a)
           Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
     Expenses   
Paid During   
the Period(a)
       Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 985.40      $ 3.98          $ 1,000.00      $ 1,021.06      $ 4.05             0.80

Service

    1,000.00        984.00        5.22            1,000.00        1,019.80        5.32             1.05  

Investor A

    1,000.00        983.90        5.22            1,000.00        1,019.80        5.32             1.05  

Investor C

    1,000.00        980.40        8.94            1,000.00        1,016.04        9.10             1.80  

Class K

    1,000.00        985.70        3.50            1,000.00        1,021.55        3.55             0.70  

Class R

    1,000.00        982.80        6.46                  1,000.00        1,018.55        6.58             1.30  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

Portfolio Information

 

TEN LARGEST HOLDINGS

 

Security(a)   Percent of
Net Assets
 

MSCI, Inc.

    3.5

Cadence Design Systems, Inc.

    3.5  

Copart, Inc.

    3.2  

Synopsys, Inc.

    3.0  

Cintas Corp.

    2.8  

Paycom Software, Inc.

    2.7  

ON Semiconductor Corp.

    2.7  

Monolithic Power Systems, Inc.

    2.6  

Match Group, Inc.

    2.6  

Veeva Systems, Inc., Class A

    2.5  

SECTOR ALLOCATION

 

Sector(b)   Percent of
Net Assets
 

Information Technology

    26.4

Industrials

    20.4  

Consumer Discretionary

    18.3  

Health Care

    13.6  

Financials

    9.5  

Communication Services

    6.1  

Energy

    2.7  

Real Estate

    1.6  

Materials

    1.2  

Short-Term Securities

    4.8  

Liabilities in Excess of Other Assets

    (4.6

 

 
(a) 

Excludes short-term securities.

 
(b) 

For Fund compliance purposes, the Fund’s sector classifications refer to one or more of the sector sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such sector sub-classifications for reporting ease.

 

 

 

 

U N D   S U M M A R Y

  11


Fund Summary  as of November 30, 2022   

BlackRock Technology Opportunities Fund

 

Investment Objective

BlackRock Technology Opportunities Fund’s (the “Fund”) investment objective is to provide long-term capital appreciation.

Portfolio Management Commentary

How did the Fund perform?

For the six-month period ended November 30, 2022, the Fund underperformed its benchmark, the MSCI All-Country World Information Technology Index.

What factors influenced performance?

Stock selection within the internet sub-sector was the largest detractor from relative performance. Among individual securities, an off-benchmark position in South Korean internet company Kakao was the largest detractor, as high inflation dampened consumer sentiment and led to cuts in advertising spending from its customers as they attempted to protect their profit margins. An off-benchmark position in workplace collaboration software provider Atlassian was another notable detractor after it reported weak earnings during the period and suggested that poor consumer sentiment led to reduced sales conversions. Lastly, an off-benchmark position in electric vehicle manufacturer Tesla notably detracted after investors grew concerned that a market downturn would have a negative impact on EV demand.

By contrast, the Fund’s overweight allocation to the internet sub-sector was the largest contributor to relative performance. At the individual security level, an off-benchmark position in Wolfspeed was the largest contributor, as the semiconductor manufacturer reported strong earnings and revenues above analyst expectations. It also raised its three-year revenue projections, highlighting its robust demand pipeline. Additionally, an overweight position in credit reporting specialist Fair Isaac was a notable contributor, as the company cited higher-than-expected transaction volume and provided a positive outlook for 2023. The Fund’s lack of a position in benchmark component Intel also contributed to performance after the semiconductor company struggled to keep up with demand in its data center business.

Describe recent portfolio activity.

Overall, the Fund increased its exposure to stable, quality stocks, adding more defensive characteristics to the portfolio in the midst of broader market volatility, and it exited out of select high-multiple stocks with negative earnings. The Fund’s exposure to semiconductor companies decreased from 27% to 25% during the period, while allocations to internet companies fell from 12% to 10%. Meanwhile, exposure to several sub-sector increased, including hardware (15% to 17%), software (25% to 26%), and services (16% to 17%). The Fund’s 2% allocation to content & infrastructure stocks remained unchanged during the period.

Describe portfolio positioning at period end.

The Fund finished the period overweight in the internet and semiconductors sub-sectors, and underweight in hardware and software. This positioning reflected the investment adviser’s view favoring value-oriented, higher-quality companies in light of higher interest rates and inflation expectations as well as additional uncertainties from slowing economic growth and ongoing geopolitical instability. While reducing its exposure to long-duration assets such as non-profitable technology stocks, the Fund has maintained its exposure to long-term secular themes within the portfolio, such as artificial intelligence, cloud computing, and electric vehicles, as well as more nascent themes such as the metaverse, space, and quantum computing. Although growth assets have been penalized due to rising rate concerns, the fundamentals of the companies within the portfolio remain compelling. The secular growth trends driving technology are multi-year transformations that are expected to persist regardless of the macroeconomic environment or geopolitical risk.

The views expressed reflect the opinions of BlackRock as of the date of this report and are subject to change based on changes in market, economic or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

 

 

 

12  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Fund Summary  as of November 30, 2022 (continued)   

BlackRock Technology Opportunities Fund

 

Performance

 

          Average Annual Total Returns(a)(b)  
          1 Year     5 Years           10 Years  
     6-Month
Total
Returns
    Without
Sales
Charge
    With
Sales
Charge
    Without
Sales
Charge
    With
Sales
Charge
           Without
Sales
Charge
    With
Sales
Charge
 

Institutional

    (9.07 )%      (38.76 )%      N/A       13.19     N/A         18.26     N/A  

Service

    (9.20     (38.92     N/A       12.91       N/A         17.99       N/A  

Investor A

    (9.21     (38.91     (42.12 )%      12.90       11.69       17.94       17.31

Investor C

    (9.56     (39.36     (39.94     12.07       12.07         17.19       17.19  

Class K

    (9.04     (38.72     N/A       13.24       N/A         18.29       N/A  

Class R

    (9.29     (39.06     N/A       12.62       N/A         17.63       N/A  

MSCI All-Country World Information Technology Index(c)

    (4.59     (22.98     N/A       13.94       N/A               16.55       N/A  

 

(a) 

Assuming maximum sales charges, if any. Average annual total returns with and without sales charges reflect reductions for distribution and service fees. See “About Fund Performance” for a detailed description of share classes, including any related sales charges and fees, and how performance was calculated for certain share classes.

 
(b) 

Under normal market conditions, the Fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in equity securities issued by U.S. and non-U.S. technology companies in all market capitalization ranges, selected for their rapid and sustainable growth potential from the development, advancement and use of technology. The Fund’s total returns prior to December 30, 2017 are the returns of the Fund when it followed different investment strategies under the name BlackRock Science & Technology Opportunities Portfolio.

 
(c) 

An index that includes large- and mid-cap securities across certain Developed Markets countries and certain Emerging Markets countries. All securities in the index are classified in the Information Technology sector as per the Global Industry Classification Standard.

 

N/A - Not applicable as share class and index do not have a sales charge.

Past performance is not an indication of future results.

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

Expense Example

 

    Actual           Hypothetical 5% Return           
     Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
    

Expenses   

Paid During   

the Period(a)

           Beginning
Account Value
(06/01/22)
     Ending
Account Value
(11/30/22)
    

Expenses   

Paid During   

the Period(a)

       Annualized
Expense
Ratio
 

Institutional

  $ 1,000.00      $ 909.30      $ 4.40          $ 1,000.00      $ 1,020.46      $ 4.66             0.92

Service

    1,000.00        908.00        5.60            1,000.00        1,019.20        5.92             1.17  

Investor A

    1,000.00        907.90        5.60            1,000.00        1,019.20        5.92             1.17  

Investor C

    1,000.00        904.40        9.17            1,000.00        1,015.44        9.70             1.92  

Class K

    1,000.00        909.60        4.15            1,000.00        1,020.72        4.41             0.87  

Class R

    1,000.00        907.10        6.79                  1,000.00        1,017.95        7.18             1.42  

 

(a) 

For each class of the Fund, expenses are equal to the annualized expense ratio for the class, multiplied by the average account value over the period, multiplied by 183/365 (to reflect the one-half year period shown).

 

See “Disclosure of Expenses” for further information on how expenses were calculated.

 

 

 

U N D   S U M M A R Y

  13


Fund Summary  as of November 30, 2022 (continued)    BlackRock Technology Opportunities Fund

 

Portfolio Information

TEN LARGEST HOLDINGS

Security(a)   Percent of
Net Assets
 

Apple Inc.

    9.3

Microsoft Corp.

    7.8  

Mastercard, Inc., Class A

    3.6  

Visa, Inc., Class A

    3.3  

ASML Holding NV

    3.3  

Tesla, Inc.

    3.1  

Alphabet, Inc., Class A

    2.6  

Cadence Design Systems, Inc.

    2.6  

Wolfspeed, Inc.

    2.6  

Automatic Data Processing, Inc.

    2.1  

 

INDUSTRY ALLOCATION

Industry(b)   Percent of
Net Assets
 

Semiconductors & Semiconductor Equipment

    25.9

Software

    25.4  

IT Services

    16.0  

Technology Hardware, Storage & Peripherals

    9.8  

Interactive Media & Services

    4.0  

Internet & Direct Marketing Retail

    3.7  

Automobiles

    3.5  

Entertainment

    2.7  

Electronic Equipment, Instruments & Components

    2.1  

Hotels, Restaurants & Leisure

    1.3  

Other (each representing less than 1%)

    5.1  

Short-Term Securities

    3.2  

Liabilities in Excess of Other Assets

    (2.7

 

 
  (a) 

Excludes short-term securities.

 
  (b) 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or ratings group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

 

14  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


About Fund Performance

 

Institutional and Class K Shares are not subject to any sales charge. These shares bear no ongoing distribution or service fees and are available only to certain eligible investors. BlackRock Capital Appreciation Fund, Inc.’s Class K Shares performance shown prior to the Class K Shares inception date of August 15, 2016 is that of BlackRock Shares. BlackRock Health Sciences Opportunities Portfolio’s Class K Shares performance shown prior to the Class K Shares inception date of June 8, 2016 is that of Investor A Shares. BlackRock Mid-Cap Growth Equity Portfolio’s Class K Shares performance shown prior to the Class K Shares inception date of March 28, 2016 is that of Institutional Shares. BlackRock Technology Opportunities Fund’s Class K Shares performance shown prior to the Class K Shares inception date of December 10, 2019 is that of Institutional Shares. The performance of each Fund’s Class K Shares would be substantially similar to Investor A Shares or Institutional Shares, as applicable, because the share classes of a Fund invest in the same portfolio of securities and performance would only differ to the extent that Class K Shares and Investor A Shares or Institutional Shares, as applicable, have different expenses. The actual returns of Class K Shares would have been higher than those of the Investor A Shares or Institutional Shares, as applicable, because Class K Shares have lower expenses than the Investor A Shares and Institutional Shares.

Service Shares (not available in BlackRock Capital Appreciation Fund, Inc. and BlackRock Infrastructure Sustainable Opportunities Fund) are not subject to any sales charge. These shares are subject to a service fee of 0.25% per year (but no distribution fee) and are only available to certain eligible investors.

Investor A Shares are subject to a maximum initial sales charge (front-end load) of 5.25% and a service fee of 0.25% per year (but no distribution fee). Certain redemptions of these shares may be subject to a contingent deferred sales charge (“CDSC”) where no initial sales charge was paid at the time of purchase. These shares are generally available through financial intermediaries.

Investor C Shares (not available in BlackRock Infrastructure Sustainable Opportunities Fund) are subject to a 1.00% CDSC if redeemed within one year of purchase. In addition, these shares are subject to a distribution fee of 0.75% per year and a service fee of 0.25% per year. These shares are generally available through financial intermediaries. These shares automatically convert to Investor A Shares after approximately eight years.

Class R Shares (not available in BlackRock Infrastructure Sustainable Opportunities Fund) are not subject to any sales charge. These shares are subject to a distribution fee of 0.25% per year and a service fee of 0.25% per year. These shares are available only to certain employer-sponsored retirement plans.

Past performance is not an indication of future results. Financial markets have experienced extreme volatility and trading in many instruments has been disrupted. These circumstances may continue for an extended period of time and may continue to affect adversely the value and liquidity of each Fund’s investments. As a result, current performance may be lower or higher than the performance data quoted. Refer to blackrock.com to obtain performance data current to the most recent month-end. Performance results do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the redemption of Fund shares. Figures shown in the performance tables assume reinvestment of all distributions, if any, at net asset value (“NAV”) on the ex-dividend date or payable date, as applicable. Investment return and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Distributions paid to each class of shares will vary because of the different levels of service, distribution and transfer agency fees applicable to each class, which are deducted from the income available to be paid to shareholders.

BlackRock Advisors, LLC (the “Manager”), each Fund’s investment adviser, has contractually and/or voluntarily agreed to waive and/or reimburse a portion of each Fund’s expenses. Without such waiver(s) and/or reimbursement(s), each Fund’s performance would have been lower. With respect to each Fund’s voluntary waiver(s), if any, the Manager is under no obligation to waive and/or reimburse or to continue waiving and/or reimbursing its fees and such voluntary waiver(s) may be reduced or discontinued at any time. With respect to each Fund’s contractual waiver(s), if any, the Manager is under no obligation to continue waiving and/or reimbursing its fees after the applicable termination date of such agreement. See the Notes to Financial Statements for additional information on waivers and/or reimbursements.

Disclosure of Expenses

Shareholders of each Fund may incur the following charges: (a) transactional expenses, such as sales charges; and (b) operating expenses, including investment advisory fees, administration fees, service and distribution fees, including 12b-1 fees, acquired fund fees and expenses, and other fund expenses. The expense examples shown (which are based on a hypothetical investment of $1,000 invested at the beginning of the period and held through the end of the period) are intended to assist shareholders both in calculating expenses based on an investment in each Fund and in comparing these expenses with similar costs of investing in other mutual funds.

The expense examples provide information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. In order to estimate the expenses a shareholder paid during the period covered by this report, shareholders can divide their account value by $1,000 and then multiply the result by the number corresponding to their Fund and share class under the heading entitled “Expenses Paid During the Period.”

The expense examples also provide information about hypothetical account values and hypothetical expenses based on a Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. In order to assist shareholders in comparing the ongoing expenses of investing in these Funds and other funds, compare the 5% hypothetical examples with the 5% hypothetical examples that appear in shareholder reports of other funds.

The expenses shown in the expense examples are intended to highlight shareholders’ ongoing costs only and do not reflect transactional expenses, such as sales charges, if any. Therefore, the hypothetical examples are useful in comparing ongoing expenses only and will not help shareholders determine the relative total expenses of owning different funds. If these transactional expenses were included, shareholder expenses would have been higher.

 

 

B O U T  U N D  E R F O R M A  N C E  /  D I S C L O S  U R E  O F  X P E N S E S

  15


Derivative Financial Instruments

 

The Funds may invest in various derivative financial instruments. These instruments are used to obtain exposure to a security, commodity, index, market, and/or other assets without owning or taking physical custody of securities, commodities and/or other referenced assets or to manage market, equity, credit, interest rate, foreign currency exchange rate, commodity and/or other risks. Derivative financial instruments may give rise to a form of economic leverage and involve risks, including the imperfect correlation between the value of a derivative financial instrument and the underlying asset, possible default of the counterparty to the transaction or illiquidity of the instrument. Pursuant to Rule 18f-4 under the 1940 Act, among other things, The Fund must either use derivative financial instruments with embedded leverage in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. The Funds’ successful use of a derivative financial instrument depends on the investment adviser’s ability to predict pertinent market movements accurately, which cannot be assured. The use of these instruments may result in losses greater than if they had not been used, may limit the amount of appreciation a Fund can realize on an investment and/or may result in lower distributions paid to shareholders. The Funds’ investments in these instruments, if any, are discussed in detail in the Notes to Financial Statements.

 

 

16  

2 0 2 2  B L A C K O C K   E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) 

November 30, 2022

  

BlackRock Capital Appreciation Fund, Inc.

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Aerospace & Defense — 2.5%

 

TransDigm Group, Inc.

    115,526     $ 72,608,091  
   

 

 

 
Automobiles — 2.7%            

Tesla, Inc.(a)

    411,354       80,090,624  
   

 

 

 
Capital Markets — 5.4%            

Blackstone, Inc., NVS

    470,453       43,060,563  

MSCI, Inc.

    66,457       33,748,858  

S&P Global, Inc.

    240,053       84,690,699  
   

 

 

 
      161,500,120  
Chemicals — 1.3%            

Sherwin-Williams Co.

    156,309       38,949,077  
   

 

 

 

Commercial Services & Supplies — 1.9%

   

Cintas Corp.

    69,624       32,150,971  

Waste Connections, Inc.

    171,201       24,738,544  
   

 

 

 
      56,889,515  
Equity Real Estate Investment Trusts (REITs) — 0.6%        

Prologis, Inc.

    141,430       16,659,040  
   

 

 

 
Health Care Equipment & Supplies — 4.8%            

Boston Scientific Corp.(a)

    670,447       30,351,136  

IDEXX Laboratories, Inc.(a)

    110,795       47,184,266  

Intuitive Surgical, Inc.(a)

    240,043       64,905,227  
   

 

 

 
      142,440,629  
Health Care Providers & Services — 3.5%            

UnitedHealth Group, Inc.

    189,480       103,789,565  
   

 

 

 
Hotels, Restaurants & Leisure — 3.2%            

Chipotle Mexican Grill, Inc.(a)

    25,979       42,266,794  

Evolution AB(b)

    511,942       52,732,050  
   

 

 

 
      94,998,844  
Interactive Media & Services — 6.4%            

Alphabet, Inc., Class A(a)

    1,382,914       139,660,485  

Match Group, Inc.(a)

    961,057       48,591,042  
   

 

 

 
      188,251,527  
Internet & Direct Marketing Retail — 6.4%            

Amazon.com, Inc.(a)

    1,968,447       190,033,873  
   

 

 

 
IT Services — 8.0%            

Adyen NV(a)(b)

    7,626       12,013,381  

Mastercard, Inc., Class A

    215,172       76,687,301  

MongoDB, Inc.(a)

    26,790       4,090,565  

Visa, Inc., Class A

    665,529       144,419,793  
   

 

 

 
      237,211,040  
Life Sciences Tools & Services — 5.3%            

Danaher Corp.

    244,437       66,831,520  

Lonza Group AG, Registered Shares

    71,500       37,615,613  

Thermo Fisher Scientific, Inc.

    94,801       53,109,416  
   

 

 

 
      157,556,549  
Oil, Gas & Consumable Fuels — 1.8%            

Cheniere Energy, Inc.

    241,033       42,267,547  

EQT Corp.

    289,301       12,269,255  
   

 

 

 
      54,536,802  

Pharmaceuticals — 3.3%

   

AstraZeneca PLC, ADR

    754,701       51,297,027  

Zoetis, Inc.

    306,735       47,280,133  
   

 

 

 
      98,577,160  
Security   Shares     Value  
Semiconductors & Semiconductor Equipment — 10.5%        

Advanced Micro Devices, Inc.(a)

    656,775     $ 50,985,443  

ASML Holding NV, Registered Shares

    165,718       100,776,430  

KLA Corp.

    140,070       55,068,520  

Marvell Technology, Inc.

    1,293,326       60,165,526  

NVIDIA Corp.

    260,951       44,160,738  
   

 

 

 
      311,156,657  
Software — 17.5%            

Bill.com Holdings, Inc.(a)

    184,566       22,225,438  

Cadence Design Systems, Inc.(a)

    333,461       57,368,630  

Intuit, Inc.

    296,653       120,912,796  

Microsoft Corp.

    993,161       253,395,098  

ServiceNow, Inc.(a)

    153,162       63,761,341  
   

 

 

 
      517,663,303  
Technology Hardware, Storage & Peripherals — 8.7%            

Apple Inc.

    1,740,317       257,619,125  
   

 

 

 
Textiles, Apparel & Luxury Goods — 4.8%            

LVMH Moet Hennessy Louis Vuitton SE

    98,484       76,426,421  

Nike, Inc., Class B

    591,008       64,827,667  
   

 

 

 
      141,254,088  
   

 

 

 
Total Common Stocks — 98.6%
    (Cost: $1,926,213,907)
        2,921,785,629  
   

 

 

 
Preferred Securities            
Preferred Stocks — 0.9%            
Interactive Media & Services — 0.9%            

Bytedance Ltd., Series E-1(a)(c)(d)

    177,291       28,879,994  
   

 

 

 
Total Long-Term Investments — 99.5%
    (Cost: $1,945,640,423)
        2,950,665,623  
   

 

 

 
Short-Term Securities            
Money Market Funds — 0.6%            

BlackRock Liquidity Funds, T-Fund, Institutional
Class, 3.57%(e)(f)

    17,361,998       17,361,998  
   

 

 

 
Total Short-Term Securities — 0.6%
    (Cost: $17,361,998)
        17,361,998  
Total Investments — 100.1%
    (Cost: $1,963,002,421)
        2,968,027,621  
Liabilities in Excess of Other Assets — (0.1)%     (4,217,434)  
   

 

 

 
Net Assets — 100.0%         $2,963,810,187  
   

 

 

 

 

(a)   

Non-income producing security.

(b)   

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(c)   

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)   

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $28,879,994, representing 1.0% of its net assets as of period end, and an original cost of $19,426,516.

(e)   

Affiliate of the Fund.

(f)   

Annualized 7-day yield as of period end.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  17


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Capital Appreciation Fund, Inc.

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
05/31/22
    Purchases
at Cost
    Proceeds
from Sale
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
11/30/22
    Shares
Held at
11/30/22
    Income    

Capital

Gain
Distributions
from Underlying
Funds

 

BlackRock Liquidity Funds,

                 

T-Fund, Institutional Class

  $ 95,737,315     $     $ (78,375,317 )(a)    $     $     $ 17,361,998       17,361,998     $ 721,813     $         —  

SL Liquidity Series, LLC,

                 

Money Market Series(b)

    11,761,599             (11,763,390 )(a)      3,949       (2,158                 30,342 (c)        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ 3,949     $ (2,158   $ 17,361,998       $ 752,155     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

As of period end, the entity is no longer held.

 
  (c) 

Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 72,608,091        $                 —        $             —        $ 72,608,091  

Automobiles

     80,090,624                            80,090,624  

Capital Markets

     161,500,120                            161,500,120  

Chemicals

     38,949,077                            38,949,077  

Commercial Services & Supplies

     56,889,515                            56,889,515  

Equity Real Estate Investment Trusts (REITs)

     16,659,040                            16,659,040  

Health Care Equipment & Supplies

     142,440,629                            142,440,629  

Health Care Providers & Services

     103,789,565                            103,789,565  

Hotels, Restaurants & Leisure

     42,266,794          52,732,050                   94,998,844  

Interactive Media & Services

     188,251,527                            188,251,527  

Internet & Direct Marketing Retail

     190,033,873                            190,033,873  

IT Services

     225,197,659          12,013,381                   237,211,040  

Life Sciences Tools & Services

     119,940,936          37,615,613                   157,556,549  

Oil, Gas & Consumable Fuels

     54,536,802                            54,536,802  

Pharmaceuticals

     98,577,160                            98,577,160  

Semiconductors & Semiconductor Equipment

     311,156,657                            311,156,657  

Software

     517,663,303                            517,663,303  

Technology Hardware, Storage & Peripherals

     257,619,125                            257,619,125  

Textiles, Apparel & Luxury Goods

     64,827,667          76,426,421                   141,254,088  

Preferred Securities

                       28,879,994          28,879,994  

Short-Term Securities

                 

Money Market Funds

     17,361,998                            17,361,998  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 2,760,360,162        $ 178,787,465        $ 28,879,994        $ 2,968,027,621  
  

 

 

      

 

 

      

 

 

      

 

 

 

See notes to financial statements.

 

 

18  

2 0 2 2  B L A C K O C K   E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) 

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Biotechnology — 21.4%

 

AbbVie, Inc.

    1,695,600     $ 273,296,808  

Alkermes PLC(a)(b)

    356,424       8,832,187  

Alnylam Pharmaceuticals, Inc.(a)

    250,177       55,186,544  

Ambrx Biopharma, Inc., ADR(a)

    842,148       412,610  

Amgen, Inc.

    1,087,435       311,441,384  

Arcutis Biotherapeutics, Inc.(a)(b)

    799,932       13,782,828  

Argenx SE, ADR(a)

    117,442       46,738,393  

Biogen, Inc.(a)

    457,568       139,636,027  

BioMarin Pharmaceutical, Inc.(a)

    491,040       49,585,219  

BioNTech SE, ADR

    137,130       22,903,453  

Blueprint Medicines Corp.(a)(b)

    223,375       10,675,091  

Cerevel Therapeutics Holdings, Inc.(a)(b)

    312,854       9,060,252  

Decibel Therapeutics, Inc.(a)(b)

    897,801       2,756,249  

Design Therapeutics, Inc.(a)(b)

    257,492       3,604,888  

Enanta Pharmaceuticals, Inc.(a)

    57,153       2,502,730  

Exact Sciences Corp.(a)

    263,958       11,864,912  

Genmab A/S(a)

    42,470       19,680,384  

Genmab A/S, ADR(a)(b)

    289,405       13,466,015  

Gilead Sciences, Inc.

    2,619,182       230,042,755  

Horizon Therapeutics PLC(a)

    248,545       24,926,578  

Imago Biosciences, Inc.(a)(b)

    907,400       32,385,106  

Immuneering Corp., Class A(a)

    264,380       1,715,826  

Immunocore Holdings PLC, ADR(a)(b)

    181,355       11,390,908  

Incyte Corp.(a)

    458,365       36,517,940  

Ionis Pharmaceuticals, Inc.(a)

    293,400       11,967,786  

Karuna Therapeutics, Inc.(a)(b)

    58,390       13,739,751  

Legend Biotech Corp., ADR(a)

    227,561       11,721,667  

Mirati Therapeutics, Inc.(a)(b)

    69,495       6,350,453  

Moderna, Inc.(a)(b)

    570,284       100,318,659  

Monte Rosa Therapeutics, Inc.(a)(b)

    533,603       4,524,953  

MoonLake Immunotherapeutics(a)(b)

    226,542       2,181,600  

Neurocrine Biosciences, Inc.(a)

    354,880       45,091,053  

Nuvalent, Inc., Class A(a)

    176,992       5,819,497  

PMV Pharmaceuticals, Inc.(a)(b)

    306,148       3,055,357  

Prime Medicine, Inc.(a)(b)

    360,982       6,205,281  

Prothena Corp. PLC(a)

    137,132       8,572,121  

PTC Therapeutics, Inc.(a)

    134,325       5,573,144  

Regeneron Pharmaceuticals, Inc.(a)

    169,782       127,625,129  

REVOLUTION Medicines, Inc.(a)

    305,798       7,213,775  

Rhythm Pharmaceuticals, Inc.(a)

    756,852       20,260,928  

Rocket Pharmaceuticals, Inc.(a)

    209,841       3,961,798  

Sage Therapeutics, Inc.(a)(b)

    343,935       14,115,092  

Sarepta Therapeutics, Inc.(a)(b)

    301,019       36,968,143  

Seagen, Inc.(a)

    341,700       41,478,963  

Sigilon Therapeutics, Inc.(a)(b)

    332,626       138,605  

Tenaya Therapeutics, Inc.(a)

    431,076       1,142,351  

TScan Therapeutics, Inc.(a)

    551,194       1,185,067  

Ultragenyx Pharmaceutical, Inc.(a)

    99,990       3,629,637  

Vertex Pharmaceuticals, Inc.(a)

    714,739       226,143,420  
   

 

 

 
      2,041,389,317  
Diversified Financial Services — 0.1%            

Health Sciences Acquisitions Corp. 2(a)

    262,308       2,596,849  

MedTech Acquisition Corp., Class A(a)

    831,621       8,357,791  
   

 

 

 
      10,954,640  
Health Care Equipment & Supplies — 19.4%        

Abbott Laboratories

    2,585,443       278,141,958  

ABIOMED, Inc.(a)

    243,643       92,045,889  

Alcon, Inc.

    1,123,798       77,418,444  

Align Technology, Inc.(a)

    63,695       12,526,259  

Bausch + Lomb Corp.(a)(b)

    1,268,266       19,188,865  

 

Security   Shares     Value  
Health Care Equipment & Supplies (continued)        

Baxter International, Inc.

    1,168,311     $ 66,044,621  

Boston Scientific Corp.(a)

    6,434,908       291,308,285  

Cooper Cos., Inc.

    103,037       32,595,755  

Dexcom, Inc.(a)

    832,633       96,818,565  

Edwards Lifesciences Corp.(a)

    607,879       46,958,653  

Glaukos Corp.(a)

    77,335       3,601,491  

Insulet Corp.(a)(b)

    137,677       41,216,364  

Intuitive Surgical, Inc.(a)

    717,534       194,014,018  

iRhythm Technologies, Inc.(a)

    36,545       3,985,232  

Masimo Corp.(a)

    99,835       14,470,085  

Medtronic PLC

    2,002,837       158,304,236  

Nevro Corp.(a)

    701,343       32,759,732  

Novocure Ltd.(a)(b)

    188,610       14,492,792  

Omnicell, Inc.(a)

    110,704       5,713,433  

Penumbra, Inc.(a)(b)

    300,145       62,883,379  

ResMed, Inc.

    334,912       77,096,742  

Stryker Corp.

    834,385       195,154,308  

Zimmer Biomet Holdings, Inc.

    239,113       28,717,471  
   

 

 

 
      1,845,456,577  
Health Care Providers & Services — 21.4%            

Agiliti, Inc.(a)(b)

    631,112       10,419,659  

Amedisys, Inc.(a)

    367,363       33,463,096  

AmerisourceBergen Corp.

    869,425       148,402,153  

Centene Corp.(a)

    1,070,505       93,187,460  

Cigna Corp.

    687,981       226,270,071  

Elevance Health, Inc.

    562,502       299,768,566  

Encompass Health Corp.

    749,047       43,804,269  

Guardant Health, Inc.(a)(b)

    208,529       10,914,408  

HCA Healthcare, Inc.

    132,351       31,793,357  

LHC Group, Inc.(a)(b)

    368,131       60,156,287  

McKesson Corp.

    382,710       146,072,753  

Quest Diagnostics, Inc.

    647,908       98,371,872  

UnitedHealth Group, Inc.

    1,517,369       831,154,043  
   

 

 

 
      2,033,777,994  
Life Sciences Tools & Services — 11.5%            

10X Genomics, Inc., Class A(a)

    166,778       6,447,638  

Agilent Technologies, Inc.

    1,016,163       157,484,942  

Avantor, Inc.(a)

    1,282,066       28,564,431  

Danaher Corp.

    1,062,813       290,583,702  

ICON PLC(a)(b)

    130,435       28,100,916  

IQVIA Holdings, Inc.(a)

    394,897       86,095,444  

IsoPlexis Corp.(a)(b)

    554,988       754,784  

Mettler-Toledo International, Inc.(a)

    16,425       24,137,523  

Nautilus Biotechnology, Inc.(a)

    308,716       558,776  

QIAGEN NV(a)

    406,956       20,160,600  

Rapid Micro Biosystems, Inc., Class A(a)(b)

    377,456       773,785  

Thermo Fisher Scientific, Inc.

    673,852       377,505,367  

Waters Corp.(a)

    175,735       60,909,751  

West Pharmaceutical Services, Inc.

    47,940       11,249,600  
   

 

 

 
      1,093,327,259  
Pharmaceuticals — 23.5%            

Arvinas, Inc.(a)

    171,970       7,057,649  

AstraZeneca PLC

    946,679       128,124,156  

AstraZeneca PLC, ADR

    398,642       27,095,697  

Bristol-Myers Squibb Co.

    615,670       49,425,987  

Catalent, Inc.(a)

    243,855       12,224,451  

Daiichi Sankyo Co. Ltd.

    1,783,500       59,070,522  

Eli Lilly & Co.(b)

    1,425,371       528,926,671  

Johnson & Johnson

    2,800,738       498,531,364  

Merck & Co., Inc.

    3,535,314       389,308,778  

Pfizer, Inc.

    5,311,709       266,275,972  

 

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  19


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

(Percentages shown are based on Net Assets)

 

Security        Shares     Value  
Pharmaceuticals (continued)                

Roche Holding AG, NVS

      134,294     $ 43,863,629  

Sanofi

      388,736       35,114,255  

Zoetis, Inc.

      1,215,671       187,383,528  
     

 

 

 
        2,232,402,659  
     

 

 

 

Total Common Stocks — 97.3%
(Cost: $5,738,749,258)

 

    9,257,308,446  
     

 

 

 
          Par
(000)
        

Other Interests(a)(c)(d)

 

Afferent Pharmaceuticals, Inc., Series C (Acquired 06/30/15, cost $0)

  USD     3,421       2,599,686  

Affinivax Inc. (Acquired 08/19/22, cost $0)

      123       1,586,886  
     

 

 

 

Total Other Interests — 0.1%
(Cost: $0)

 

    4,186,572  
     

 

 

 
          Shares         

Preferred Securities

 

Preferred Stocks — 0.6%                
Biotechnology — 0.2%                

Cellarity, Inc., Series B (Acquired 01/15/21, cost $5,149,998)(a)(c)(d)

      858,333       3,398,999  

Goldfinch Bio, Inc., Series B (Acquired 06/26/20 -03/21/22,
cost $4,152,184)(a)(c)(d)

      3,518,800       1,126,016  

Laronde, Inc., Series B (Acquired 07/28/21,
cost $10,822,560)(a)(c)(d)

      386,520       9,740,304  

Neurogene, Inc., Series B (Acquired 12/14/20 -09/22/21,
cost $5,099,600)(a)(c)(d)

      2,090,000       5,099,600  
     

 

 

 
        19,364,919  
Health Care Equipment & Supplies — 0.2%        

Exo Imaging, Inc., Series C (Acquired 06/24/21, cost $11,178,997)(a)(c)(d)

      1,908,330       7,060,821  

Quanta Dialysis Technologies Ltd., Series D (Acquired 06/18/21,
cost $9,727,321)(a)(c)(d)

      80,024,425       6,365,663  

Swift Health Systems, Inc., Series D (Acquired 08/27/21,
cost $5,271,070)(a)(c)(d)

      1,700,345       3,264,662  
     

 

 

 
        16,691,146  
Pharmaceuticals — 0.0%                

Insitro, Series C (Acquired 03/10/21, cost
$10,839,964)(a)(c)(d)

      592,636       7,046,442  
     

 

 

 
Software — 0.2%                

Carbon Health Technologies, Inc. (Acquired 07/09/21,
cost $16,855,000)(a)(c)(d)

      16,855       16,891,744  
     

 

 

 

Total Preferred Securities — 0.6%
(Cost: $79,096,694)

 

    59,994,251  
     

 

 

 
Security   Shares     Value  

Warrants(a)

 

Biotechnology — 0.0%            

Nuvation Bio, Inc. (Issued/Exercisable 08/17/20, 1 Share for 1 Warrant, Expires 07/07/27, Strike Price USD 0.00)

    77,354     $ 9,901  
   

 

 

 
Health Care Providers & Services — 0.0%        

CareMax, Inc. (Issued/Exercisable 09/15/20, 1 Share for 1 Warrant, Expires 07/16/25, Strike

   

Price USD 0.00)

    88,432       48,638  
   

 

 

 

Total Warrants — 0.0%
(Cost: $306,235)

 

    58,539  
   

 

 

 

Total Long-Term Investments — 98.0%
(Cost: $5,818,152,187)

 

    9,321,547,808  
   

 

 

 

Short-Term Securities

 

Money Market Funds — 3.4%            

BlackRock Liquidity Funds, T-Fund, Institutional
Class, 3.57%(e)(f)

    154,471,762       154,471,762  

SL Liquidity Series, LLC, Money Market Series, 4.05%(e)(f)(g)

    165,225,283       165,159,193  
   

 

 

 

Total Short-Term Securities — 3.4%
(Cost: $319,601,508)

 

    319,630,955  
   

 

 

 

Total Investments — 101.4%
(Cost: $6,137,753,695)

 

    9,641,178,763  

Liabilities in Excess of Other Assets — (1.4)%

 

    (130,915,453
   

 

 

 

Net Assets — 100.0%

 

  $ 9,510,263,310  
   

 

 

 

 

(a)  

Non-income producing security.

(b)  

All or a portion of this security is on loan.

(c)  

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)  

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $64,180,823, representing 0.7% of its net assets as of period end, and an original cost of $79,096,694.

(e)  

Affiliate of the Fund.

(f)  

Annualized 7-day yield as of period end.

(g)  

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

 

 

20  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
05/31/22
     Purchases
at Cost
     Proceeds
from Sale
     Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
11/30/22
     Shares
Held at
11/30/22
     Income      Capital
Gain
Distributions
from
Underlying
Funds
 

BlackRock Liquidity Funds, T-Fund, Institutional Class

   $  371,570,572      $      $ (217,098,810 )(a)    $      $      $  154,471,762        154,471,762      $  1,504,513      $  

SL Liquidity Series, LLC, Money Market Series

     130,080,903        35,093,374 (a)              (15,756      672        165,159,193        165,225,283        707,008 (b)         
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ (15,756    $  672      $ 319,630,955         $ 2,211,521      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 

 

  (b) 

Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

Forward Foreign Currency Exchange Contracts

 

Currency Purchased      Currency Sold      Counterparty    Settlement
Date
     Unrealized
Appreciation
(Depreciation)
 

EUR

     13,687,000      USD      13,678,481      JPMorgan Chase Bank N.A.      12/15/22      $ 583,720  

GBP

     41,086,000      USD      47,204,831      JPMorgan Chase Bank N.A.      12/15/22        2,344,328  
                 

 

 

 
                  $ 2,928,048  
                 

 

 

 

USD

     8,189,544      CHF      7,735,600      Deutsche Bank AG      12/15/22        (3,071

USD

     53,230,298      EUR      52,211,700      Bank of New York Mellon      12/15/22        (1,175,616

USD

     71,615,362      GBP      64,859,000      State Street Bank & Trust Co.      12/15/22        (6,603,714

USD

     44,254,136      GBP      37,750,000      UBS AG      12/15/22        (1,271,852
                 

 

 

 
                    (9,054,253
                 

 

 

 
                  $ (6,126,205
                 

 

 

 

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Assets — Derivative Financial Instruments

                    

Forward foreign currency exchange contracts Unrealized appreciation on forward foreign currency exchange contracts

   $  —      $  —      $  —      $  2,928,048      $  —      $  —      $  2,928,048  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities — Derivative Financial Instruments

                    

Forward foreign currency exchange contracts Unrealized depreciation on forward foreign currency exchange contracts

   $      $      $      $ 9,054,253      $      $      $ 9,054,253  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  21


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

 

For the period ended November 30, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

 

      Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Net Realized Gain (Loss) from

                    

Forward foreign currency exchange contracts

   $      $  —      $      $ 12,062,437      $  —      $  —      $ 12,062,437  

Options purchased(a)

                   (425,702                           (425,702
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $      $      $ (425,702    $ 12,062,437      $      $      $ 11,636,735  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on

                    

Forward foreign currency exchange contracts

   $      $      $      $ (11,204,774    $      $      $ (11,204,774
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

Options purchased are included in net realized gain (loss) from investments — unaffiliated.

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

Forward foreign currency exchange contracts

          

Average amounts purchased — in USD

       $142,808,759

Average amounts sold — in USD

       $30,441,656

Options

    

Average value of option contracts purchased

       $— (a)  

 

  (a) 

Derivative not held at any quarter-end. The risk exposure table serves as an indicator of activity during the period.

 

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments – Offsetting as of Period End

The Fund’s derivative assets and liabilities (by type) were as follows:

 

      Assets      Liabilities  

Derivative Financial Instruments

     

Forward foreign currency exchange contracts

   $  2,928,048      $  9,054,253  
  

 

 

    

 

 

 

Total derivative assets and liabilities in the Statements of Assets and Liabilities

   $ 2,928,048      $ 9,054,253  
  

 

 

    

 

 

 

Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”)

             
  

 

 

    

 

 

 

Total derivative assets and liabilities subject to an MNA

   $ 2,928,048      $ 9,054,253  
  

 

 

    

 

 

 

 

 

 

22  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

 

The following table presents the Funds’s derivative assets and liabilities by counterparty net of amounts available for offset under an MNA and net of the related collateral received and pledged by the Funds:

 

Counterparty    Derivative
Assets
Subject to
an MNA by
Counterparty
     Derivatives
Available
for Offset(a)
     Non- Cash
Collateral
Received(b)
     Cash
Collateral
Received(b)
     Net
Amount of
Derivative
Assets(c)
 

JPMorgan Chase Bank N.A

   $  2,928,048      $      $  —      $  —      $  2,928,048  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
Counterparty    Derivative
Liabilities
Subject to
an MNA by
Counterparty
     Derivatives
Available
for Offset(a)
     Non- Cash
Collateral
Pledged(b)
     Cash
Collateral
Pledged(b)
     Net
Amount of
Derivative
Liabilities(d)
 

Bank of New York Mellon

   $ 1,175,616      $      $      $      $ 1,175,616  

Deutsche Bank AG

     3,071                             3,071  

State Street Bank and Trust Co.

     6,603,714                             6,603,714  

UBS AG

     1,271,852                             1,271,852  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 
   $ 9,054,253      $      $      $      $ 9,054,253  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

  (a) 

The amount of derivatives available for offset is limited to the amount of derivative assets and/or liabilities that are subject to an MNA.

 
  (b) 

Excess of collateral received/pledged, if any, from the individual counterparty is not shown for financial reporting purposes.

 
  (c) 

Net amount represents the net amount receivable from the counterparty in the event of default.

 
  (d) 

Net amount represents the net amount payable from the counterparty in the event of default.

 

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  23


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Health Sciences Opportunities Portfolio

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Biotechnology

   $ 2,021,708,933        $ 19,680,384        $        $ 2,041,389,317  

Diversified Financial Services

     10,954,640                            10,954,640  

Health Care Equipment & Supplies

     1,845,456,577                            1,845,456,577  

Health Care Providers & Services

     2,033,777,994                            2,033,777,994  

Life Sciences Tools & Services

     1,093,327,259                            1,093,327,259  

Pharmaceuticals

     1,966,230,097          266,172,562                   2,232,402,659  

Other Interests

                       4,186,572          4,186,572  

Preferred Securities

                       59,994,251          59,994,251  

Warrants

     58,539                            58,539  

Short-Term Securities

                 

Money Market Funds

     154,471,762                            154,471,762  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 9,125,985,801        $ 285,852,946        $ 64,180,823          9,476,019,570  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV(a)

                    165,159,193  
                 

 

 

 
                  $ 9,641,178,763  

Derivative Financial Instruments(b)

                 

Assets

                 

Foreign Currency Exchange Contracts

   $        $ 2,928,048        $        $ 2,928,048  

Liabilities

                 

Foreign Currency Exchange Contracts

              (9,054,253                 (9,054,253
  

 

 

      

 

 

      

 

 

      

 

 

 
   $        $ (6,126,205      $        $ (6,126,205
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a)

Certain investments of the Fund were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 
  (b)

Derivative financial instruments are forward foreign currency exchange contracts. Forward foreign currency exchange contracts are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

24  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited)

November 30,2022

  

BlackRock Infrastructure Sustainable Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Commercial Services & Supplies — 3.8%

   

Smart Metering Systems PLC

    34,778     $ 335,749  
   

 

 

 

Diversified Telecommunication Services — 8.3%

   

Cellnex Telecom SA(a)

    14,802       509,018  

IHS Holding Ltd.(b)(c)

    12,275       88,626  

Infrastrutture Wireless Italiane SpA(a)

    13,418       133,828  
   

 

 

 
      731,472  
Electric Utilities — 26.9%            

CLP Holdings Ltd.

    35,500       257,604  

Constellation Energy Corp.

    1,784       171,478  

EDP - Energias de Portugal SA

    55,573       263,696  

Enel SpA

    83,846       452,331  

Eversource Energy

    3,521       291,750  

Exelon Corp.

    5,567       230,307  

Hydro One Ltd.(a)

    5,334       149,177  

NextEra Energy, Inc.

    974       82,498  

Terna - Rete Elettrica Nazionale

    50,884       389,768  

Xcel Energy, Inc.

    1,194       83,843  
   

 

 

 
      2,372,452  
Equity Real Estate Investment Trusts (REITs) — 15.6%        

Aedifica SA

    1,018       80,221  

Alexandria Real Estate Equities, Inc.

    1,639       255,045  

American Tower Corp.

    1,410       311,963  

Equinix, Inc.

    274       189,238  

Physicians Realty Trust.

    8,848       132,101  

SBA Communications Corp.

    1,368       409,442  
   

 

 

 
      1,378,010  
IT Services — 4.5%            

NEXTDC Ltd.(b)

    57,086       391,676  
   

 

 

 
Multi-Utilities — 9.9%            

Consolidated Edison, Inc.

    888       87,059  

National Grid PLC

    25,014       307,699  

Public Service Enterprise Group, Inc.

    6,458       391,032  

REN - Redes Energeticas Nacionais SGPS SA

    32,541       86,177  
   

 

 

 
      871,967  
Oil, Gas & Consumable Fuels — 1.5%            

Archaea Energy, Inc.(b)

    4,960       128,662  
   

 

 

 
Security   Shares     Value  
Road & Rail — 4.5%            

Canadian Pacific Railway Ltd.

    1,132     $ 92,679  

CSX Corp.

    6,658       217,650  

West Japan Railway Co.

    2,000       85,199  
   

 

 

 
      395,528  
Transportation Infrastructure — 11.7%            

Aena SME SA(a)(b)

    1,420       183,227  

Flughafen Zurich AG, Registered Shares(b)

    1,268       210,836  

Fraport AG Frankfurt Airport Services Worldwide(b)

    8,262       361,586  

Hamburger Hafen und Logistik AG

    6,538       79,305  

Transurban Group

    19,705       192,649  
   

 

 

 
      1,027,603  
Water Utilities — 4.8%            

Severn Trent PLC

    12,857       423,153  
   

 

 

 

Total Long-Term Investments — 91.5% (Cost: $8,630,540)

      8,056,272  
   

 

 

 

Short-Term Securities

 

Money Market Funds — 7.4%            

BlackRock Liquidity Funds, T-Fund, Institutional Class, 3.57%(d)(e)

    585,752       585,752  

SL Liquidity Series, LLC, Money Market Series, 4.05%(d)(e)(f)

    68,022       67,995  
   

 

 

 

Total Short-Term Securities — 7.4%
(Cost: $653,749)

      653,747  
   

 

 

 

Total Investments — 98.9%
(Cost: $9,284,289)

      8,710,019  

Other Assets Less Liabilities — 1.1%

      97,107  
   

 

 

 

Net Assets — 100.0%

    $ 8,807,126  
   

 

 

 

 

(a)

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(b)

Non-income producing security.

(c)

All or a portion of this security is on loan.

(d) 

Affiliate of the Fund.

(e)

Annualized 7-day yield as of period end.

(f)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer    Value at
05/31/22
     Purchases
at Cost
     Proceeds
from Sale
     Net
Realized
Gain (Loss)
     Change in
Unrealized
Appreciation
(Depreciation)
     Value at
11/30/22
     Shares
Held at
11/30/22
     Income     

Capital

Gain
Distributions
from
Underlying
Funds

 

BlackRock Liquidity Funds, T-Fund, Institutional Class

   $ 94,744      $ 491,008 (a)     $      $      $      $ 585,752        585,752      $ 4,655      $  

SL Liquidity Series, LLC, Money Market Series

            68,000 (a)              (3      (2      67,995        68,022        137 (b)        
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 
            $ (3    $ (2    $ 653,747         $ 4,792      $  
           

 

 

    

 

 

    

 

 

       

 

 

    

 

 

 

 

  (a)

Represents net amount purchased (sold).

 
  (b)

Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  25


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Infrastructure Sustainable Opportunities Fund

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Derivative Financial Instruments Outstanding as of Period End

OTC Total Return Swaps

 

Reference Entity    Payment
Frequency
     Counterparty(a)      Termination
Date
     Net
Notional
     Accrued
Unrealized
Appreciation
(Depreciation)
     Net Value of
Reference
Entity
    

Gross Notional
Amount

Net

Asset
Percentage

 

Equity Securities Long/Short

     Monthly        Goldman Sachs Bank USA (c)       02/27/23      $ 131,076      $ 3,959 (b)     $ 135,011        1.5

 

  (a)

The Fund receives the total return on a portfolio of long positions underlying the total return swap. The Fund pays the total return on a portfolio of short positions underlying the total return swap. In addition, the Fund pays or receives a variable rate of interest, based on a specified benchmark. The benchmark and spread are determined based upon the country and/or currency of the individual underlying positions.

 
  (b) 

Amount includes $24 of net dividends and financing fees.

 

The following are the specified benchmarks (plus or minus a range) used in determining the variable rate of interest:

 

 

(c)

 
Range:   26 basis points
Benchmarks:   Euro Short-Term Rate:
      EUR 1 Day

The following table represents the individual long positions and related values of equity securities underlying the total return swap with Goldman Sachs Bank USA, as of period end, termination date February 27, 2023:

 

        Shares        Value        %of
Basket
Value
 

Reference Entity — Long

              
Common Stocks               

Electric Utilities

              

EDP - Energias de Portugal SA

       28,453        $ 135,011          100.0
         

 

 

      

 

 

 

Net Value of Reference Entity — Goldman Sachs Bank USA

          $ 135,011       
         

 

 

      

Balances Reported in the Statements of Assets and Liabilities for OTC Swaps

 

      Swap
Premiums
Paid
   Swap
Premiums
Received
   Unrealized
Appreciation
   Unrealized
Depreciation

OTC Swaps

   $ —    $ —    $3,959    $ —

Derivative Financial Instruments Categorized by Risk Exposure

As of period end, the fair values of derivative financial instruments located in the Statements of Assets and Liabilities were as follows:

 

     Commodity
Contracts
     Credit
Contracts
     Equity
Contracts
     Foreign
Currency
Exchange
Contracts
     Interest
Rate
Contracts
     Other
Contracts
     Total  

Assets — Derivative Financial Instruments

                   

Swaps — OTC

                   
Unrealized appreciation on OTC swaps;                                                

Swap premiums paid

  $      $      $ 3,959      $      $      $      $ 3,959  
 

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

 

 

26  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Infrastructure Sustainable Opportunities Fund

 

For the period ended November 30, 2022, the effect of derivative financial instruments in the Statements of Operations was as follows:

      Commodity
Contracts
       Credit
Contracts
       Equity
Contracts
       Foreign
Currency
Exchange
Contracts
       Interest
Rate
Contracts
       Other
Contracts
       Total  

Net Realized Gain (Loss) from

                                

Swaps

   $  —        $  —        $ (2,884      $  —        $  —        $  —        $ (2,884
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Net Change in Unrealized Appreciation (Depreciation) on

                                

Swaps

   $        $        $ 95        $        $        $        $ 95  
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

Average Quarterly Balances of Outstanding Derivative Financial Instruments

 

Total return swaps

        

  Average notional amount

   $ 137,680  

For more information about the Fund’s investment risks regarding derivative financial instruments, refer to the Notes to Financial Statements.

Derivative Financial Instruments – Offsetting as of Period End

The Fund’s derivative assets and liabilities (by type) were as follows:

 

      Assets        Liabilities  

Derivative Financial Instruments

       

Swaps — OTC(a)

   $ 3,959        $  
  

 

 

      

 

 

 

Total derivative assets and liabilities in the Statements of Assets and Liabilities

   $ 3,959        $  
  

 

 

      

 

 

 

Derivatives not subject to a Master Netting Agreement or similar agreement (“MNA”)

               
  

 

 

      

 

 

 

Total derivative assets and liabilities subject to an MNA

   $ 3,959        $  
  

 

 

      

 

 

 

 

  (a) 

Includes unrealized appreciation (depreciation) on OTC swaps and swap premiums paid/received in the Statements of Assets and Liabilities.

 

The following table presents the Fund’s derivative assets by counterparty net of amounts available for offset under an MNA and net of the related collateral received by the Fund:

 

Counterparty    Derivative
Assets
Subject to
an MNA by
Counterparty
       Derivatives
Available
for Offset(a)
       Non- Cash
Collateral
Received(b)
       Cash
Collateral
Received(b)
       Net
Amount
of
Derivative
Assets(c)
 

Goldman Sachs Bank USA

   $ 3,959        $        $        $        $ 3,959  
  

 

 

      

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

The amount of derivatives available for offset is limited to the amount of derivative assets and/or liabilities that are subject to an MNA.

 
  (b)

Excess of collateral received/pledged, if any, from the individual counterparty is not shown for financial reporting purposes.

 
  (c) 

Net amount represents the net amount receivable from the counterparty in the event of default.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  27


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Infrastructure Sustainable Opportunities Fund

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Commercial Services & Supplies

   $ 335,749        $        $        $ 335,749  

Diversified Telecommunication Services

     88,626          642,846                   731,472  

Electric Utilities

     1,009,053          1,363,399                   2,372,452  

Equity Real Estate Investment Trusts (REITs)

     1,297,789          80,221                   1,378,010  

IT Services

              391,676                   391,676  

Multi-Utilities

     478,091          393,876                   871,967  

Oil, Gas & Consumable Fuels

     128,662                            128,662  

Road & Rail

     310,329          85,199                   395,528  

Transportation Infrastructure

              1,027,603                   1,027,603  

Water Utilities

              423,153                   423,153  

Short-Term Securities

                 

Money Market Funds

     585,752                            585,752  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 4,234,051        $ 4,407,973        $          8,642,024  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV(a)

                    67,995  
                 

 

 

 
                  $ 8,710,019  
                 

 

 

 

Derivative Financial Instruments(b)

                 

Assets

                 

Equity Contracts

   $        $ 3,959        $        $ 3,959  
  

 

 

      

 

 

      

 

 

      

 

 

 

 

  (a) 

Certain investments of the Fund were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 
  (b) 

Derivative financial instruments are swaps. Swaps are valued at the unrealized appreciation (depreciation) on the instrument.

 

See notes to financial statements.

 

 

28  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited)

November 30, 2022

  

BlackRock Mid-Cap Growth Equity Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Aerospace & Defense — 4.0%

   

HEICO Corp.(a)

    1,507,401     $ 244,666,256  

TransDigm Group, Inc.

    426,354       267,963,489  
   

 

 

 
      512,629,745  
Automobiles — 2.0%            

Ferrari NV

    1,154,737       257,564,088  
   

 

 

 
Banks — 0.0%            

SVB Financial Group(b)

    13,681       3,170,982  
   

 

 

 
Capital Markets — 9.5%            

Ares Management Corp., Class A

    2,079,284       162,995,073  

KKR & Co., Inc.(a)

    5,642,896       292,979,160  

LPL Financial Holdings, Inc.

    27,060       6,405,373  

MSCI, Inc.

    885,694       449,781,984  

Tradeweb Markets, Inc., Class A

    4,696,042       288,618,741  
   

 

 

 
      1,200,780,331  
Commercial Services & Supplies — 9.6%            

Cintas Corp.

    772,805       356,865,893  

Copart, Inc.(b)

    6,025,072       401,028,792  

Rollins, Inc.

    6,162,761       249,222,055  

Waste Connections, Inc.

    1,509,306       218,094,717  
   

 

 

 
      1,225,211,457  
Communications Equipment — 1.4%            

Motorola Solutions, Inc.

    641,628       174,651,142  
   

 

 

 
Construction & Engineering — 1.4%            

WillScot Mobile Mini Holdings Corp.(b)

    3,551,710       171,227,939  
   

 

 

 
Construction Materials — 1.2%            

Vulcan Materials Co.(a)

    807,668       148,069,774  
   

 

 

 
Distributors — 1.5%            

Pool Corp.(a)

    576,049       189,756,301  
   

 

 

 
Electronic Equipment, Instruments & Components — 1.4%  

Teledyne Technologies, Inc.(a)(b)

    435,079       182,776,688  
   

 

 

 
Entertainment — 3.5%            

Liberty Media Corp. - Liberty Formula One, Class C, NVS(b)

    4,062,670       247,579,110  

Live Nation Entertainment, Inc.(a)(b)

    2,739,656       199,337,370  
   

 

 

 
      446,916,480  
Equity Real Estate Investment Trusts (REITs) — 1.6%            

Rexford Industrial Realty, Inc.(a)

    643,462       35,577,014  

SBA Communications Corp.

    567,542       169,865,321  
   

 

 

 
      205,442,335  
Health Care Equipment & Supplies — 3.0%            

IDEXX Laboratories, Inc.(a)(b)

    735,281       313,134,120  

Insulet Corp.(a)(b)

    238,357       71,356,935  
   

 

 

 
      384,491,055  
Health Care Technology — 3.2%            

Doximity, Inc., Class A(a)(b)

    2,634,176       89,535,642  

Veeva Systems, Inc., Class A(b)

    1,677,737       319,374,016  
   

 

 

 
      408,909,658  
Hotels, Restaurants & Leisure — 8.8%            

Domino’s Pizza, Inc.

    48,312       18,780,324  

Evolution AB(c)

    2,537,953       261,419,193  

Expedia Group, Inc.(b)

    2,402,795       256,714,618  

Penn Entertainment, Inc.(a)(b)

    1,265,262       44,524,570  
Security   Shares     Value  
Hotels, Restaurants & Leisure (continued)            

Planet Fitness, Inc., Class A(b)

    3,835,188     $ 300,525,331  

Vail Resorts, Inc.

    903,787       232,761,304  
   

 

 

 
      1,114,725,340  
Interactive Media & Services — 2.6%            

Match Group, Inc.(a)(b)

    6,412,038       324,192,641  
   

 

 

 
Internet & Direct Marketing Retail — 2.0%            

Etsy, Inc.(a)(b)

    1,910,962       252,418,971  
   

 

 

 
IT Services — 1.6%            

Globant SA(a)(b)

    1,043,251       195,484,373  

MongoDB, Inc.(a)(b)

    42,422       6,477,415  
   

 

 

 
      201,961,788  
Life Sciences Tools & Services — 7.4%            

Agilent Technologies, Inc.(a)

    733,950       113,747,571  

Bio-Techne Corp.

    2,286,936       194,366,690  

Charles River Laboratories International, Inc.(b)

    931,415       212,893,526  

Mettler-Toledo International, Inc.(a)(b)

    77,712       114,202,447  

Repligen Corp.(a)(b)

    440,401       78,761,315  

West Pharmaceutical Services, Inc.

    941,001       220,815,295  
   

 

 

 
      934,786,844  
Machinery — 1.3%            

Chart Industries, Inc.(b)

    233,604       33,403,036  

IDEX Corp.(a)

    565,676       134,342,393  
   

 

 

 
      167,745,429  
Media — 0.0%            

Cable One, Inc.

    3,586       2,597,304  
   

 

 

 
Oil, Gas & Consumable Fuels — 2.7%            

Cheniere Energy, Inc.(a)

    1,313,429       230,322,910  

Diamondback Energy, Inc.

    447,959       66,306,891  

EQT Corp.

    996,040       42,242,056  
   

 

 

 
      338,871,857  
Professional Services — 1.8%            

CoStar Group, Inc.(b)

    2,777,373       225,078,308  
   

 

 

 
Road & Rail — 2.3%            

Old Dominion Freight Line, Inc.(a)

    978,850       296,209,798  
   

 

 

 
Semiconductors & Semiconductor Equipment — 9.3%            

Enphase Energy, Inc.(b)

    641,328       205,603,343  

Entegris, Inc.(a)

    3,939,516       304,485,192  

Monolithic Power Systems, Inc.(a)

    867,528       331,360,995  

ON Semiconductor Corp.(b)

    4,529,378       340,609,226  
   

 

 

 
      1,182,058,756  
Software — 12.7%            

Bill.com Holdings, Inc.(a)(b)

    1,826,778       219,980,607  

Cadence Design Systems, Inc.(b)

    2,601,080       447,489,803  

Five9, Inc.(a)(b)

    1,306,379       83,751,958  

HubSpot, Inc.(a)(b)

    382,433       115,888,672  

Paycom Software, Inc.(b)

    1,009,917       342,462,855  

Synopsys, Inc.(b)

    1,129,326       383,451,350  

Tyler Technologies, Inc.(b)

    62,010       21,253,307  
   

 

 

 
      1,614,278,552  
Specialty Retail — 2.8%            

Burlington Stores, Inc.(a)(b)

    554,694       108,542,522  

Tractor Supply Co.(a)

    1,104,498       249,958,942  
   

 

 

 
      358,501,464  
 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  29


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Mid-Cap Growth Equity Portfolio

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  
Textiles, Apparel & Luxury Goods — 1.2%            

Lululemon Athletica, Inc.(b)

    388,824     $ 147,873,655  
   

 

 

 
Total Long-Term Investments — 99.8%
    (Cost: $10,454,427,628)
        12,672,898,682  
   

 

 

 

Short-Term Securities

   
Money Market Funds — 4.8%            

BlackRock Liquidity Funds, T-Fund, Institutional
Class, 3.57%(d)(e)

    29,166,488       29,166,488  

SL Liquidity Series, LLC, Money Market Series,
4.05%(d)(e)(f)

    578,243,481       578,095,913  
   

 

 

 
Total Short-Term Securities — 4.8%
    (Cost: $607,135,013)
        607,262,401  
   

 

 

 
Total Investments — 104.6%
    (Cost: $11,061,562,641)
        13,280,161,083  
Liabilities in Excess of Other Assets — (4.6)%     (580,879,380)  
   

 

 

 
Net Assets — 100.0%         $12,699,281,703  
   

 

 

 

 

(a)

All or a portion of this security is on loan.

 
(b) 

Non-income producing security.

 
(c) 

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

 
(d)

Affiliate of the Fund.

 
(e)

Annualized 7-day yield as of period end.

 
(f) 

All or a portion of this security was purchased with the cash collateral from loaned securities.

 
 

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
05/31/22
    Purchases at
Cost
    Proceeds
from Sale
    Net
Realized
Gain(Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
11/30/22
   

Shares

Held at

11/30/22

    Income    

Capital

Gain

Distributions

from Underlying

Funds

 
                                                                 

BlackRock Liquidity Funds, T-Fund, Institutional Class

  $ 73,220,432     $     $  (44,053,944)(a)     $     $     $ 29,166,488       29,166,488     $ 2,047,248     $  

SL Liquidity Series, LLC, Money Market Series

    194,058,888       384,086,813 (a)            (122,451     72,663       578,095,913       578,243,481       562,810 (b)        
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $  (122,451)     $ 72,663     $  607,262,401       $  2,610,058     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

 

 

30  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Mid-Cap Growth Equity Portfolio

 

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 512,629,745        $        $             —        $ 512,629,745  

Automobiles

     257,564,088                            257,564,088  

Banks

     3,170,982                            3,170,982  

Capital Markets

     1,200,780,331                            1,200,780,331  

Commercial Services & Supplies

     1,225,211,457                            1,225,211,457  

Communications Equipment

     174,651,142                            174,651,142  

Construction & Engineering

     171,227,939                            171,227,939  

Construction Materials

     148,069,774                            148,069,774  

Distributors

     189,756,301                            189,756,301  

Electronic Equipment, Instruments & Components

     182,776,688                            182,776,688  

Entertainment

     446,916,480                            446,916,480  

Equity Real Estate Investment Trusts (REITs)

     205,442,335                            205,442,335  

Health Care Equipment & Supplies

     384,491,055                            384,491,055  

Health Care Technology

     408,909,658                            408,909,658  

Hotels, Restaurants & Leisure

     853,306,147          261,419,193                   1,114,725,340  

Interactive Media & Services

     324,192,641                            324,192,641  

Internet & Direct Marketing Retail

     252,418,971                            252,418,971  

IT Services

     201,961,788                            201,961,788  

Life Sciences Tools & Services

     934,786,844                            934,786,844  

Machinery

     167,745,429                            167,745,429  

Media

     2,597,304                            2,597,304  

Oil, Gas & Consumable Fuels

     338,871,857                            338,871,857  

Professional Services

     225,078,308                            225,078,308  

Road & Rail

     296,209,798                            296,209,798  

Semiconductors & Semiconductor Equipment

     1,182,058,756                            1,182,058,756  

Software

     1,614,278,552                            1,614,278,552  

Specialty Retail

     358,501,464                            358,501,464  

Textiles, Apparel & Luxury Goods

     147,873,655                            147,873,655  

Short-Term Securities

                 

Money Market Funds

     29,166,488                            29,166,488  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $ 12,440,645,977        $  261,419,193        $          12,702,065,170  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV(a)

                    578,095,913  
                 

 

 

 
                  $ 13,280,161,083  
                 

 

 

 

 

  (a) 

Certain investments of the Fund were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

See notes to financial statements.

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  31


Schedule of Investments  (unaudited)

November 30, 2022

  

BlackRock Technology Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares     Value  

Common Stocks

 

Aerospace & Defense — 0.1%

 

Rocket Lab U.S.A., Inc.(a)(b)

    837,912     $ 3,510,851  
   

 

 

 
Automobiles — 3.5%  

BYD Co. Ltd., Class H

    795,500       20,253,261  

Tesla, Inc.(a)

    655,871       127,698,084  
   

 

 

 
      147,951,345  
Banks — 0.1%  

Klarna Holdings AB (Acquired 09/15/20, cost

   

$11,017,172)(a)(c)(d)

    25,600       4,978,103  
   

 

 

 
Capital Markets — 0.9%  

S&P Global, Inc.

    110,536       38,997,101  
   

 

 

 
Communications Equipment — 0.7%  

Motorola Solutions, Inc.

    107,210       29,182,562  
   

 

 

 
Diversified Consumer Services — 0.2%  

Think & Learn Private Ltd. (Acquired 09/30/20, cost $3,427,642)(a)(c)(d)

    2,241       7,024,226  
   

 

 

 
Electrical Equipment — 0.5%  

Sungrow Power Supply Co. Ltd., Class A

    1,141,900       18,732,161  
   

 

 

 
Electronic Equipment, Instruments & Components — 2.1%  

CDW Corp.

    391,964       73,940,089  

Flex Ltd.(a)

    663,109       14,575,136  
   

 

 

 
      88,515,225  
Entertainment — 2.7%  

Electronic Arts, Inc.

    142,082       18,581,484  

Netflix, Inc.(a)

    99,563       30,419,483  

Spotify Technology SA(a)(b)

    181,852       14,442,686  

Warner Music Group Corp., Class A

    1,462,672       50,125,769  
   

 

 

 
      113,569,422  
Equity Real Estate Investment Trusts (REITs) — 0.5%  

SBA Communications Corp.

    66,909       20,025,864  
   

 

 

 
Hotels, Restaurants & Leisure — 1.3%  

Booking Holdings, Inc.(a)

    11,210       23,310,634  

Trip.com Group Ltd.(a)

    960,250       30,390,108  
   

 

 

 
      53,700,742  
Interactive Media & Services — 3.2%  

Alphabet, Inc., Class A(a)

    1,080,337       109,103,234  

ZoomInfo Technologies, Inc.(a)

    839,127       23,999,032  
   

 

 

 
      133,102,266  
Internet & Direct Marketing Retail — 3.7%  

Alibaba Group Holding Ltd., ADR(a)

    293,455       25,694,920  

Amazon.com, Inc.(a)

    656,984       63,425,235  

Coupang, Inc.(a)(b)

    800,814       15,599,857  

Jasper Infotech Private Ltd. (Acquired 05/07/14 -10/29/14, cost $1,414,399)(a)(c)(d)

    304,000       296,175  

MercadoLibre, Inc.(a)

    53,299       49,620,569  
   

 

 

 
      154,636,756  
IT Services — 16.0%  

Accenture PLC, Class A

    136,740       41,149,168  

Adyen NV(a)(e)

    36,822       58,006,389  

Automatic Data Processing, Inc.

    326,676       86,288,199  

Block, Inc.(a)

    419,971       28,461,435  

Globant SA(a)(b)

    88,070       16,502,557  

GMO Payment Gateway, Inc.

    392,800       35,563,801  

Mastercard, Inc., Class A

    419,552       149,528,333  

MongoDB, Inc.(a)

    159,959       24,424,140  

PayPal Holdings, Inc.(a)

    558,057       43,757,249  
Security   Shares     Value  
IT Services (continued)  

Shopify, Inc., Class A(a)

    334,298     $ 13,666,102  

Snowflake, Inc., Class A(a)

    47,770       6,826,333  

Twilio, Inc., Class A(a)

    219,488       10,759,302  

Visa, Inc., Class A

    642,949       139,519,933  

Wise PLC, Class A(a)

    1,918,022       15,156,977  
   

 

 

 
      669,609,918  
Machinery — 0.6%  

Wuxi Lead Intelligent Equipment Co. Ltd., Class A .

    4,051,680       25,213,594  
   

 

 

 
Professional Services — 0.5%  

Equifax, Inc.(b)

    110,883       21,884,978  
   

 

 

 
Road & Rail — 0.6%  

Uber Technologies, Inc.(a)

    860,061       25,062,177  
   

 

 

 
Semiconductors & Semiconductor Equipment — 25.3%  

Advanced Micro Devices, Inc.(a)(b)

    1,063,316       82,545,221  

Alphawave IP Group PLC(a)(b)

    9,867,850       12,606,820  

Analog Devices, Inc.

    132,930       22,851,996  

ASML Holding NV

    224,942       137,331,625  

Broadcom, Inc.

    130,348       71,825,658  

First Solar, Inc.(a)

    97,195       16,769,053  

GLOBALFOUNDRIES, Inc.(a)(b)

    527,468       33,942,566  

Lam Research Corp.

    167,747       79,240,328  

Marvell Technology, Inc.

    1,419,849       66,051,376  

Micron Technology, Inc.(b)

    682,550       39,349,008  

Monolithic Power Systems, Inc.

    172,099       65,734,934  

NVIDIA Corp.

    440,071       74,473,215  

NXP Semiconductors NV

    300,542       52,847,305  

QUALCOMM, Inc.

    482,267       61,001,953  

SOITEC(a)

    418,311       68,045,698  

STMicroelectronics NV

    1,718,480       66,517,054  

Wolfspeed, Inc.(a)(b)

    1,183,664       107,618,731  
   

 

 

 
      1,058,752,541  
Software — 24.6%  

Adobe, Inc.(a)

    78,082       26,932,824  

Altium Ltd.

    1,642,474       43,541,223  

ANSYS, Inc.(a)

    133,169       33,864,877  

Aspen Technology, Inc.(a)(b)

    164,033       37,809,607  

Atlassian Corp. Ltd., Class A(a)

    209,085       27,505,132  

Cadence Design Systems, Inc.(a)

    629,795       108,349,932  

Constellation Software, Inc.

    22,912       36,936,498  

Crowdstrike Holdings, Inc., Class A(a)

    159,476       18,762,351  

Dassault Systemes SE

    660,488       24,627,811  

Databricks, Inc. (Acquired 07/24/20 - 09/02/20, cost $5,122,891)(a)(c)(d)

    319,983       17,637,463  

Fair Isaac Corp.(a)

    80,770       50,054,784  

Gitlab, Inc., Class A(a)(b)

    355,692       14,067,619  

Intuit, Inc.

    162,063       66,055,258  

Microsoft Corp.

    1,273,779       324,991,974  

Oracle Corp.

    803,329       66,700,407  

Salesforce, Inc.(a)

    150,520       24,120,830  

ServiceNow, Inc.(a)

    88,194       36,715,162  

Splunk, Inc.(a)

    204,347       15,873,675  

Unqork, Inc. (Acquired 03/05/21, cost $4,093,769)(a)(c)(d)

    149,520       2,371,387  

Xero Ltd.(a)

    617,823       30,702,898  

Zscaler, Inc.(a)(b)

    150,963       20,146,012  
   

 

 

 
      1,027,767,724  
 

 

 

32  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Technology Opportunities Fund

(Percentages shown are based on Net Assets)

 

Security   Shares      Value  

Technology Hardware, Storage & Peripherals — 9.8%

 

Apple Inc.

    2,630,611      $ 389,409,347  

Dell Technologies, Inc., Class C

    437,308        19,587,025  
    

 

 

 
       408,996,372  
    

 

 

 

Total Common Stocks — 96.9%
(Cost: $3,032,900,509)

 

     4,051,213,928  
    

 

 

 

Preferred Securities

 

Preferred Stocks — 2.6%  
Diversified Consumer Services — 0.2%  

Think & Learn Private Ltd., Series F (Acquired 09/30/20, cost $6,867,746)(a)(c)(d)

    2,371        7,431,700  
    

 

 

 
Food Products — 0.2%  

Farmer’s Business Network, Inc., Series F
(Acquired 07/31/20, cost $6,419,592)(a)(c)(d)

    194,200        10,378,048  
    

 

 

 
Interactive Media & Services — 0.8%  

Bytedance Ltd., Series E-1 (Acquired 11/11/20, cost $22,196,442)(a)(c)(d)

    202,570        32,997,842  
    

 

 

 
Road & Rail — 0.1%  

FlixMobility GmbH, Series F (Acquired 07/26/19, cost $2,490,608)(a)(c)(d)

    125        2,355,004  
    

 

 

 
Semiconductors & Semiconductor Equipment — 0.6%  

PsiQuantum Corp., Series C (Acquired 09/09/19, cost $2,698,453)(a)(c)(d)

    581,814        11,991,187  

SambaNova Systems, Inc., Series C (Acquired 02/20/20, cost $9,804,574)(a)(c)(d)

    184,153        11,691,874  
    

 

 

 
       23,683,061  
Software — 0.7%  

Databricks, Inc.

    

Series F, 0.00% (Acquired 10/22/19, cost
$3,700,005)(a)(c)(d)

    258,450        14,245,764  

Series G, 0.00% (Acquired 02/01/21, cost
$12,500,003)(a)(c)(d)

    211,425        11,653,746  

Unqork, Inc.

    

Series A, 0.00% (Acquired 03/05/21, cost
$194,941)(a)(c)(d)

    7,120        112,923  

Series B, 0.00% (Acquired 03/05/21, cost
$314,316)(a)(c)(d)

    11,480        182,073  
Security   Shares      Value  

Software (continued)

 

Unqork, Inc.

    

Series C, 0.00% (Acquired 09/18/20, cost $8,323,340)(a)(c)(d)

    304,000      $ 4,821,440  

Series Seed, 0.00% (Acquired 03/05/21, cost $489,544)(a)(c)(d)

    17,880        283,577  

Series Seed A, 0.00% (Acquired 03/05/21, cost $180,704)(a)(c)(d)

    6,600        104,676  
    

 

 

 
       31,404,199  
    

 

 

 

Total Preferred Securities — 2.6%
(Cost: $76,181,919)

 

     108,249,854  
    

 

 

 

Total Long-Term Investments — 99.5%
(Cost: $3,109,082,428)

 

     4,159,463,782  
    

 

 

 

Short-Term Securities

 

Money Market Funds — 3.2%  

BlackRock Liquidity Funds, T-Fund, Institutional
Class, 3.57%(f)(g)

    31,093,980        31,093,980  

SL Liquidity Series, LLC, Money Market Series, 4.05%(f)(g)(h)

    101,173,076        101,172,930  
    

 

 

 

Total Short-Term Securities — 3.2%
(Cost: $132,236,831)

 

     132,266,910  
    

 

 

 

Total Investments — 102.7%
(Cost: $3,241,319,259)

 

     4,291,730,692  

Liabilities in Excess of Other Assets — (2.7)%

 

     (113,585,074
    

 

 

 

Net Assets — 100.0%

 

   $  4,178,145,618  
    

 

 

 

 

(a)

Non-income producing security.

(b) 

All or a portion of this security is on loan.

(c)

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

(d)

Restricted security as to resale, excluding 144A securities. The Fund held restricted securities with a current value of $140,557,208, representing 3.4% of its net assets as of period end, and an original cost of $101,257,792.

(e)

Security exempt from registration pursuant to Rule 144A under the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration to qualified institutional investors.

(f)

Affiliate of the Fund.

(g)

Annualized 7-day yield as of period end.

(h)

All or a portion of this security was purchased with the cash collateral from loaned securities.

 

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  33


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Technology Opportunities Fund

 

Affiliates

Investments in issuers considered to be affiliate(s) of the Fund during the six months ended November 30, 2022 for purposes of Section 2(a)(3) of the Investment Company Act of 1940, as amended, were as follows:

 

Affiliated Issuer   Value at
05/31/22
    Purchases
at Cost
    Proceeds
from Sale
    Net
Realized
Gain (Loss)
    Change in
Unrealized
Appreciation
(Depreciation)
    Value at
11/30/22
   

Shares

Held at
11/30/22

    Income    

Capital

Gain
Distributions
from Underlying
Funds

 

BlackRock Liquidity Funds, T-Fund, Institutional Class

  $ 65,188,334     $     $ (34,094,354 )(a)    $     $     $ 31,093,980       31,093,980     $ 472,199     $         —  

SL Liquidity Series, LLC, Money Market Series

    104,736,728     $       (3,522,393 )(a)      (42,756     1,351       101,172,930       101,173,076       475,764 (b)       
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 
        $ (42,756   $ 1,351     $     132,266,910       $     947,963     $  
       

 

 

   

 

 

   

 

 

     

 

 

   

 

 

 

 

  (a) 

Represents net amount purchased (sold).

 
  (b) 

Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and other payments to and from borrowers of securities.

 

For Fund compliance purposes, the Fund’s industry classifications refer to one or more of the industry sub-classifications used by one or more widely recognized market indexes or rating group indexes, and/or as defined by the investment adviser. These definitions may not apply for purposes of this report, which may combine such industry sub-classifications for reporting ease.

Fair Value Hierarchy as of Period End

Various inputs are used in determining the fair value of financial instruments. For a description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the Fund’s financial instruments categorized in the fair value hierarchy. The breakdown of the Fund’s financial instruments into major categories is disclosed in the Schedule of Investments above.

 

      Level 1        Level 2        Level 3        Total  

Assets

                 

Investments

                 

Long-Term Investments

                 

Common Stocks

                 

Aerospace & Defense

   $ 3,510,851        $        $        $ 3,510,851  

Automobiles

     127,698,084          20,253,261                   147,951,345  

Banks

                       4,978,103          4,978,103  

Capital Markets

     38,997,101                            38,997,101  

Communications Equipment

     29,182,562                            29,182,562  

Diversified Consumer Services

                       7,024,226          7,024,226  

Electrical Equipment

              18,732,161                   18,732,161  

Electronic Equipment, Instruments & Components

     88,515,225                            88,515,225  

Entertainment

     113,569,422                            113,569,422  

Equity Real Estate Investment Trusts (REITs)

     20,025,864                            20,025,864  

Hotels, Restaurants & Leisure

     23,310,634          30,390,108                   53,700,742  

Interactive Media & Services

     133,102,266                            133,102,266  

Internet & Direct Marketing Retail

     154,340,581                   296,175          154,636,756  

IT Services

     560,882,751          108,727,167                   669,609,918  

Machinery

              25,213,594                   25,213,594  

Professional Services

     21,884,978                            21,884,978  

Road & Rail

     25,062,177                            25,062,177  

Semiconductors & Semiconductor Equipment

     786,858,164          271,894,377                   1,058,752,541  

Software

     908,886,942          98,871,932          20,008,850          1,027,767,724  

Technology Hardware, Storage & Peripherals

     408,996,372                            408,996,372  

Preferred Securities

                       108,249,854          108,249,854  

Short-Term Securities

                 

Money Market Funds

     31,093,980                            31,093,980  
  

 

 

      

 

 

      

 

 

      

 

 

 
   $     3,475,917,954        $     574,082,600        $     140,557,208          4,190,557,762  
  

 

 

      

 

 

      

 

 

      

 

 

 

Investments valued at NAV

                    101,172,930  
                 

 

 

 
                  $      4,291,730,692  
                 

 

 

 

 

 

34  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Schedule of Investments  (unaudited) (continued)

November 30, 2022

  

BlackRock Technology Opportunities Fund

 

A reconciliation of Level 3 financial instruments is presented when the Fund had a significant amount of Level 3 investments at the beginning and/or end of the year in relation to net assets. The following table is a reconciliation of Level 3 investments for which significant unobservable inputs were used in determining fair value:

 

      Common
Stocks
       Preferred
Stocks
       Total            

Assets

                 

Opening Balance, as of May 31, 2022

   $ 65,174,021        $ 119,603,445        $ 184,777,466                        

Transfers into Level 3

                             

Transfers out of Level 3

                             

Accrued discounts/premiums

                             

Net realized gain (loss)

              388,435          388,435       

Net change in unrealized appreciation (depreciation)(a)(b)

     (32,866,667        (10,550,084        (43,416,751     

Purchases

                             

Sales

              (1,191,942        (1,191,942     
  

 

 

      

 

 

      

 

 

      

Closing Balance, as of November 30, 2022

   $ 32,307,354        $  108,249,854        $  140,557,208       
  

 

 

      

 

 

      

 

 

      

Net change in unrealized appreciation (depreciation) on investments still held at November 30, 2022(b)

   $     (32,866,667      $     (10,550,084      $     (43,416,751     
  

 

 

      

 

 

      

 

 

      

 

  (a) 

Included in the related net change in unrealized appreciation (depreciation) in the Statements of Operations.

 
  (b) 

Any difference between net change in unrealized appreciation (depreciation) and net change in unrealized appreciation (depreciation) on investments still held at November 30, 2022, is generally due to investments no longer held or categorized as Level 3 at period end.

 

The following table summarizes the valuation approaches used and unobservable inputs utilized by the BlackRock Valuation Committee (the “Valuation Committee”) to determine the value of certain of the Fund’s Level 3 investments as of period end.

 

      Value        Valuation Approach       

Unobservable

Inputs

     Range of
Unobservable Inputs
Utilized(a)
       Weighted Average of
Unobservable Inputs
Based on Fair Value
 

Assets

                      

Common Stocks

   $ 32,307,354          Market        Revenue Multiple        3.13x-28.00x          18.28x  

Preferred Securities(b)

     108,249,854          Market        Revenue Multiple        3.35x-28.00x          12.26x  
             Volatility        50%                     
             Time to Exit        4.0                     
             Market Adjustment Multiple        1.00x                     
  

 

 

                     
   $      140,557,208                      
  

 

 

                     

 

  (a) 

A significant change in unobservable input would have resulted in a correlated (inverse) significant change to value.

 
  (b) 

The fund valued certain of its Level 3 investments using recent prior transaction prices as the best approximation of fair value. The value of Level 3 investments obtained using recent prior transactions, for which inputs are unobservable, is $32,997,842 as of November 30, 2022.

 

See notes to financial statements.

 

 

C H E D U L E S   O F   I N V E  S T M E N T S

  35


 

Statements of Assets and Liabilities  (unaudited)

November 30, 2022

 

    

BlackRock

Capital

Appreciation

Fund,

Inc.

    

BlackRock

Health

Sciences
Opportunities
Portfolio

    BlackRock
Infrastructure
Sustainable
Opportunities
Fund
 

ASSETS

      

Investments, at value — unaffiliated(a)(b)

  $ 2,950,665,623      $ 9,321,547,808     $ 8,056,272  

Investments, at value — affiliated(c)

    17,361,998        319,630,955       653,747  

Cash

    116,145        77,782        

Foreign currency, at value(d)

                 133,243  

Receivables:

      

Investments sold

           47,369,522 (e)        

Securities lending income — affiliated

    12,372        140,873       61  

Capital shares sold

    1,517,171        7,052,038        

Dividends — unaffiliated

    2,142,661        12,221,510       20,446  

Dividends — affiliated

    127,407        340,496       1,632  

From the Manager

                 8,959  

Unrealized appreciation on:

      

Forward foreign currency exchange contracts

           2,928,048        

OTC swaps

                 3,959  

Deferred offering costs

                 882  

Prepaid expenses

    104,206        139,682       38,303  
 

 

 

    

 

 

   

 

 

 

Total assets

        2,972,047,583        9,711,448,714           8,917,504  
 

 

 

    

 

 

   

 

 

 

LIABILITIES

      

Collateral on securities loaned

           165,216,682       68,000  

Payables:

      

Investments purchased

           2,131,798        

Accounting services fees

    49,985        130,282       9,211  

Administration fees

           411,374       3  

Capital shares redeemed

    5,651,052        15,020,181        

Investment advisory fees

    1,490,356        5,037,302        

Directors’ and Officer’s fees

    5,925        28,912       1,911  

Other accrued expenses

    70,881        213,077       4,655  

Other affiliate fees

    77,527        102,873        

Professional fees

    65,178        64,922       26,391  

Service and distribution fees

    361,104        1,153,411       20  

Transfer agent fees

    465,388        2,620,337       187  

Unrealized depreciation on forward foreign currency exchange contracts

           9,054,253        
 

 

 

    

 

 

   

 

 

 

Total liabilities

    8,237,396        201,185,404       110,378  
 

 

 

    

 

 

   

 

 

 

NET ASSETS

  $ 2,963,810,187      $     9,510,263,310     $ 8,807,126  
 

 

 

    

 

 

   

 

 

 

NET ASSETS CONSIST OF:

      

Paid-in capital

  $ 1,926,441,611      $ 6,091,077,892     $ 9,988,218  

Accumulated earnings (loss)

    1,037,368,576        3,419,185,418       (1,181,092
 

 

 

    

 

 

   

 

 

 

NET ASSETS

  $ 2,963,810,187      $ 9,510,263,310     $ 8,807,126  
 

 

 

    

 

 

   

 

 

 

(a) Investments, at cost — unaffiliated

  $ 1,945,640,423      $ 5,818,152,187     $ 8,630,540  

(b) Securities loaned, at value

  $      $ 165,101,227     $ 67,146  

(c) Investments, at cost — affiliated

  $ 17,361,998      $ 319,601,508     $ 653,749  

(d) Foreign currency, at cost

  $      $     $ 131,144  

(e) $15,050,402 is expected to be collected at least one year after May 31, 2022.

      

 

 

36  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Assets and Liabilities  (unaudited) (continued)

November 30, 2022

 

    

BlackRock
Capital
Appreciation
Fund,

Inc.

    

BlackRock

Health

Sciences
Opportunities
Portfolio

     BlackRock
Infrastructure
Sustainable
Opportunities
Fund
 

NET ASSET VALUE

       
Institutional                    

Net assets

  $ 667,594,662      $ 5,028,931,985      $ 95,243  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    23,759,486        70,249,937        10,847  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 28.10      $ 71.59      $ 8.78  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Service                    

Net assets

    N/A      $ 37,601,229        N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    N/A        558,028        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

    N/A      $ 67.38        N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    N/A        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

    N/A      $ 0.001        N/A  
 

 

 

    

 

 

    

 

 

 
Investor A                    

Net assets

  $ 1,631,467,386      $ 3,206,759,046      $ 101,203  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    66,032,315        47,834,541        11,539  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 24.71      $ 67.04      $ 8.77  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Investor C                    

Net assets

  $ 39,574,138      $ 505,612,615        N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    2,811,198        9,090,253        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 14.08      $ 55.62        N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001        N/A  
 

 

 

    

 

 

    

 

 

 
Class K                    

Net assets

  $ 603,449,781      $ 465,152,167      $
 
 
8,610,680
 
 
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    21,232,870        6,486,695        980,462  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 28.42      $ 71.71      $ 8.78  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    300 million        Unlimited        Unlimited  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001      $ 0.001  
 

 

 

    

 

 

    

 

 

 
Class R                    

Net assets

  $ 21,724,220      $ 266,206,268        N/A  
 

 

 

    

 

 

    

 

 

 

Shares outstanding

    1,218,168        4,097,107        N/A  
 

 

 

    

 

 

    

 

 

 

Net asset value

  $ 17.83      $ 64.97        N/A  
 

 

 

    

 

 

    

 

 

 

Shares authorized

    500 million        Unlimited        N/A  
 

 

 

    

 

 

    

 

 

 

Par value

  $ 0.10      $ 0.001        N/A  
 

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  37


 

Statements of Assets and Liabilities  (unaudited) (continued)

November 30, 2022

 

    

BlackRock

Mid-Cap

Growth

Equity

Portfolio

   

BlackRock
Technology
Opportunities

Fund

 

ASSETS

   

Investments, at value — unaffiliated(a)(b)

  $ 12,672,898,682     $ 4,159,463,782  

Investments, at value — affiliated(c)

    607,262,401       132,266,910  

Cash

          120,952  

Cash pledged for collateral — exchange-traded options written

          200  

Foreign currency, at value(d)

    1,276       5,095  

Receivables:

   

Investments sold

    21,019,327        

Securities lending income — affiliated

    147,137       97,828  

Capital shares sold

    15,693,720       6,236,400  

Dividends — unaffiliated

    5,214,358       2,610,793  

Dividends — affiliated

    42,995       178,380  

From the Manager

    199,941       112,073  

Prepaid expenses

    471,339       138,658  
 

 

 

   

 

 

 

Total assets

        13,322,951,176       4,301,231,071  
 

 

 

   

 

 

 

LIABILITIES

   

Collateral on securities loaned

    578,395,778       101,364,674  

Payables:

   

Investments purchased

          2,875,645  

Accounting services fees

    175,255       65,972  

Administration fees

    413,304       124,323  

Capital shares redeemed

    34,890,879       13,105,422  

Deferred foreign capital gain tax

          493,938  

Investment advisory fees

    6,296,796       2,552,455  

Directors’ and Officer’s fees

    61,030       15,978  

Other accrued expenses

    245,855       339,707  

Other affiliate fees

    38,240        

Professional fees

    61,527       82,360  

Service and distribution fees

    569,830       500,107  

Transfer agent fees

    2,520,979       1,564,872  
 

 

 

   

 

 

 

Total liabilities

    623,669,473       123,085,453  
 

 

 

   

 

 

 

NET ASSETS

  $ 12,699,281,703     $ 4,178,145,618  
 

 

 

   

 

 

 

NET ASSETS CONSIST OF:

   

Paid-in capital

  $ 13,052,629,175     $ 3,812,483,326  

Accumulated earnings (loss)

    (353,347,472     365,662,292  
 

 

 

   

 

 

 

NET ASSETS

  $ 12,699,281,703     $ 4,178,145,618  
 

 

 

   

 

 

 

(a) Investments, at cost — unaffiliated

  $ 10,454,427,628     $     3,109,082,428  

(b) Securities loaned, at value

  $ 559,569,968     $ 99,038,879  

(c) Investments, at cost — affiliated

  $ 607,135,013     $ 132,236,831  

(d) Foreign currency, at cost

  $ 1,475     $ 5,628  

 

 

38  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Assets and Liabilities  (unaudited) (continued)

November 30, 2022

 

    

BlackRock

Mid-Cap
Growth

Equity

Portfolio

   

BlackRock

Technology

Opportunities

Fund

 

NET ASSET VALUE

       

Institutional

       

Net assets

    $ 5,997,719,359       $ 2,284,643,094  
   

 

 

     

 

 

 

Shares outstanding

      185,413,794         55,452,863  
   

 

 

     

 

 

 

Net asset value

    $ 32.35       $ 41.20  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Service

       

Net assets

    $ 76,721,713       $ 46,019,807  
   

 

 

     

 

 

 

Shares outstanding

      2,657,059         1,197,990  
   

 

 

     

 

 

 

Net asset value

    $ 28.87       $ 38.41  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Investor A

       

Net assets

    $ 1,767,701,583       $ 1,450,087,046  
   

 

 

     

 

 

 

Shares outstanding

      64,252,389         38,695,173  
   

 

 

     

 

 

 

Net asset value

    $ 27.51       $ 37.47  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Investor C

       

Net assets

    $ 214,339,492       $ 244,267,229  
   

 

 

     

 

 

 

Shares outstanding

      10,446,610         8,143,266  
   

 

 

     

 

 

 

Net asset value

    $ 20.52       $ 30.00  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Class K

       

Net assets

    $ 4,550,173,084       $ 122,019,722  
   

 

 

     

 

 

 

Shares outstanding

      140,032,792         2,956,516  
   

 

 

     

 

 

 

Net asset value

    $ 32.49       $ 41.27  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

Class R

       

Net assets

    $ 92,626,472       $ 31,108,720  
   

 

 

     

 

 

 

Shares outstanding

      3,455,158         827,659  
   

 

 

     

 

 

 

Net asset value

    $ 26.81       $ 37.59  
   

 

 

     

 

 

 

Shares authorized

      Unlimited         Unlimited  
   

 

 

     

 

 

 

Par value

    $ 0.001       $ 0.001  
   

 

 

     

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  39


 

Statements of Operations  (unaudited)

Six Months Ended November 30, 2022

 

    

BlackRock

Capital

Appreciation

Fund,

Inc.

   

BlackRock

Health

Sciences
Opportunities
Portfolio

    BlackRock
Infrastructure
Sustainable
Opportunities
Fund
 

INVESTMENT INCOME

     

Dividends — unaffiliated

  $ 11,689,057     $ 57,910,615     $ 108,789  

Dividends — affiliated

    721,813       1,504,513       4,655  

Securities lending income — affiliated — net

    30,342       707,008       137  

Foreign taxes withheld

    (80,169     (318,635     (8,689
 

 

 

   

 

 

   

 

 

 

Total investment income

    12,361,043       59,803,501       104,892  
 

 

 

   

 

 

   

 

 

 

EXPENSES

     

Investment advisory

    9,974,221       30,502,267       35,181  

Service and distribution — class specific

    2,382,443       7,000,663       123  

Transfer agent — class specific

    1,354,251       4,621,945       43  

Accounting services

    105,159       264,283       18,537  

Professional

    75,378       69,989       28,001  

Registration

    71,906       110,664       15,074  

Custodian

    38,643       160,952       6,579  

Directors and Officer

    19,410       37,273       3,374  

Printing and postage

    18,540       26,944       3,810  

Administration

          1,575,250       1,869  

Administration — class specific

          912,006       880  

Offering

                61,000  

Miscellaneous

    30,860       125,044       4,536  
 

 

 

   

 

 

   

 

 

 

Total expenses

    14,070,811       45,407,280       179,007  

Less:

     

Fees waived and/or reimbursed by the Manager

    (23,527     (62,966     (136,184

Administration fees waived by the Manager — class specific

                (857

Transfer agent fees waived and/or reimbursed by the Manager — class specific

                (26
 

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    14,047,284       45,344,314       41,940  
 

 

 

   

 

 

   

 

 

 

Net investment income (loss)

    (1,686,241     14,459,187       62,952  
 

 

 

   

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

     

Net realized gain (loss) from:

     

Investments — unaffiliated

    49,456,430       105,481,470       (590,838

Investments — affiliated

    3,949       (15,756     (3

Forward foreign currency exchange contracts

          12,062,437        

Foreign currency transactions

    (101,340     (131,930     (12,654

Swaps

                (2,884
 

 

 

   

 

 

   

 

 

 
    49,359,039       117,396,221       (606,379
 

 

 

   

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

     

Investments — unaffiliated

    (298,564,965     444,561,516       (325,725

Investments — affiliated

    (2,158     672       (2

Forward foreign currency exchange contracts

          (11,204,774      

Foreign currency translations

    (3,587     (9,294     1,070  

Swaps

                95  
 

 

 

   

 

 

   

 

 

 
    (298,570,710     433,348,120       (324,562
 

 

 

   

 

 

   

 

 

 

Net realized and unrealized gain (loss)

    (249,211,671     550,744,341       (930,941
 

 

 

   

 

 

   

 

 

 

NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS

  $     (250,897,912)     $     565,203,528     $     (867,989)  
 

 

 

   

 

 

   

 

 

 

See notes to financial statements.

 

 

 

40  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Operations  (unaudited) (continued)

Six Months Ended November 30, 2022

 

    BlackRock        
    Mid-Cap     BlackRock  
    Growth     Technology  
    Equity     Opportunities  
     Portfolio     Fund  

INVESTMENT INCOME

   

Dividends — unaffiliated

  $ 34,467,857     $ 13,447,718  

Dividends — affiliated

    2,047,248       472,199  

Securities lending income — affiliated — net

    562,810       475,764  

Foreign taxes withheld

    (115,666     (443,404
 

 

 

   

 

 

 

Total investment income

    36,962,249       13,952,277  
 

 

 

   

 

 

 

EXPENSES

   

Investment advisory

    40,675,168       17,460,349  

Transfer agent — class specific

    6,828,927       2,865,451  

Service and distribution — class specific

    3,687,757       3,361,119  

Administration

    2,202,540       830,022  

Administration — class specific

    1,301,636       453,485  

Accounting services

    369,140       140,475  

Registration

    278,522       231,102  

Custodian

    155,659       154,123  

Professional

    65,392       73,791  

Directors and Officer

    44,922       24,012  

Printing and postage

    36,313       21,915  

Miscellaneous

    86,187       60,953  
 

 

 

   

 

 

 

Total expenses

    55,732,163       25,676,797  

Less:

   

Fees waived and/or reimbursed by the Manager

    (73,159     (13,212

Administration fees waived by the Manager — class specific

    (849,217     (442,087

Transfer agent fees waived and/or reimbursed by the Manager — class specific

    (1,274,304     (1,048,497
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    53,535,483       24,173,001  
 

 

 

   

 

 

 

Net investment loss

    (16,573,234     (10,220,724
 

 

 

   

 

 

 

REALIZED AND UNREALIZED GAIN (LOSS)

   

Net realized loss from:

   

Investments — unaffiliated

    (1,346,962,252     (197,543,949

Investments — affiliated

    (122,451     (42,756

Foreign currency transactions

    (52,028     42,420  
 

 

 

   

 

 

 
    (1,347,136,731     (197,544,285
 

 

 

   

 

 

 

Net change in unrealized appreciation (depreciation) on:

   

Investments — unaffiliated(a)

    1,116,652,136       (267,259,379

Investments — affiliated

    72,663       1,351  

Foreign currency translations

    (93,968     39,989  
 

 

 

   

 

 

 
    1,116,630,831       (267,218,039
 

 

 

   

 

 

 

Net realized and unrealized loss

    (230,505,900     (464,762,324
 

 

 

   

 

 

 

NET DECREASE IN NET ASSETS RESULTING FROM OPERATIONS

  $
(247,079,134)
 
  $
    (474,983,048)
 
 

 

 

   

 

 

 

(a) Net of reduction in deferred foreign capital gain tax of

          755,841  

See notes to financial statements.

 

 

 

I N A N C I A L  T A T E M E N T S

  41


 

Statements of Changes in Net Assets

Six Months Ended November 30, 2022

 

   

BlackRock Capital Appreciation Fund, Inc.

           BlackRock Health Sciences Opportunities Portfolio  
    

Six Months

Ended

11/30/22

(unaudited)

    Year Ended
05/31/22
           

Six Months

Ended

11/30/22

(unaudited)

    Year Ended
05/31/22
 

INCREASE (DECREASE) IN NET ASSETS

               

OPERATIONS

               

Net investment income (loss)

    $ (1,686,241   $ (16,516,609         $ 14,459,187     $ 16,788,132  

Net realized gain

      49,359,039       368,362,544             117,396,221       1,099,713,705  

Net change in unrealized appreciation (depreciation)

      (298,570,710     (1,070,518,893           433,348,120       (1,482,036,501
   

 

 

   

 

 

         

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

      (250,897,912     (718,672,958           565,203,528       (365,534,664
   

 

 

   

 

 

         

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

               

Institutional

      (49,249,384     (130,528,578           (332,060,115     (516,524,194

Service

                        (2,505,628     (3,833,641

Investor A

      (107,430,249     (328,770,936           (217,566,520     (314,788,449

Investor C

      (4,511,618     (13,984,071           (43,035,902     (65,533,391

Class K

      (32,967,155     (101,284,889           (29,314,217     (43,731,512

Class R

      (1,927,272     (6,004,941           (18,223,606     (25,626,380
   

 

 

   

 

 

         

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

      (196,085,678     (580,573,415           (642,705,988     (970,037,567
   

 

 

   

 

 

         

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

               

Net increase (decrease) in net assets derived from capital share transactions

      (122,640,264     254,523,260             93,655,735       (174,654,649
   

 

 

   

 

 

         

 

 

   

 

 

 

Capital contribution from affiliate

                              183,194  
   

 

 

   

 

 

         

 

 

   

 

 

 

NET ASSETS

               

Total increase (decrease) in net assets

      (569,623,854     (1,044,723,113           16,153,275       (1,510,043,686

Beginning of period

      3,533,434,041       4,578,157,154             9,494,110,035       11,004,153,721  
   

 

 

   

 

 

         

 

 

   

 

 

 

End of period

    $     2,963,810,187     $     3,533,434,041           $     9,510,263,310     $     9,494,110,035  
   

 

 

   

 

 

         

 

 

   

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

42  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Statements of Changes in Net Assets (continued)

Six Months Ended November 30, 2022

 

    BlackRock Infrastructure Sustainable Opportunities Fund           

 

     BlackRock Mid-Cap Growth Equity Portfolio  
    

Six Months

Ended

11/30/22

(unaudited)

   

Period from
09/30/21(a)

to 05/31/22

           

Six Months

Ended

11/30/22

(unaudited)

   

Year Ended

05/31/22

 

INCREASE (DECREASE) IN NET ASSETS

               

OPERATIONS

               

Net investment income (loss)

    $ 62,952     $ 75,299           $ (16,573,234   $ (96,337,557

Net realized gain (loss)

      (606,379     219,282             (1,347,136,731     (861,239,707

Net change in unrealized appreciation (depreciation)

      (324,562     (243,994           1,116,630,831       (3,892,585,642
   

 

 

   

 

 

         

 

 

   

 

 

 

Net increase (decrease) in net assets resulting from operations

      (867,989     50,587             (247,079,134     (4,850,162,906
   

 

 

   

 

 

         

 

 

   

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(b)

               

Institutional

      (3,459     (797                 (495,288,827

Service

                              (6,119,263

Investor A

      (3,414     (706                 (153,891,201

Investor C

                              (26,348,042

Class K

      (318,351     (76,679                 (214,611,593

Class R

                              (6,308,880
   

 

 

   

 

 

         

 

 

   

 

 

 

Decrease in net assets resulting from distributions to shareholders

      (325,224     (78,182                 (902,567,806
   

 

 

   

 

 

         

 

 

   

 

 

 

CAPITAL SHARE TRANSACTIONS

               

Net increase (decrease) in net assets derived from capital share transactions

      7,794       10,020,140             (857,203,251     3,483,893,548  
   

 

 

   

 

 

         

 

 

   

 

 

 

NET ASSETS

               

Total increase (decrease) in net assets

      (1,185,419     9,992,545             (1,104,282,385     (2,268,837,164

Beginning of period

      9,992,545                   13,803,564,088       16,072,401,252  
   

 

 

   

 

 

         

 

 

   

 

 

 

End of period

    $     8,807,126     $     9,992,545           $     12,699,281,703     $     13,803,564,088  
   

 

 

   

 

 

         

 

 

   

 

 

 

 

(a)

Commencement of operations.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  43


 

Statements of Changes in Net Assets  (continued)

Six Months Ended November 30, 2022

 

          BlackRock Technology Opportunities Fund  
    

Six Months

Ended

11/30/22

(unaudited)

   

Year Ended

05/31/22

 

INCREASE (DECREASE) IN NET ASSETS

       

OPERATIONS

       

Net investment loss

    $ (10,220,724     $ (48,945,433

Net realized loss

      (197,544,285       (141,299,490

Net change in unrealized appreciation (depreciation)

      (267,218,039       (1,754,816,313
   

 

 

     

 

 

 

Net decrease in net assets resulting from operations

      (474,983,048       (1,945,061,236
   

 

 

     

 

 

 

DISTRIBUTIONS TO SHAREHOLDERS(a)

       

Institutional

              (364,665,690

Service

              (6,205,984

Investor A

              (200,086,265

Investor C

              (39,592,660

Class K

              (13,962,671

Class R

              (3,782,264
   

 

 

     

 

 

 

Decrease in net assets resulting from distributions to shareholders

              (628,295,534
   

 

 

     

 

 

 

CAPITAL SHARE TRANSACTIONS

       

Net decrease in net assets derived from capital share transactions

      (504,256,655       (435,571,918
   

 

 

     

 

 

 

NET ASSETS

       

Total decrease in net assets

      (979,239,703       (3,008,928,688

Beginning of period

      5,157,385,321         8,166,314,009  
   

 

 

     

 

 

 

End of period

    $     4,178,145,618       $     5,157,385,321  
   

 

 

     

 

 

 

 

(a) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

See notes to financial statements.

 

 

44  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc.
    Institutional

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20 to
05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
     

Net asset value, beginning of period

  $ 31.98     $ 43.32      $ 38.32     $ 30.52      $ 33.72      $ 29.08     $ 25.17    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment income (loss)(a)

    0.01       (0.09      (0.06     (0.07      (0.05      0.00 (b)(c)       0.01 (d)    

Net realized and unrealized gain (loss)

    (2.24     (6.14      7.06       10.81        0.23        7.97       4.78    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net increase (decrease) from investment operations

    (2.23     (6.23      7.00       10.74        0.18        7.97       4.79    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Distributions from net realized gain(e)

    (1.65     (5.11      (2.00     (2.94      (3.38      (3.33     (0.88  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net asset value, end of period

  $ 28.10     $ 31.98      $ 43.32     $ 38.32      $ 30.52      $ 33.72     $ 29.08    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total Return(f)

                  

Based on net asset value

    (6.87 )%(g)      (17.30 )%       18.72 %(g)       38.17      1.77      30.19     19.89  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Ratios to Average Net Assets(h)

                  

Total expenses

    0.72 %(i)       0.70      0.72 %(i)       0.75      0.75      0.76     0.81  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total expenses after fees waived and/or reimbursed

    0.72 %(i)       0.70      0.72 %(i)       0.75      0.75      0.76     0.81  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment income (loss)

    0.05 %(i)       (0.21 )%       (0.21 )%(i)       (0.22 )%       (0.17 )%       0.01 %(b)       0.05 %(d)    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Supplemental Data

                  

Net assets, end of period (000)

  $  667,595     $  943,275      $  1,072,833     $ 911,484      $ 644,983      $  600,032     $  508,965    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Portfolio turnover rate

    29     55      25     42      48      42     62  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Amount is less than $0.005 per share.

(d) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.04 per share and 0.17%, respectively, resulting from a special dividend.

(e) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(f) 

Where applicable, assumes the reinvestment of distributions.

(g) 

Not annualized.

(h) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(i) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  45


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)
    Investor A

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
     

Net asset value, beginning of period

  $ 28.38     $ 39.00      $ 34.74     $ 27.99      $ 31.25      $ 27.16     $ 23.63    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment loss(a)

    (0.03     (0.18      (0.11     (0.14      (0.12      (0.08 )(b)       (0.06 )(c)    

Net realized and unrealized gain (loss)

    (1.99     (5.39      6.37       9.83        0.18        7.41       4.47    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net increase (decrease) from investment operations

    (2.02     (5.57      6.26       9.69        0.06        7.33       4.41    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Distributions from net realized gain(d)

    (1.65     (5.05      (2.00     (2.94      (3.32      (3.24     (0.88  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net asset value, end of period

  $ 24.71     $ 28.38      $ 39.00     $ 34.74      $ 27.99      $ 31.25     $ 27.16    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total Return(e)

                  

Based on net asset value

    (7.01 )%(f)       (17.51 )%       18.51 %(f)       37.84      1.48      29.85     19.57  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Ratios to Average Net Assets(g)

                  

Total expenses

    1.00 %(h)       0.97      0.97 %(h)       1.01      1.01      1.04     1.08  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total expenses after fees waived and/or reimbursed

    1.00 %(h)       0.97      0.97 %(h)       1.01      1.01      1.04     1.08  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment loss

    (0.23 )%(h)       (0.48 )%       (0.46 )%(h)       (0.48 )%       (0.43 )%       (0.28 )%(b)       (0.23 )%(c)    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Supplemental Data

                  

Net assets, end of period (000)

  $  1,631,467     $  1,871,340      $  2,551,211     $  2,195,906      $  1,692,630      $  1,751,581     $  1,597,563    
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Portfolio turnover rate

    29     55      25     42      48      42     62  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c)

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.04 per share and 0.17%, respectively, resulting from a special dividend.

(d)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

46  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)
    Investor C

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
     

Net asset value, beginning of period

  $ 17.01     $ 25.27     $ 23.27     $ 19.81      $ 23.29      $ 20.88     $ 18.52    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment loss(a)

    (0.08     (0.29     (0.20     (0.25      (0.24      (0.23 )(b)       (0.20 )(c)    

Net realized and unrealized gain (loss)

    (1.20     (3.05     4.20       6.65        0.04        5.56       3.44    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net increase (decrease) from investment operations

    (1.28     (3.34     4.00       6.40        (0.20      5.33       3.24    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Distributions from net realized gain(d)

    (1.65     (4.92     (2.00     (2.94      (3.28      (2.92     (0.88  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net asset value, end of period

  $ 14.08     $ 17.01     $ 25.27     $ 23.27      $ 19.81      $ 23.29     $ 20.88    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total Return(e)

                 

Based on net asset value

    (7.38 )%(f)      (18.18 )%      17.89 %(f)      36.73      0.72      28.77     18.61  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Ratios to Average Net Assets(g)

                 

Total expenses

    1.84 %(h)      1.76     1.77 %(h)      1.79      1.81      1.84     1.89  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total expenses after fees waived and/or reimbursed

    1.83 %(h)      1.76     1.77 %(h)      1.79      1.81      1.84     1.89  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment loss

    (1.07 )%(h)      (1.28 )%      (1.27 )%(h)      (1.26 )%       (1.23 )%       (1.09 )%(b)      (1.06 )%(c)   
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Supplemental Data

                 

Net assets, end of period (000)

  $ 39,574     $  48,332     $ 72,075     $  89,336      $  195,908      $  276,097     $  286,460    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Portfolio turnover rate

    29     55     25     42      48      42     62  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c)

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.04 per share and 0.17%, respectively, resulting from a special dividend.

(d)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  47


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)
    Class K

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
     

Net asset value, beginning of period

  $ 32.32     $ 43.71     $ 38.63     $ 30.71      $ 33.91      $ 29.24     $ 25.27    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment income (loss)(a)

    0.02       (0.06     (0.03     (0.04      (0.02      0.04 (b)       0.05 (c)    

Net realized and unrealized gain (loss)

    (2.27     (6.20     7.11       10.90        0.23        8.01       4.80    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net increase (decrease) from investment operations

    (2.25     (6.26     7.08       10.86        0.21        8.05       4.85    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Distributions from net realized gain(d)

    (1.65     (5.13     (2.00     (2.94      (3.41      (3.38     (0.88  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net asset value, end of period

  $ 28.42     $ 32.32     $ 43.71     $ 38.63      $ 30.71      $ 33.91     $ 29.24    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total Return(e)

                 

Based on net asset value

    (6.86 )%(f)      (17.22 )%      18.78 %(f)      38.33      1.86      30.36     20.05  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Ratios to Average Net Assets(g)

                 

Total expenses

    0.65 %(h)       0.64     0.63 %(h)       0.64      0.65      0.65     0.67  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Total expenses after fees waived and/or reimbursed

    0.65 %(h)       0.63     0.63 %(h)       0.64      0.64      0.65     0.67  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Net investment income (loss)

    0.12 %(h)       (0.15 )%      (0.13 )%(h)      (0.11 )%       (0.06 )%       0.14 %(b)       0.18 %(c)    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Supplemental Data

                 

Net assets, end of period (000)

  $  603,450     $  646,115     $ 845,106     $  682,107      $  552,523      $  568,169     $  425,347    
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

Portfolio turnover rate

    29     55     25     42      48      42     62  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

   

 

(a)

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.04 per share and 0.17%, respectively, resulting from a special dividend.

(d)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

48  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Capital Appreciation Fund, Inc. (continued)  
           Class R  
                

Six Months

Ended
11/30/22

     

 

    Year Ended      

 

     Period from
10/01/20
    Year Ended      Year Ended      Year Ended     Year Ended  
            (unaudited)            05/31/22             to 05/31/21     09/30/20      09/30/19      09/30/18     09/30/17  

Net asset value, beginning of period

    $ 21.02       $ 30.12        $ 27.30     $ 22.65      $ 26.00      $ 23.12     $ 20.30  
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

      (0.05       (0.23        (0.15     (0.17      (0.16      (0.13 )(b)      (0.10 )(c)  

Net realized and unrealized gain (loss)

      (1.49       (3.88        4.97       7.76        0.09        6.19       3.80  
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

      (1.54       (4.11        4.82       7.59        (0.07      6.06       3.70  
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(d)

      (1.65       (4.99        (2.00     (2.94      (3.28      (3.18     (0.88
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

    $ 17.83       $ 21.02        $ 30.12     $ 27.30      $ 22.65      $ 26.00     $ 23.12  
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(e)

                      

Based on net asset value

      (7.20 )%(f)        (17.82 )%         18.26 %(f)      37.45      1.19      29.49     19.27
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(g)

                      

Total expenses

      1.37 %(h)        1.33        1.30 %(h)      1.28      1.29      1.30     1.35
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

      1.36 %(h)        1.33        1.30 %(h)      1.28      1.29      1.30     1.35
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

      (0.60 )%(h)        (0.85 )%         (0.80 )%(h)      (0.75 )%       (0.71 )%       (0.54 )%(b)      (0.50 )%(c) 
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

                      

Net assets, end of period (000)

    $ 21,724       $ 24,371        $ 36,933     $ 37,741      $ 54,828      $ 84,484     $ 75,765  
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

      29       55        25     42      48      42     62
   

 

 

     

 

 

      

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.06 per share and 0.21%, respectively, resulting from a special dividend.

(c) 

Net investment loss per share and the ratio of net investment loss to average net assets includes $ 0.04 per share and 0.17%, respectively, resulting from a special dividend.

(d) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(e) 

Where applicable, assumes the reinvestment of distributions.

(f) 

Not annualized.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

 

See

notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  49


 

Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio  
    Institutional  

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 72.10     $ 81.77     $ 75.37     $ 61.55      $ 67.67      $ 57.28      $ 50.30  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income(a)

    0.16       0.24       0.13       0.19        0.28        0.24        0.14  

Net realized and unrealized gain (loss)

    4.13       (2.75     9.66       16.26        (1.64      12.18        7.92  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    4.29       (2.51     9.79       16.45        (1.36      12.42        8.06  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Distributions(b)

                

From net investment income

    (0.14     (0.16     (0.13     (0.32      (0.23      (0.02       

From net realized gain

    (4.66     (7.00     (3.26     (2.31      (4.53      (2.01      (1.08
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total distributions

    (4.80     (7.16     (3.39     (2.63      (4.76      (2.03      (1.08
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 71.59     $ 72.10     $ 81.77     $ 75.37      $ 61.55      $ 67.67      $ 57.28  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

                

Based on net asset value

    6.55 %(d)       (3.55 )%(e)       13.37 %(d)       27.34 %(f)        (1.84 )%       22.47      16.53
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                

Total expenses

    0.84 %(h)       0.85     0.84 %(h)       0.85      0.85      0.87      0.89
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.84 %(h)       0.85     0.84 %(h)       0.85      0.84      0.86      0.89
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment income

    0.47 %(h)       0.31     0.24 %(h)       0.28      0.45      0.40      0.27
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

                

Net assets, end of period (000)

  $  5,028,932     $  5,062,514     $  5,990,131     $  5,133,191      $  3,095,352      $  2,944,146      $  2,190,418  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    13     51     19     28      41      39      39
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f)

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h)

Annualized.

See notes to financial statements.

 

 

50  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
   

Service

 
    Six Months Ended
11/30/22
    Year Ended     Period from
10/01/20
    Year Ended     Year Ended      Year Ended      Year Ended  
                (unaudited)     05/31/22     to 05/31/21     09/30/20     09/30/19      09/30/18      09/30/17  

Net asset value, beginning of period

    $ 68.16     $ 77.63     $ 71.63     $ 58.66     $ 64.73      $ 54.90      $ 48.39  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)(a)

      0.05       0.01       (0.03     (0.01     0.08        0.05        (0.01

Net realized and unrealized gain (loss)

      3.88       (2.61     9.18       15.48       (1.57      11.67        7.60  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

      3.93       (2.60     9.15       15.47       (1.49      11.72        7.59  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Distributions(b)

                 

From net investment income

      (0.05     —         —         (0.19     (0.05      —          —    

From net realized gain

      (4.66     (6.87     (3.15     (2.31     (4.53      (1.89      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total distributions

      (4.71     (6.87     (3.15     (2.50     (4.58      (1.89      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

    $ 67.38     $ 68.16     $ 77.63     $ 71.63     $ 58.66      $ 64.73      $ 54.90  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

      6.38 %(d)      (3.83 )%(e)      13.15 %(d)      26.96 %(f)      (2.16 )%       22.10      16.20
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

      1.14 %(h)      1.14     1.14 %(h)      1.15     1.15      1.17      1.17
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

      1.14 %(h)       1.14     1.14 %(h)       1.15     1.15      1.16      1.17
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income (loss)

      0.17 %(h)      0.02     (0.07 )%(h)      (0.02 )%      0.14      0.10      (0.02 )% 
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

    $  37,601     $  36,625     $  43,825     $  40,252     $  34,708      $  39,325      $  33,231  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

      13     51     19     28     41      39      39
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  51


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Investor A  
   

Six Months

Ended

11/30/22

    Year Ended     Period from
10/01/20
    Year Ended     Year Ended     Year Ended     Year Ended  
          (unaudited)     05/31/22     to 05/31/21     09/30/20     09/30/19     09/30/18     09/30/17  

Net asset value, beginning of period

             $ 67.84     $ 77.31     $ 71.37     $ 58.45     $ 64.50     $ 54.70     $ 48.22  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)(a)

      0.07       0.05       (0.01     0.01       0.10       0.06       (0.01

Net realized and unrealized gain (loss)

      3.86       (2.59     9.15       15.42       (1.56     11.63       7.57  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

      3.93       (2.54     9.14       15.43       (1.46     11.69       7.56  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions(b)

               

From net investment income

      (0.07     —         —         (0.20     (0.06     —         —    

From net realized gain

      (4.66     (6.93     (3.20     (2.31     (4.53     (1.89     (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions

      (4.73     (6.93     (3.20     (2.51     (4.59     (1.89     (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

    $ 67.04     $ 67.84     $ 77.31     $ 71.37     $ 58.45     $ 64.50     $ 54.70  

Total Return(c)

               

Based on net asset value

      6.41 %(d)       (3.78 )%(e)       13.18 %(d)       26.99 %(f)       (2.11 )%      22.13     16.20
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(g)

               

Total expenses

      1.10 %(h)       1.09     1.10 %(h)       1.11     1.12     1.15     1.17
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

      1.09 %(h)       1.09     1.10 %(h)       1.11     1.12     1.14     1.17
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income (loss)

      0.22 %(h)       0.07     (0.02 )%(h)       0.01     0.17     0.11     (0.02 )% 
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

               

Net assets, end of period (000)

    $  3,206,759     $  3,151,912     $  3,496,818     $  3,135,882     $  2,598,888     $  2,767,303     $  2,597,901  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

      13     51     19     28     41     39     39
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f)

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h)

Annualized.

See notes to financial statements.

 

 

52  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Investor C  
   

Six Months

Ended

11/30/22

    Year Ended     Period from
10/01/20
    Year Ended     Year Ended      Year Ended      Year Ended  
                (unaudited)     05/31/22     to 05/31/21     09/30/20     09/30/19      09/30/18      09/30/17  

Net asset value, beginning of period

    $ 57.24     $ 66.15     $ 61.38     $ 50.74     $ 56.55      $ 48.54      $ 43.22  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss(a)

      (0.14     (0.43     (0.33     (0.40     (0.28      (0.30      (0.33

Net realized and unrealized gain (loss)

      3.18       (2.17     7.85       13.34       (1.38      10.20        6.73  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

      3.04       (2.60     7.52       12.94       (1.66      9.90        6.40  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(b)

      (4.66     (6.31     (2.75     (2.30     (4.15      (1.89      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

    $ 55.62     $ 57.24     $ 66.15     $ 61.38     $ 50.74      $ 56.55      $ 48.54  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

      6.00 %(d)       (4.50 )%(e)      12.61 %(d)      26.09 %(f)       (2.82 )%       21.22      15.37
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

      1.85 %(h)       1.84     1.84 %(h)       1.85     1.85      1.87      1.90
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

      1.85 %(h)       1.84     1.84 %(h)       1.85     1.85      1.87      1.90
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss

      (0.53 )%(h)      (0.68 )%      (0.77 )%(h)      (0.72 )%      (0.56 )%       (0.61 )%       (0.75 )% 
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

    $  505,613     $  542,880     $ 719,525     $  773,522     $  745,636      $  1,017,205      $  954,780  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

      13     51     19     28     41      39      39
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f) 

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h)

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  53


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Class K  
   

Six Months

Ended

11/30/22

    Year Ended     Period from
10/01/20
    Year Ended     Year Ended      Year Ended      Year Ended  
                (unaudited)     05/31/22     to 05/31/21     09/30/20     09/30/19      09/30/18      09/30/17  

Net asset value, beginning of period

    $ 72.21     $ 81.91     $ 75.50     $ 61.63     $ 67.75      $ 57.37      $ 50.32  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income(a)

      0.19       0.33       0.18       0.27       0.34        0.32        0.26  

Net realized and unrealized gain (loss)

      4.14       (2.77     9.68       16.28       (1.65      12.17        7.87  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

      4.33       (2.44     9.86       16.55       (1.31      12.49        8.13  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Distributions(b)

                 

From net investment income

      (0.17     (0.26     (0.19     (0.37     (0.28      (0.10      —    

From net realized gain

      (4.66     (7.00     (3.26     (2.31     (4.53      (2.01      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total distributions

      (4.83     (7.26     (3.45     (2.68     (4.81      (2.11      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

    $ 71.71     $ 72.21     $ 81.91     $ 75.50     $ 61.63      $ 67.75      $ 57.37  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

      6.60 %(d)       (3.44 )%(e)      13.45 %(d)      27.47 %(f)      (1.75 )%       22.58      16.67
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

      0.75 %(h)       0.74     0.74 %(h)       0.75     0.75      0.77      0.78
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

      0.75 %(h)       0.74     0.74 %(h)       0.75     0.75      0.76      0.78
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment income

      0.57 %(h)       0.42     0.34 %(h)       0.39     0.55      0.53      0.47
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

    $  465,152     $  436,984     $ 464,179     $ 344,822     $  171,517      $  130,129      $  48,253  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

      13     51     19     28     41      39      39
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d)

Not annualized.

(e)

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f)

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h)

Annualized.

See notes to financial statements.

 

 

54  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Health Sciences Opportunities Portfolio (continued)  
    Class R  
       

Six Months

Ended
11/30/22

    Year Ended     Period from
10/01/20
    Year
Ended
    Year Ended      Year Ended      Year Ended  
                (unaudited)     05/31/22     to 05/31/21     09/30/20     09/30/19      09/30/18      09/30/17  

Net asset value, beginning of period

    $ 65.94     $ 75.28     $ 69.54     $ 57.05     $ 63.09      $ 53.71      $ 47.51  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss(a)

      (0.05     (0.21     (0.18     (0.20     (0.09      (0.11      (0.16

Net realized and unrealized gain (loss)

      3.74       (2.52     8.91       15.05       (1.53      11.38        7.44  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

      3.69       (2.73     8.73       14.85       (1.62      11.27        7.28  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Distributions(b)

                 

From net investment income

      —         —         —         (0.05     —          —          —    

From net realized gain

      (4.66     (6.61     (2.99     (2.31     (4.42      (1.89      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total distributions

      (4.66     (6.61     (2.99     (2.36     (4.42      (1.89      (1.08
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net asset value, end of period

    $ 64.97     $ 65.94     $ 75.28     $ 69.54     $ 57.05      $ 63.09      $ 53.71  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

      6.21 %(d)       (4.12 )%(e)      12.91 %(d)      26.60 %(f)      (2.44 )%       21.75      15.85
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(g)

                 

Total expenses

      1.46 %(h)       1.45     1.44 %(h)       1.45     1.45      1.46      1.49
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

      1.46 %(h)       1.45     1.44 %(h)       1.45     1.45      1.46      1.49
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Net investment loss

      (0.15 )%(h)      (0.29 )%      (0.37 )%(h)      (0.32 )%      (0.15 )%       (0.20 )%       (0.33 )% 
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

    $  266,206     $  263,195     $ 289,676     $ 260,488     $  224,862      $  241,495      $  198,426  
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

      13     51     19     28     41      39      39
   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Includes a capital contribution from affiliate, which had no impact on the Fund’s total return.

(f)

Includes a payment received from an affiliate, which had no impact on the Fund’s total return.

(g) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(h) 

Annualized.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  55


Financial Highlights  

(For a share outstanding throughout each period)

 

    BlackRock Infrastructure
Sustainable Opportunities Fund
 
    Institutional  
   

Six Months

Ended

11/30/22

(unaudited)

   

Period from

09/30/21(a)

to 05/31/22

 
     

Net asset value, beginning of period

  $ 9.97     $ 10.00  
 

 

 

   

 

 

 

Net investment income(b)

    0.06       0.07  

Net realized and unrealized loss

    (0.92     (0.02
 

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.86     0.05  
 

 

 

   

 

 

 

Distributions(c)

   

From net investment income

    (0.07     (0.04

From net realized gain

    (0.26     (0.04
 

 

 

   

 

 

 

Total distributions

    (0.33     (0.08
 

 

 

   

 

 

 

Net asset value, end of period

  $ 8.78     $ 9.97  
 

 

 

   

 

 

 

Total Return(d)

   

Based on net asset value

    (8.67 )%(e)      0.45 %(e) 
 

 

 

   

 

 

 

Ratios to Average Net Assets(f)

   

Total expenses

    2.77 %(g)(h)      3.62 %(g)(i) 
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.99 %(g)      1.00 %(g) 
 

 

 

   

 

 

 

Net investment income

    1.39 %(g)      1.09 %(g) 
 

 

 

   

 

 

 

Supplemental Data

   

Net assets, end of period (000)

  $ 95     $ 107  
 

 

 

   

 

 

 

Portfolio turnover rate

    50     70
 

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Aggregate total return.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Offering costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.15%.

(i) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.45%.

See notes to financial statements.

 

 

56  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

   

BlackRock Infrastructure Sustainable

Opportunities Fund (continued)

 
    Investor A  
   

Six Months

Ended

11/30/22

(unaudited)

   

Period from

09/30/21(a)

to 05/31/22

 
     

Net asset value, beginning of period

  $ 9.96     $ 10.00  
 

 

 

   

 

 

 

Net investment income(b)

    0.05       0.06  

Net realized and unrealized loss

    (0.92     (0.03
 

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.87     0.03  
 

 

 

   

 

 

 

Distributions(c)

   

From net investment income

    (0.06     (0.03

From net realized gain

    (0.26     (0.04
 

 

 

   

 

 

 

Total distributions

    (0.32     (0.07
 

 

 

   

 

 

 

Net asset value, end of period

  $ 8.77     $ 9.96  
 

 

 

   

 

 

 

Total Return(d)

   

Based on net asset value

    (8.78 )%(e)      0.29 %(e) 
 

 

 

   

 

 

 

Ratios to Average Net Assets(f)

   

Total expenses

    2.94 %(g)(h)      3.88 %(g)(i) 
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.22 %(g)      1.25 %(g) 
 

 

 

   

 

 

 

Net investment income

    1.15 %(g)      0.84 %(g) 
 

 

 

   

 

 

 

Supplemental Data

   

Net assets, end of period (000)

  $ 101     $ 109  
 

 

 

   

 

 

 

Portfolio turnover rate

    50     70
 

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Aggregate total return.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Offering costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.31%.

(i) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.71%.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  57


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

   

BlackRock Infrastructure Sustainable

Opportunities Fund (continued)

 
    Class K  
   

Six Months

Ended

11/30/22

(unaudited)

   

Period from

09/30/21(a)

to 05/31/22

 
     

Net asset value, beginning of period

  $ 9.97     $ 10.00  
 

 

 

   

 

 

 

Net investment income(b)

    0.06       0.08  

Net realized and unrealized loss

    (0.92     (0.03
 

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.86     0.05  
 

 

 

   

 

 

 

Distributions(c)

   

From net investment income

    (0.07     (0.04

From net realized gain

    (0.26     (0.04
 

 

 

   

 

 

 

Total distributions

    (0.33     (0.08
 

 

 

   

 

 

 

Net asset value, end of period

  $ 8.78     $ 9.97  
 

 

 

   

 

 

 

Total Return(d)

   

Based on net asset value

    (8.65 )%(e)      0.46 %(e) 
 

 

 

   

 

 

 

Ratios to Average Net Assets(f)

   

Total expenses

    3.37 %(g)(h)      3.36 %(g)(i) 
 

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.95 %(g)      0.95 %(g) 
 

 

 

   

 

 

 

Net investment income

    1.44 %(g)      1.13 %(g) 
 

 

 

   

 

 

 

Supplemental Data

   

Net assets, end of period (000)

  $ 8,611     $ 9,777  
 

 

 

   

 

 

 

Portfolio turnover rate

    50     70
 

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Aggregate total return.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Offering costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.07%.

(i) 

Audit, offering, organization and printing costs were not annualized in the calculation of the expense ratios. If these expenses were annualized, the total expenses would have been 4.21%.

See notes to financial statements.

 

 

58  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio  
    Institutional  
    Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    Period from
10/01/20 to
05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 
               

Net asset value, beginning of period

  $ 32.83     $ 45.95     $ 36.56     $ 28.68      $ 27.87      $ 22.10     $ 17.87  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

    (0.04     (0.23     (0.15     (0.14      (0.09      (0.11     (0.05 )(b)  

Net realized and unrealized gain (loss)

    (0.44     (10.52     9.54       8.14        1.95        6.63       4.28  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.48     (10.75     9.39       8.00        1.86        6.52       4.23  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.37           (0.12      (1.05      (0.75      
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 32.35     $ 32.83     $ 45.95     $ 36.56      $ 28.68      $ 27.87     $ 22.10  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(d)

               

Based on net asset value

    (1.46 )%(e)       (24.87 )%      25.68 %(e)       27.98      7.43      30.34     23.67
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(f)

               

Total expenses

    0.84 %(g)       0.81     0.80 %(g)       0.85      0.87      0.93 %(h)       1.08 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.80 %(g)       0.80     0.80 %(g)       0.80      0.80      0.86     1.08
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

    (0.23 )%(g)       (0.52 )%      (0.52 )%(g)       (0.43 )%       (0.34 )%       (0.45 )%      (0.25 )%(b)  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $  5,997,719     $  7,095,644     $  9,260,191     $  6,003,280      $  2,700,531      $  1,063,328     $  278,701  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    21     28     22     35      38      43     59
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d)

Where applicable, assumes the reinvestment of distributions.

(e)

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g)

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

     Six Months
Ended
11/30/22
(unaudited)
     Year Ended
05/31/22
   

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

            N/A        N/A       N/A       N/A        N/A        0.93      1.07
 

 

 

    

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  59


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Service  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 
               

Net asset value, beginning of period

  $ 29.34     $ 41.34      $ 32.95     $ 25.92      $ 25.30      $ 20.18     $ 16.35  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

    (0.07     (0.31      (0.20     (0.19      (0.15      (0.17     (0.12 )(b)  

Net realized and unrealized gain (loss)

    (0.40     (9.39      8.59       7.34        1.76        6.04       3.95  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.47     (9.70      8.39       7.15        1.61        5.87       3.83  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.30            (0.12      (0.99      (0.75      
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 28.87     $ 29.34      $ 41.34     $ 32.95      $ 25.92      $ 25.30     $ 20.18  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(d)

                

Based on net asset value

    (1.60 )%(e)      (25.06 )%       25.46 %(e)      27.68      7.15      30.03     23.43
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(f)

                

Total expenses

    1.10 %(g)      1.09      1.10 %(g)       1.11      1.16      1.25 %(h)      1.29
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.05 %(g)      1.05      1.05 %(g)       1.05      1.05      1.12     1.29
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

    (0.48 )%(g)      (0.77 )%       (0.78 )%(g)      (0.67 )%       (0.59 )%       (0.73 )%      (0.67 )%(b) 
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

                

Net assets, end of period (000)

  $ 76,722     $  81,276      $ 104,997     $  83,680      $ 61,293      $  33,768     $  12,718  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    21     28      22     35      38      43     59
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

     Six Months
Ended
11/30/22
(unaudited)
     Year Ended
05/31/22
    

Period from
10/01/20

to 05/31/21

     Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

    N/A        N/A        N/A        N/A        N/A        1.25      N/A  
 

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

60  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Investor A  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
   

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 27.96     $ 39.50     $ 31.48     $ 24.78      $ 24.22      $ 19.30     $ 15.66  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

    (0.06     (0.29     (0.19     (0.18      (0.14      (0.18     (0.10 )(b)  

Net realized and unrealized gain (loss)

    (0.39     (8.94     8.21       7.00        1.68        5.79       3.74  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.45     (9.23     8.02       6.82        1.54        5.61       3.64  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.31           (0.12      (0.98      (0.69      
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 27.51     $ 27.96     $ 39.50     $ 31.48      $ 24.78      $ 24.22     $ 19.30  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(d)

               

Based on net asset value

    (1.61 )%(e)       (25.05 )%      25.48 %(e)       27.61      7.17      29.98     23.24
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(f)

               

Total expenses

    1.13 %(g)       1.09     1.09 %(g)       1.14      1.16      1.29 %(h)       1.41 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.05 %(g)       1.05     1.05 %(g)       1.05      1.05      1.19     1.39
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

    (0.48 )%(g)       (0.78 )%      (0.78 )%(g)       (0.67 )%       (0.58 )%       (0.82 )%      (0.59 )%(b) 
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $  1,767,702     $  1,913,190     $ 2,577,151     $  1,917,773      $  1,335,467      $  801,263     $  525,736  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    21     28     22     35      38      43     59
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

     Six Months
Ended
11/30/22
(unaudited)
     Year Ended
05/31/22
   

Period from

10/01/20

to 05/31/21

     Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

    N/A        N/A       N/A        N/A        N/A        1.26      1.39
 

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  61


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Investor C  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
   

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 20.93     $ 30.22     $ 24.20     $ 19.21      $ 19.04      $ 15.36     $ 12.55  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

    (0.12     (0.43     (0.29     (0.30      (0.24      (0.26     (0.18 )(b) 

Net realized and unrealized gain (loss)

    (0.29     (6.67     6.31       5.41        1.28        4.57       2.99  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.41     (7.10     6.02       5.11        1.04        4.31       2.81  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.19           (0.12      (0.87      (0.63      
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 20.52     $ 20.93     $ 30.22     $ 24.20      $ 19.21      $ 19.04     $ 15.36  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(d)

               

Based on net asset value

    (1.96 )%(e)      (25.61 )%      24.88 %(e)      26.72      6.33      29.05     22.39
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(f)

               

Total expenses

    1.82 %(g)       1.78     1.80 %(g)       1.84      1.86      1.94 %(h)       2.11 %(h) 
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.80 %(g)       1.78     1.79 %(g)       1.80      1.80      1.88     2.10
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

    (1.23 )%(g)      (1.51 )%      (1.52 )%(g)      (1.42 )%       (1.33 )%       (1.49 )%      (1.30 )%(b) 
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $  214,339     $  243,284     $ 357,360     $  280,143      $ 209,923      $  164,083     $  72,814  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    21     28     22     35      38      43     59
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

     Six Months
Ended
11/30/22
(unaudited)
     Year Ended
05/31/22
    

Period from
10/01/20

to 05/31/21

     Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

    N/A        N/A        N/A        N/A        N/A        1.94      2.10
 

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

62  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Class K  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
   

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
    Year Ended
09/30/19
    Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 32.96     $ 46.10     $ 36.66     $ 28.74     $ 27.93     $ 22.14     $ 17.88  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(a)

    (0.02     (0.17     (0.12     (0.12     (0.09     (0.07     (0.03 )(b) 

Net realized and unrealized gain (loss)

    (0.45     (10.58     9.56       8.16       1.96       6.62       4.29  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.47     (10.75     9.44       8.04       1.87       6.55       4.26  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.39           (0.12     (1.06     (0.76      
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 32.49     $ 32.96     $ 46.10     $ 36.66     $ 28.74     $ 27.93     $ 22.14  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

             

Based on net asset value

    (1.43 )%(e)       (24.79 )%      25.75 %(e)       28.06     7.47     30.46     23.83
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

             

Total expenses

    0.70 %(g)       0.70     0.70 %(g)       0.73 %(h)       0.76 %(h)       0.80 %(h)       0.95
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.70 %(g)       0.70     0.70 %(g)       0.73     0.75     0.76     0.95
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.13 )%(g)       (0.40 )%      (0.42 )%(g)       (0.36 )%      (0.31 )%      (0.29 )%      (0.17 )%(b) 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

             

Net assets, end of period (000)

  $  4,550,173     $  4,376,642     $ 3,674,402     $  2,011,727     $  652,138     $  139,138     $ 4,103  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    21     28     22     35     38     43     59
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g) 

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

 

     Six Months
Ended
11/30/22
(unaudited)
  Year Ended
05/31/22
  

Period from
10/01/20

to 05/31/21

   Year Ended
09/30/20
   Year Ended
09/30/19
   Year Ended
09/30/18
   Year Ended
09/30/17
Expense ratios   N/A   N/A    N/A    0.73%    0.75%    0.80%    N/A

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  63


 

Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Mid-Cap Growth Equity Portfolio (continued)  
    Class R  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
   

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 27.28     $ 38.65     $ 30.85     $ 24.34      $ 23.83      $ 19.02     $ 15.47  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

    (0.10     (0.37     (0.25     (0.24      (0.19      (0.22     (0.14 )(b)  

Net realized and unrealized gain (loss)

    (0.37     (8.73     8.05       6.87        1.65        5.69       3.69  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (0.47     (9.10     7.80       6.63        1.46        5.47       3.55  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(c)

          (2.27           (0.12      (0.95      (0.66      
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

  $ 26.81     $ 27.28     $ 38.65     $ 30.85      $ 24.34      $ 23.83     $ 19.02  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(d)

               

Based on net asset value

    (1.72 )%(e)      (25.24 )%      25.28 %(e)      27.33      6.89      29.63     22.95
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(f)

               

Total expenses

    1.43 %(g)      1.40     1.39 %(g)      1.45      1.47      1.59 %(h)      1.76
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    1.30 %(g)      1.30     1.30 %(g)      1.30      1.30      1.43     1.65
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

    (0.73 )%(g)      (1.02 )%      (1.03 )%(g)      (0.92 )%       (0.83 )%       (1.05 )%      (0.86 )%(b) 
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

               

Net assets, end of period (000)

  $ 92,626     $  93,527     $ 98,300     $  59,411      $ 40,999      $  22,880     $  10,177  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

    21     28     22     35      38      43     59
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Net investment income per share and the ratio of net investment income to average net assets includes $0.06 per share and 0.35%, respectively, resulting from a special dividend.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g)

Annualized.

(h) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

 

     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    

Period from
10/01/20

to 05/31/21

     Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

    N/A       N/A        N/A        N/A        N/A        1.58      N/A  
 

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

64  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Financial Highlights

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund  
    Institutional  

 

  Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
    Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Net asset value, beginning of period

  $ 45.31     $ 64.81     $ 55.33     $ 32.63      $ 31.83      $ 25.64      $ 19.18  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.06     (0.30     (0.28     (0.22      (0.10      (0.09      (0.12

Net realized and unrealized gain (loss)

    (4.05     (14.51     12.67       23.43        1.20        8.25        6.78  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    (4.11     (14.81     12.39       23.21        1.10        8.16        6.66  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(b)

          (4.69     (2.91     (0.51      (0.30      (1.97      (0.20
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 41.20     $ 45.31     $ 64.81     $ 55.33      $ 32.63      $ 31.83      $ 25.64  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

                

Based on net asset value

    (9.07 )%(d)       (25.09 )%      22.68 %(d)       72.07      3.63      34.02      35.13
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(e)

                

Total expenses

    0.99 %(f)       0.94     0.92 %(f)       0.98      1.02      1.10      1.22 %(g)  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    0.92 %(f)       0.92     0.92 %(f)       0.92      0.92      0.99      1.21
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss

    (0.31 )%(f)       (0.48 )%      (0.66 )%(f)       (0.50 )%       (0.32 )%       (0.32 )%       (0.54 )% 
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

                

Net assets, end of period (000)

  $  2,284,643     $  2,943,616     $  4,958,187     $  3,641,519      $  1,033,286      $  584,654      $  147,796  
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    18     29     25     27      33      49      51
 

 

 

   

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios.

See notes to financial statements.

 

 

I N A N C I A L  T A T E M E N T S

  65


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Service  
    

Six Months
Ended
11/30/22

(unaudited)

    Year Ended
05/31/22
    

Period from
10/01/20

to 05/31/21

    Year Ended
09/30/20
     Year Ended
09/30/19
    Year Ended
09/30/18
     Year Ended
09/30/17
 

Net asset value, beginning of period

    $ 42.30     $ 60.86      $ 52.20     $ 30.88      $ 30.22     $ 24.44      $ 18.34  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Net investment loss(a)

      (0.11     (0.42      (0.37     (0.30      (0.17     (0.15      (0.16
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Net realized and unrealized gain (loss)

      (3.78     (13.52      11.94       22.13        1.13       7.85        6.46  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Net increase (decrease) from investment operations

      (3.89     (13.94      11.57       21.83        0.96       7.70        6.30  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Distributions from net realized gain(b)

            (4.62      (2.91     (0.51      (0.30     (1.92      (0.20
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Net asset value, end of period

    $ 38.41     $ 42.30      $ 60.86     $ 52.20      $ 30.88     $ 30.22      $ 24.44  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total Return(c)

                  

Based on net asset value

      (9.20 )%(d)      (25.28 )%       22.46 %(d)      71.68      3.36     33.74      34.77
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Ratios to Average Net Assets(e)

                  

Total expenses

      1.21 %(f)      1.19      1.17 %(f)      1.19      1.25 %(g)      1.37      1.48 %(g) 
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

      1.17 %(f)      1.17      1.16 %(f)      1.17      1.17     1.22      1.47
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Net investment loss

      (0.55 )%(f)      (0.73 )%       (0.90 )%(f)      (0.74 )%       (0.57 )%      (0.55 )%       (0.77 )% 
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Supplemental Data

                  

Net assets, end of period (000)

    $ 46,020     $ 55,439      $ 83,886     $ 50,710      $ 20,429     $ 15,208      $ 6,312  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Portfolio turnover rate

      18     29      25     27      33     49      51
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(a)

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, assumes the reinvestment of distributions.

(d)

Not annualized.

(e)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees with no financial impact to the expense ratios.

See notes to financial statements.

 

 

66  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Investor A  
            Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

    $ 41.27     $ 59.47      $ 51.06     $ 30.22      $ 29.58      $ 23.95     $ 17.98  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

      (0.11     (0.41      (0.36     (0.29      (0.17      (0.16     (0.17
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net realized and unrealized gain (loss)

      (3.69     (13.19      11.68       21.64        1.11        7.69       6.34  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

      (3.80     (13.60      11.32       21.35        0.94        7.53       6.17  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(b)

            (4.60      (2.91     (0.51      (0.30      (1.90     (0.20
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

    $ 37.47     $ 41.27      $ 59.47     $ 51.06      $ 30.22      $ 29.58     $ 23.95  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(c)

                  

Based on net asset value

      (9.21 )%(d)       (25.28 )%       22.48 %(d)       71.65      3.36      33.70     34.74
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(e)

                  

Total expenses

      1.24 %(f)       1.21      1.19 %(f)       1.25      1.29      1.38 %(g)       1.50
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

      1.17 %(f)       1.17      1.17 %(f)       1.17      1.17      1.26     1.49
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

      (0.55 )%(f)       (0.73 )%       (0.91 )%(f)       (0.74 )%       (0.58 )%       (0.59 )%      (0.83 )% 
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

                  

Net assets, end of period (000)

    $ 1,450,087     $ 1,695,648      $ 2,524,052     $ 1,773,399      $ 672,110      $ 627,626     $ 271,307  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

      18     29      25     27      33      49     51
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a)

Based on average shares outstanding.

(b)

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d)

Not annualized.

(e)

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

            Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

      N/A       N/A        N/A       N/A        N/A        1.37      N/A  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  67


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Investor C  
          Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
    Year Ended
09/30/17
 

Net asset value, beginning of period

    $ 33.17     $ 48.77      $ 42.52     $ 25.43      $ 25.13      $ 20.72     $ 15.70  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss(a)

      (0.20     (0.68      (0.54     (0.48      (0.32      (0.31     (0.28

Net realized and unrealized gain (loss)

      (2.97     (10.52      9.70       18.08        0.92        6.57       5.50  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net increase (decrease) from investment operations

      (3.17     (11.20      9.16       17.60        0.60        6.26       5.22  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Distributions from net realized gain(b)

            (4.40      (2.91     (0.51      (0.30      (1.85     (0.20
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net asset value, end of period

    $ 30.00     $ 33.17      $ 48.77     $ 42.52      $ 25.43      $ 25.13     $ 20.72  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total Return(c)

                  

Based on net asset value

      (9.56 )%(d)      (25.81 )%       21.89 %(d)      70.39      2.60      32.68     33.73
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Ratios to Average Net Assets(e)

                  

Total expenses

      1.98 %(f)       1.92      1.91 %(f)       1.98      2.02      2.10 %(g)       2.27
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

      1.92 %(f)      1.91      1.90 %(f)      1.92      1.92      2.01     2.25
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Net investment loss

      (1.30 )%(f)      (1.47 )%       (1.65 )%(f)      (1.49 )%       (1.33 )%       (1.34 )%      (1.59 )% 
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Supplemental Data

                  

Net assets, end of period (000)

    $ 244,267     $ 291,802      $ 427,435     $ 317,792      $ 152,505      $ 142,942     $ 76,957  
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

Portfolio turnover rate

      18     29      25     27      33      49     51
   

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

   

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c)

Where applicable, excludes the effects of any sales charges and assumes the reinvestment of distributions.

(d)

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f)

Annualized.

(g) 

Includes recoupment of past waived and/or reimbursed fees. Excluding the recoupment of past waived and/or reimbursed fees, the ratios were as follows:

 

    

Six Months

Ended

11/30/22
(unaudited)

    Year
Ended
05/31/22
    Period from
10/01/20 to
05/31/21
     Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 

Expense ratios

    N/A       N/A       N/A        N/A        N/A        2.09      N/A  
 

 

 

   

 

 

   

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

See notes to financial statements.

 

 

68  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Class K  
     Six Months
Ended
11/30/22
(unaudited)
    Year
Ended
05/31/22
    Period
from
10/01/20
to
05/31/21
    Period from
12/10/19(a)
to 09/30/20
 
         

Net asset value, beginning of period

  $ 45.37     $ 64.89     $ 55.36     $ 34.59  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss(b)

    (0.05     (0.24     (0.24     (0.16

Net realized and unrealized gain (loss)

    (4.05     (14.55     12.68       20.93  
 

 

 

   

 

 

   

 

 

   

 

 

 

Net increase (decrease) from investment operations

    (4.10     (14.79     12.44       20.77  
 

 

 

   

 

 

   

 

 

   

 

 

 

Distributions from net realized gain(c)

          (4.73     (2.91      
 

 

 

   

 

 

   

 

 

   

 

 

 

Net asset value, end of period

  $ 41.27     $ 45.37     $ 64.89     $ 55.36  
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Return(d)

       

Based on net asset value

    (9.04 )%(e)      (25.05 )%      22.77 %(e)      60.05 %(e) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets(f)

       

Total expenses

    0.87 %(g)       0.84     0.83 %(g)      0.87 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Total expenses after fees waived and/or reimbursed

    0.87 %(g)       0.83     0.82 %(g)      0.86 %(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Net investment loss

    (0.25 )%(g)      (0.38 )%      (0.56 )%(g)      (0.46 )%(g) 
 

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental Data

       

Net assets, end of period (000)

  $ 122,020     $ 135,879     $ 122,568     $ 75,426  
 

 

 

   

 

 

   

 

 

   

 

 

 

Portfolio turnover rate

    18     29     25     27 %(h)  
 

 

 

   

 

 

   

 

 

   

 

 

 

 

(a) 

Commencement of operations.

(b) 

Based on average shares outstanding.

(c) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(d) 

Where applicable, assumes the reinvestment of distributions.

(e) 

Not annualized.

(f) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(g)

Annualized.

(h) 

Portfolio turnover is representative of the Fund for the entire year.

See notes to financial statements.

 

 

I N A N C I A L  I G H L I G H T S

  69


Financial Highlights  (continued)

(For a share outstanding throughout each period)

 

    BlackRock Technology Opportunities Fund (continued)  
    Class R  
     Six Months
Ended
11/30/22
(unaudited)
    Year Ended
05/31/22
     Period from
10/01/20
to 05/31/21
    Year Ended
09/30/20
     Year Ended
09/30/19
     Year Ended
09/30/18
     Year Ended
09/30/17
 
               

Net asset value, beginning of period

  $ 41.44     $ 59.75      $ 51.37     $ 30.48      $ 29.90      $ 24.20      $ 18.21  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss(a)

    (0.15     (0.56      (0.46     (0.38      (0.24      (0.23      (0.23

Net realized and unrealized gain (loss)

    (3.70     (13.25      11.75       21.78        1.12        7.78        6.42  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net increase (decrease) from investment operations

    (3.85     (13.81      11.29       21.40        0.88        7.55        6.19  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Distributions from net realized gain(b)

          (4.50      (2.91     (0.51      (0.30      (1.85      (0.20
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net asset value, end of period

  $ 37.59     $ 41.44      $ 59.75     $ 51.37      $ 30.48      $ 29.90      $ 24.20  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total Return(c)

                 

Based on net asset value

    (9.29 )%(d)      (25.47 )%       22.28 %(d)      71.20      3.12      33.35      34.41
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Ratios to Average Net Assets(e)

                 

Total expenses

    1.58 %(f)      1.54      1.50 %(f)      1.57      1.60      1.69      1.81
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Total expenses after fees waived and/or reimbursed

    1.42 %(f)      1.42      1.42 %(f)      1.42      1.42      1.53      1.77
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Net investment loss

    (0.80 )%(f)      (0.98 )%       (1.17 )%(f)      (0.99 )%       (0.83 )%       (0.87 )%       (1.11 )% 
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Supplemental Data

                 

Net assets, end of period (000)

  $ 31,109     $ 35,001      $ 50,186     $ 38,907      $ 18,799      $ 13,577      $ 9,700  
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

Portfolio turnover rate

    18     29      25     27      33      49      51
 

 

 

   

 

 

    

 

 

   

 

 

    

 

 

    

 

 

    

 

 

 

 

(a) 

Based on average shares outstanding.

(b) 

Distributions for annual periods determined in accordance with U.S. federal income tax regulations.

(c) 

Where applicable, assumes the reinvestment of distributions.

(d) 

Not annualized.

(e) 

Excludes fees and expenses incurred indirectly as a result of investments in underlying funds.

(f) 

Annualized.

See notes to financial statements.

 

 

70  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited)

 

1.

ORGANIZATION

BlackRock Capital Appreciation Fund, Inc. (the “Corporation”) and BlackRock FundsSM (the “Trust”) are each registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as open-end management investment companies. The Corporation is organized as a Maryland corporation. The Trust is organized as a Massachusetts business trust. BlackRock Capital Appreciation Fund, Inc. is the only series of the Corporation. BlackRock Health Sciences Opportunities Portfolio, BlackRock Infrastructure Sustainable Opportunities Fund, BlackRock Mid-Cap Growth Equity Portfolio and BlackRock Technology Opportunities Fund are series of the Trust. The following are referred to herein collectively as the “Funds” or individually as a “Fund”:

 

Fund Name   Herein Referred To As      Diversification Classification  

BlackRock Capital Appreciation Fund, Inc.

    Capital Appreciation        Diversified  

BlackRock Health Sciences Opportunities Portfolio

    Health Sciences Opportunities        Diversified  

BlackRock Infrastructure Sustainable Opportunities Fund

    Infrastructure Sustainable Opportunities        Non-Diversified  

BlackRock Mid-Cap Growth Equity Portfolio

    Mid-Cap Growth Equity        Diversified  

BlackRock Technology Opportunities Fund

    Technology Opportunities        Diversified  

Each Fund offers multiple classes of shares. All classes of shares have identical voting, dividend, liquidation and other rights and are subject to the same terms and conditions, except that certain classes bear expenses related to the shareholder servicing and distribution of such shares. Institutional, Service and Class K Shares are sold only to certain eligible investors. Service, Investor A, Investor C and Class R Shares bear certain expenses related to shareholder servicing of such shares, and Investor C and Class R Shares also bear certain expenses related to the distribution of such shares. Investor A and Investor C Shares are generally available through financial intermediaries. Class R Shares are sold only to certain employer-sponsored retirement plans. Each class has exclusive voting rights with respect to matters relating to its shareholder servicing and distribution expenditures (except that Investor C shareholders may vote on material changes to the Investor A Shares distribution and service plan).

 

Share Class   Initial Sales Charge    CDSC      Conversion Privilege

Institutional, Service and Class K Shares

  No      No      None

Investor A Shares

  Yes      No (a)     None

Investor C Shares

  No      Yes (b)     To Investor A Shares after approximately 8 years

 

  (a) 

Investor A Shares may be subject to a contingent deferred sales charge (“CDSC”) for certain redemptions where no initial sales charge was paid at the time of purchase.

 
  (b) 

A CDSC of 1.00% is assessed on certain redemptions of Investor C Shares made within one year after purchase.

 

The Board of Directors of the Corporation and the Board of Trustees of the Trust are collectively referred to throughout this report as the “Board”, and the directors/trustees thereof are collectively referred to throughout this report as “Directors.”

The Funds, together with certain other registered investment companies advised by BlackRock Advisors, LLC (the “Manager”) or its affiliates, are included in a complex of funds referred to as the BlackRock Multi-Asset Complex.

 

2.

SIGNIFICANT ACCOUNTING POLICIES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which may require management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the financial statements, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies. Below is a summary of significant accounting policies:

Investment Transactions and Income Recognition: For financial reporting purposes, investment transactions are recorded on the dates the transactions are executed. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recorded on the ex-dividend dates. Non-cash dividends, if any, are recorded on the ex-dividend dates at fair value. Dividends from foreign securities where the ex-dividend dates may have passed are subsequently recorded when the Funds are informed of the ex-dividend dates. Under the applicable foreign tax laws, a withholding tax at various rates may be imposed on capital gains, dividends and interest. Upon notification from issuers, a portion of the dividend income received from a real estate investment trust may be redesignated as a reduction of cost of the related investment and/or realized gain. Income, expenses and realized and unrealized gains and losses are allocated daily to each class based on its relative net assets.

Foreign Currency Translation: Each Fund’s books and records are maintained in U.S. dollars. Securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars using exchange rates determined as of the close of trading on the New York Stock Exchange (“NYSE”). Purchases and sales of investments are recorded at the rates of exchange prevailing on the respective dates of such transactions. Generally, when the U.S. dollar rises in value against a foreign currency, the investments denominated in that currency will lose value; the opposite effect occurs if the U.S. dollar falls in relative value.

Each Fund does not isolate the effect of fluctuations in foreign exchange rates from the effect of fluctuations in the market prices of investments for financial reporting purposes. Accordingly, the effects of changes in exchange rates on investments are not segregated in the Statements of Operations from the effects of changes in market prices of those investments, but are included as a component of net realized and unrealized gain (loss) from investments. Each Fund reports realized currency gains (losses) on foreign currency related transactions as components of net realized gain (loss) for financial reporting purposes, whereas such components are generally treated as ordinary income for U.S. federal income tax purposes.

ForeignTaxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  71


Notes to Financial Statements  (unaudited) (continued)

 

invests. These foreign taxes, if any, are paid by each Fund and are reflected in its Statements of Operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “Foreign taxes withheld”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of November 30, 2022, if any, are disclosed in the Statements of Assets and Liabilities.

The Funds file withholding tax reclaims in certain jurisdictions to recover a portion of amounts previously withheld. The Funds may record a reclaim receivable based on collectability, which includes factors such as the jurisdiction’s applicable laws, payment history and market convention. The Statements of Operations include tax reclaims recorded as well as professional and other fees, if any, associated with recovery of foreign withholding taxes.

Collateralization: If required by an exchange or counterparty agreement, the Funds may be required to deliver/deposit cash and/or securities to/with an exchange, or broker-dealer or custodian as collateral for certain investments.

Distributions: Distributions paid by the Funds are recorded on the ex-dividend dates. The character and timing of distributions are determined in accordance with U.S. federal income tax regulations, which may differ from U.S. GAAP.

Offering Costs: Offering costs are amortized over a 12-month period beginning with the commencement of operations of a class of shares.

Indemnifications: In the normal course of business, a Fund enters into contracts that contain a variety of representations that provide general indemnification. A Fund’s maximum exposure under these arrangements is unknown because it involves future potential claims against a Fund, which cannot be predicted with any certainty.

Other: Expenses directly related to a Fund or its classes are charged to that Fund or the applicable class. Expenses directly related to the Funds and other shared expenses prorated to the Funds are allocated daily to each class based on their relative net assets or other appropriate methods. Other operating expenses shared by several funds, including other funds managed by the Manager, are prorated among those funds on the basis of relative net assets or other appropriate methods.

The Funds have an arrangement with their custodian whereby credits are earned on uninvested cash balances, which could be used to reduce custody fees and/or overdraft charges. The Funds may incur charges on overdrafts, subject to certain conditions.

 

3.

INVESTMENT VALUATION AND FAIR VALUE MEASUREMENTS

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund is open for business and, for financial reporting purposes, as of the report date. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. The Board of each Fund has approved the designation of each Fund’s Manager as the valuation designee for each Fund. Each Fund determines the fair values of its financial instruments using various independent dealers or pricing services under the Manager’s policies. If a security’s market price is not readily available or does not otherwise accurately represent the fair value of the security, the security will be valued in accordance with the Manager’s policies and procedures as reflecting fair value. The Manager has formed a committee (the “Valuation Committee”) to develop pricing policies and procedures and to oversee the pricing function for all financial instruments, with assistance from other BlackRock pricing committees.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Funds’ assets and liabilities:

 

   

Equity investments traded on a recognized securities exchange are valued at that day’s official closing price, as applicable, on the exchange where the stock is primarily traded. Equity investments traded on a recognized exchange for which there were no sales on that day may be valued at the last available bid (long positions) or ask (short positions) price.

 

   

Investments in open-end U.S. mutual funds (including money market funds) are valued at that day’s published net asset value (“NAV”).

 

   

The Funds value their investment in SL Liquidity Series, LLC, Money Market Series (the “Money Market Series”) at fair value, which is ordinarily based upon their pro rata ownership in the underlying fund’s net assets.

 

   

Forward foreign currency exchange contracts are valued at the mean between the bid and ask prices and are determined as of the close of trading on the NYSE based on that day’s prevailing forward exchange rate for the underlying currencies.

 

   

Swap agreements are valued utilizing quotes received daily by independent pricing services or through brokers, which are derived using daily swap curves and models that incorporate a number of market data factors, such as discounted cash flows, trades and values of the underlying reference instruments.

Generally, trading in foreign instruments is substantially completed each day at various times prior to the close of trading on the NYSE. Each business day, the Funds use current market factors supplied by independent pricing services to value certain foreign instruments (“Systematic Fair Value Price”). The Systematic Fair Value Price is designed to value such foreign securities at fair value as of the close of trading on the NYSE, which follows the close of the local markets.

If events (e.g., market volatility, company announcement or a natural disaster) occur that are expected to materially affect the value of such investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Valuation Committee in accordance with the Manager’s policies and procedures as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Valuation Committee include market approach, income approach and cost approach. Valuation techniques such as discounted cash flow, use of market comparables and matrix pricing are types of valuation approaches and are typically used in determining fair value. When determining the price for Fair Valued Investments, the Valuation Committee seeks to determine the price that each Fund might reasonably expect to receive or pay from the current sale or purchase of that asset or liability in an arm’s-length transaction. Fair value determinations shall be based upon all available factors that the Valuation Committee deems relevant and consistent with the principles of fair value measurement.

 

 

72  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

For investments in equity or debt issued by privately held companies or funds (“Private Company” or collectively, the “Private Companies”) and other Fair Valued Investments, the fair valuation approaches that are used by the Valuation Committee and third-party pricing services utilized by the Valuation Committee include one or a combination of, but not limited to, the following inputs.

 

Standard Inputs Generally Considered By The Valuation Committee And Third-Party Pricing Services

Market approach

 

(i)  recent market transactions, including subsequent rounds of financing, in the underlying investment or comparable issuers;

(ii) recapitalizations and other transactions across the capital structure; and

(iii)  market multiples of comparable issuers.

Income approach                                         

 

(i)  future cash flows discounted to present and adjusted as appropriate for liquidity, credit, and/or market risks;

(ii) quoted prices for similar investments or assets in active markets; and

(iii)  other risk factors, such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks, recovery rates, liquidation amounts and/or default rates.

Cost approach

 

(i)  audited or unaudited financial statements, investor communications and financial or operational metrics issued by the Private Company;

(ii) changes in the valuation of relevant indices or publicly traded companies comparable to the Private Company;

(iii)  relevant news and other public sources; and

(iv)  known secondary market transactions in the Private Company’s interests and merger or acquisition activity in companies comparable to the Private Company.

Investments in series of preferred stock issued by Private Companies are typically valued utilizing market approach in determining the enterprise value of the company. Such investments often contain rights and preferences that differ from other series of preferred and common stock of the same issuer. Enterprise valuation techniques such as an option pricing model (“OPM”), a probability weighted expected return model (“PWERM”), current value method or a hybrid of those techniques are used as deemed appropriate under the circumstances. The use of these valuation techniques involve a determination of the exit scenarios of the investment in order to appropriately allocate the enterprise value of the company among the various parts of its capital structure.

The Private Companies are not subject to the public company disclosure, timing, and reporting standards applicable to other investments held by a Fund. Typically, the most recently available information by a Private Company is as of a date that is earlier than the date a Fund is calculating its NAV. This factor may result in a difference between the value of the investment and the price a Fund could receive upon the sale of the investment.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

 

   

Level 1 – Unadjusted price quotations in active markets/exchanges for identical assets or liabilities that each Fund has the ability to access;

 

   

Level 2 – Other observable inputs (including, but not limited to, quoted prices for similar assets or liabilities in markets that are active, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the assets or liabilities (such as interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and default rates) or other market–corroborated inputs); and

 

   

Level 3 – Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available (including the Valuation Committee’s assumptions used in determining the fair value of financial instruments).

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Investments classified within Level 3 have significant unobservable inputs used by the Valuation Committee in determining the price for Fair Valued Investments. Level 3 investments include equity or debt issued by Private Companies that may not have a secondary market and/or may have a limited number of investors. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

As of November 30, 2022, certain investments of the Funds were fair valued using NAV per share as no quoted market value is available and therefore have been excluded from the fair value hierarchy.

 

4.

SECURITIES AND OTHER INVESTMENTS

Preferred Stocks: Preferred stock has a preference over common stock in liquidation (and generally in receiving dividends as well), but is subordinated to the liabilities of the issuer in all respects. As a general rule, the market value of preferred stock with a fixed dividend rate and no conversion element varies inversely with interest rates and perceived credit risk, while the market price of convertible preferred stock generally also reflects some element of conversion value. Because preferred stock is junior to debt securities and other obligations of the issuer, deterioration in the credit quality of the issuer will cause greater changes in the value of a preferred stock than in a more senior debt security with similar stated yield characteristics. Unlike interest payments on debt securities, preferred stock dividends are payable only if declared by the issuer’s board of directors. Preferred stock also may be subject to optional or mandatory redemption provisions.

Warrants: Warrants entitle a fund to purchase a specified number of shares of common stock and are non-income producing. The purchase price and number of shares are subject to adjustment under certain conditions until the expiration date of the warrants, if any. If the price of the underlying stock does not rise above the strike price before the

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  73


Notes to Financial Statements  (unaudited) (continued)

 

warrant expires, the warrant generally expires without any value and a fund will lose any amount it paid for the warrant. Thus, investments in warrants may involve more risk than investments in common stock. Warrants may trade in the same markets as their underlying stock; however, the price of the warrant does not necessarily move with the price of the underlying stock.

Securities Lending: The Funds may lend their securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by a bank, or securities issued or guaranteed by the U.S. Government. The initial collateral received by each Fund is required to have a value of at least 102% of the current value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current market value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund, or excess collateral returned by the Fund, on the next business day. During the term of the loan, the Fund is entitled to all distributions made on or in respect of the loaned securities, but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of period end, any securities on loan were collateralized by cash and/or U.S. Government obligations. Cash collateral invested by the securities lending agent, BlackRock Investment Management, LLC (“BIM”), if any, is disclosed in the Schedules of Investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan, if any, are disclosed in the Funds’ Schedules of Investments. The market value of any securities on loan and the value of any related collateral are shown separately in the Statements of Assets and Liabilities as a component of investments at value – unaffiliated and collateral on securities loaned, respectively.

Securities lending transactions are entered into by the Funds under Master Securities Lending Agreements (each, an “MSLA”), which provide the right, in the event of default (including bankruptcy or insolvency), for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the Fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. When the value of the collateral is greater than that of the market value of the securities loaned, the lender is left with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and a Fund can reinvest cash collateral received in connection with loaned securities. Upon an event of default, the parties’ obligations to return the securities or collateral to the other party are extinguished, and the parties can resell or re-pledge the loaned securities or the collateral received in connection with the loaned securities in order to satisfy the defaulting party’s net payment obligation for all transactions under the MSLA. The defaulting party remains liable for any deficiency.

As of period end, the following table is a summary of the Funds’ securities on loan by counterparty which are subject to offset under an MSLA:

 

Fund Name/Counterparty     
Securities
Loaned at Value
 
 
    
Cash
Collateral Received(a)
 
 
   
Non-Cash
Collateral Received(a)
 
 
    
Net
Amount(b)
 
 

Health Sciences Opportunities

          

Barclays Capital, Inc.

   $ 8,673,848      $ (8,588,600   $      $ 85,248  

BNP Paribas SA

     786,357        (786,357             

BofA Securities, Inc.

     145,288        (138,600            6,688  

Citigroup Global Markets, Inc.

     6,226,008        (6,152,350            73,658  

Credit Suisse Securities (USA) LLC

     72,536        (72,536             

Goldman Sachs & Co. LLC

     23,377,257        (23,203,290            173,967  

J.P. Morgan Securities LLC

     123,936,938        (123,936,938             

Jefferies LLC

     105,000        (105,000             

Morgan Stanley

     776,680        (749,677            27,003  

National Financial Services LLC

     659,639        (653,250            6,389  

State Street Bank & Trust Co.

     245,584        (243,462            2,122  

Toronto-Dominion Bank

     12,281        (11,950            331  

UBS Securities LLC

     83,811        (83,811             
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 165,101,227      $ (164,725,821   $      $ 375,406  
  

 

 

    

 

 

   

 

 

    

 

 

 

Infrastructure Sustainable Opportunities

          

J.P. Morgan Securities LLC

   $ 67,146      $ (67,146   $      $  
  

 

 

    

 

 

   

 

 

    

 

 

 

Mid-Cap Growth Equity

          

Barclays Capital, Inc.

   $ 15,562,616      $ (15,562,616   $      $  

Citigroup Global Markets, Inc.

     39,357,743        (39,357,743             

Credit Suisse Securities (USA) LLC

     274,577        (274,577             

Goldman Sachs & Co. LLC

     89,911,505        (89,911,505             

J.P. Morgan Securities LLC

     213,195,936        (213,195,936             

Jefferies LLC

     2,285,922        (2,285,922             

Morgan Stanley

     193,191,517        (193,191,517             

National Financial Services LLC

     1,170,260        (1,170,260             

State Street Bank & Trust Co.

     4,525,950        (4,525,950             

Toronto-Dominion Bank

     93,942        (93,942             
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 559,569,968      $ (559,569,968   $      $  
  

 

 

    

 

 

   

 

 

    

 

 

 

Technology Opportunities

          

Barclays Capital, Inc.

   $ 27,560      $ (27,560   $      $  

Citigroup Global Markets, Inc.

     27,245,162        (27,245,162             

Goldman Sachs & Co. LLC

     21,940,270        (21,940,270             

 

 

 

74  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

Fund Name/Counterparty     
Securities
Loaned at Value
 
 
    

Cash

Collateral Received(a)

 

 

   
Non-Cash
Collateral Received(a)
 
 
    
Net
Amount(b)
 
 

Technology Opportunities (continued)

          

J.P. Morgan Securities LLC

   $ 8,450,692      $ (8,450,692   $      $  

Morgan Stanley

     31,780,313        (31,780,313             

National Financial Services LLC

     1,522,648        (1,522,648             

State Street Bank & Trust Co.

     7,110,954        (7,110,954             

Toronto-Dominion Bank

     961,280        (961,280             
  

 

 

    

 

 

   

 

 

    

 

 

 
   $ 99,038,879      $ (99,038,879   $      $  
  

 

 

    

 

 

   

 

 

    

 

 

 

 

  (a) 

Collateral received in excess of the market value of securities on loan is not presented in this table. The total cash collateral received by each Fund is disclosed in the Funds’ Statements of Assets and Liabilities.

 
  (b) 

The market value of the loaned securities is determined as of November 30, 2022. Additional collateral is delivered to the Fund on the next business day in accordance with the MSLA. The net amount would be subject to the borrower default indemnity in the event of default by the counterparty.

 

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, the Funds benefit from a borrower default indemnity provided by BIM. BIM’s indemnity allows for full replacement of the securities loaned to the extent the collateral received does not cover the value on the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received. Such losses are borne entirely by the Funds.

 

5.

DERIVATIVE FINANCIAL INSTRUMENTS

The Funds engage in various portfolio investment strategies using derivative contracts both to increase the returns of the Funds and/or to manage their exposure to certain risks such as credit risk, equity risk, interest rate risk, foreign currency exchange rate risk, commodity price risk or other risks (e.g., inflation risk). Derivative financial instruments categorized by risk exposure are included in the Schedules of Investments. These contracts may be transacted on an exchange or over-the-counter (“OTC”).

Forward Foreign Currency Exchange Contracts: Forward foreign currency exchange contracts are entered into to gain or reduce exposure to foreign currencies (foreign currency exchange rate risk).

A forward foreign currency exchange contract is an agreement between two parties to buy and sell a currency at a set exchange rate on a specified date. These contracts help to manage the overall exposure to the currencies in which some of the investments held by the Funds are denominated and in some cases, may be used to obtain exposure to a particular market. The contracts are traded OTC and not on an organized exchange.

The contract is marked-to-market daily and the change in market value is recorded as unrealized appreciation (depreciation) in the Statements of Assets and Liabilities. When a contract is closed, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the value at the time it was opened and the value at the time it was closed. Non-deliverable forward foreign currency exchange contracts are settled with the counterparty in cash without the delivery of foreign currency. The use of forward foreign currency exchange contracts involves the risk that the value of a forward foreign currency exchange contract changes unfavorably due to movements in the value of the referenced foreign currencies, and such value may exceed the amounts reflected in the Statements of Assets and Liabilities. Cash amounts pledged for forward foreign currency exchange contracts are considered restricted and are included in cash pledged as collateral for OTC derivatives in the Statements of Assets and Liabilities. A Fund’s risk of loss from counterparty credit risk on OTC derivatives is generally limited to the aggregate unrealized gain netted against any collateral held by the Fund.

Options: The Funds may purchase and write call and put options to increase or decrease their exposure to the risks of underlying instruments, including equity risk, interest rate risk and/or commodity price risk and/or, in the case of options written, to generate gains from options premiums.

A call option gives the purchaser (holder) of the option the right (but not the obligation) to buy, and obligates the seller (writer) to sell (when the option is exercised) the underlying instrument at the exercise or strike price at any time or at a specified time during the option period. A put option gives the holder the right to sell and obligates the writer to buy the underlying instrument at the exercise or strike price at any time or at a specified time during the option period.

Premiums paid on options purchased and premiums received on options written, as well as the daily fluctuation in market value, are included in investments at value –unaffiliated and options written at value, respectively, in the Statements of Assets and Liabilities. When an instrument is purchased or sold through the exercise of an option, the premium is offset against the cost or proceeds of the underlying instrument. When an option expires, a realized gain or loss is recorded in the Statements of Operations to the extent of the premiums received or paid. When an option is closed or sold, a gain or loss is recorded in the Statements of Operations to the extent the cost of the closing transaction exceeds the premiums received or paid. When the Funds write a call option, such option is typically “covered,” meaning that they hold the underlying instrument subject to being called by the option counterparty. When the Funds write a put option, cash is segregated in an amount sufficient to cover the obligation. These amounts, which are considered restricted, are included in cash pledged as collateral for options written in the Statements of Assets and Liabilities.

In purchasing and writing options, the Funds bear the risk of an unfavorable change in the value of the underlying instrument or the risk that they may not be able to enter into a closing transaction due to an illiquid market. Exercise of a written option could result in the Funds purchasing or selling a security when they otherwise would not, or at a price different from the current market value.

Swaps: Swap contracts are entered into to manage exposure to issuers, markets and securities. Such contracts are agreements between the Funds and a counterparty to make periodic net payments on a specified notional amount or a net payment upon termination. Swap agreements are privately negotiated in the OTC market and may be entered into as a bilateral contract (“OTC swaps”) or centrally cleared (“centrally cleared swaps”).

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  75


Notes to Financial Statements  (unaudited) (continued)

 

For OTC swaps, any upfront premiums paid and any upfront fees received are shown as swap premiums paid and swap premiums received, respectively, in the Statements of Assets and Liabilities and amortized over the term of the contract. The daily fluctuation in market value is recorded as unrealized appreciation (depreciation) on OTC Swaps in the Statements of Assets and Liabilities. Payments received or paid are recorded in the Statements of Operations as realized gains or losses, respectively. When an OTC swap is terminated, a realized gain or loss is recorded in the Statements of Operations equal to the difference between the proceeds from (or cost of) the closing transaction and the Funds basis in the contract, if any. Generally, the basis of the contract is the premium received or paid.

 

   

Total return swaps — Total return swaps are entered into to obtain exposure to a security or market without owning such security or investing directly in such market or to exchange the risk/return of one security or market (e.g., fixed-income) with another security or market (e.g., equity or commodity prices) (equity risk, commodity price risk and/or interest rate risk).

Total return swaps are agreements in which there is an exchange of cash flows whereby one party commits to make payments based on the total return (distributions plus capital gains/losses) of an underlying instrument, or basket of underlying instruments, in exchange for fixed or floating rate interest payments. If the total return of the instrument(s) or index underlying the transaction exceeds or falls short of the offsetting fixed or floating interest rate obligation, the Funds receive payment from or make a payment to the counterparty.

Certain total return swaps are designed to function as a portfolio of direct investments in long and short equity positions. This means that the Fund has the ability to trade in and out of these long and short positions within the swap and will receive the economic benefits and risks equivalent to direct investment in these positions, subject to certain adjustments due to events related to the counterparty. Benefits and risks include capital appreciation (depreciation), corporate actions and dividends received and paid, all of which are reflected in the swap’s market value. The market value also includes interest charges and credits (“financing fees”) related to the notional values of the long and short positions and cash balances within the swap. These interest charges and credits are based on a specified benchmark rate plus or minus a specified spread determined based upon the country and/or currency of the positions in the portfolio.

Positions within the swap and financing fees are reset periodically. During a reset, any unrealized appreciation (depreciation) on positions and accrued financing fees become available for cash settlement between the Funds and the counterparty. The amounts that are available for cash settlement are recorded as realized gains or losses in the Statements of Operations. Cash settlement in and out of the swap may occur at a reset date or any other date, at the discretion of the Funds and the counterparty, over the life of the agreement. Certain swaps have no stated expiration and can be terminated by either party at any time.

Swap transactions involve, to varying degrees, elements of interest rate, credit and market risks in excess of the amounts recognized in the Statements of Assets and Liabilities. Such risks involve the possibility that there will be no liquid market for these agreements, that the counterparty to the agreements may default on its obligation to perform or disagree as to the meaning of the contractual terms in the agreements, and that there may be unfavorable changes in interest rates and/or market values associated with these transactions.

Master Netting Arrangements: In order to define its contractual rights and to secure rights that will help it mitigate its counterparty risk, a Fund may enter into an International Swaps and Derivatives Association, Inc. Master Agreement (“ISDA Master Agreement”) or similar agreement with its counterparties. An ISDA Master Agreement is a bilateral agreement between a Fund and a counterparty that governs certain OTC derivatives and typically contains, among other things, collateral posting terms and netting provisions in the event of a default and/or termination event. Under an ISDA Master Agreement, a Fund may, under certain circumstances, offset with the counterparty certain derivative financial instruments’ payables and/or receivables with collateral held and/or posted and create one single net payment. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of default including the bankruptcy or insolvency of the counterparty. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against the right of offset in bankruptcy, insolvency or other events.

Collateral Requirements: For derivatives traded under an ISDA Master Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty.

Cash collateral that has been pledged to cover obligations of the Funds and cash collateral received from the counterparty, if any, is reported separately in the Statements of Assets and Liabilities as cash pledged as collateral and cash received as collateral, respectively. Non-cash collateral pledged by the Funds, if any, is noted in the Schedules of Investments. Generally, the amount of collateral due from or to a counterparty is subject to a certain minimum transfer amount threshold before a transfer is required, which is determined at the close of business of the Funds. Any additional required collateral is delivered to/pledged by the Funds on the next business day. Typically, the counterparty is not permitted to sell, re-pledge or use cash and non-cash collateral it receives. A Fund generally agrees not to use non-cash collateral that it receives but may, absent default or certain other circumstances defined in the underlying ISDA Master Agreement, be permitted to use cash collateral received. In such cases, interest may be paid pursuant to the collateral arrangement with the counterparty. To the extent amounts due to the Funds from the counterparties are not fully collateralized, each Fund bears the risk of loss from counterparty non-performance. Likewise, to the extent the Funds have delivered collateral to a counterparty and stand ready to perform under the terms of their agreement with such counterparty, each Fund bears the risk of loss from a counterparty in the amount of the value of the collateral in the event the counterparty fails to return such collateral. Based on the terms of agreements, collateral may not be required for all derivative contracts.

For financial reporting purposes, the Fund do not offset derivative assets and derivative liabilities that are subject to netting arrangements, if any, in the Statements of Assets and Liabilities.

 

6.

INVESTMENT ADVISORY AGREEMENT AND OTHER TRANSACTIONS WITH AFFILIATES

Investment Advisory: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Investment Advisory Agreement with the Manager, the Funds’ investment adviser and an indirect, wholly-owned subsidiary of BlackRock, Inc. (“BlackRock”), to provide investment advisory services and, with respect to Capital Appreciation, administrative services. The Manager is responsible for the management of each Fund’s portfolio and provides the personnel, facilities, equipment and certain other services necessary to the operations of each Fund.

 

 

76  

2 0 2 2  B L A C K O C K   E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

For such services, each Fund pays the Manager a monthly fee at an annual rate equal to the following percentages of the average daily value of each Fund’s net assets:

 

Average Daily Net Assets           Investment Advisory Fees
Capital  Appreciation
 

First $1 billion

    0.650

$1 billion - $1.5 billion

    0.625  

$1.5 billion - $5 billion

    0.600  

$5 billion - $7.5 billion

    0.575  

Greater than $7.5 billion

    0.550  

 

Average Daily Net Assets           Investment Advisory Fees
Health Sciences  Opportunities
 

First $1 billion

    0.750

$1 billion - $2 billion

    0.700  

$2 billion - $3 billion

    0.675  

$3 billion - $10 billion

    0.650  

Greater than $10 billion

    0.640  

 

     Investment Advisory Fees  
Average Daily Net Assets   Infrastructure Sustainable Opportunities     Technology Opportunities  

First $1 billion

    0.800     0.820

$1 billion - $3 billion

    0.750       0.770  

$3 billion - $5 billion

    0.720       0.740  

$5 billion - $10 billion

    0.700       0.710  

Greater than $10 billion

    0.680       0.700  

 

Average Daily Net Assets           Investment Advisory  Fees
Mid-Cap Growth Equity
 

First $1 billion

    0.700

$1 billion - $3 billion

    0.660  

$3 billion - $5 billion

    0.630  

$5 billion - $10 billion

    0.610  

$10 billion - $18 billion

    0.600  

Greater than $18 billion

    0.590  

With respect to Infrastructure Sustainable Opportunities, the Manager entered into separate sub-advisory agreements with each of BlackRock International Limited (“BIL”) and BlackRock (Singapore) Limited (“BSL”), each an affiliate of the Manager. The Manager pays BIL and BSL for services they provide, for that portion of the Fund for which BIL and BSL, as applicable, act as sub-adviser, a monthly fee that is equal to a percentage of the investment advisory fees paid by the Fund to the Manager.

Service and Distribution Fees: The Corporation, on behalf of Capital Appreciation, and the Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into a Distribution Agreement and a Distribution and Service Plan with BlackRock Investments, LLC (“BRIL”), an affiliate of the Manager. Pursuant to the Distribution and Service Plan and in accordance with Rule 12b-1 under the 1940 Act, each Fund pays BRIL ongoing service and distribution fees. The fees are accrued daily and paid monthly at annual rates based upon the average daily net assets of the relevant share class of each Fund as follows:

 

Share Class   Service Fees     Distribution Fees  

Service

    0.25     N/A  

Investor A

    0.25       N/A  

Investor C

    0.25       0.75

Class R

    0.25       0.25  

BRIL and broker-dealers, pursuant to sub-agreements with BRIL, provide shareholder servicing and distribution services to the Funds. The ongoing service and/or distribution fee compensates BRIL and each broker-dealer for providing shareholder servicing and/or distribution related services to shareholders.

For the six months ended November 30, 2022, the following table shows the class specific service and distribution fees borne directly by each share class of each Fund:

 

Fund Name   Service      Investor A      Investor C      Class R      Total  

Capital Appreciation

  $      $ 2,116,752      $ 209,993      $ 55,698      $ 2,382,443  

Health Sciences Opportunities

    44,407        3,809,062        2,515,157        632,037        7,000,663  

Infrastructure Sustainable Opportunities

           123                      123  

Mid-Cap Growth Equity

    96,143        2,250,843        1,111,585        229,186        3,687,757  

Technology Opportunities

    61,801        1,915,374        1,303,100        80,844        3,361,119  

 

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  77


Notes to Financial Statements  (unaudited) (continued)

 

Administration: The Trust, on behalf of Health Sciences Opportunities, Infrastructure Sustainable Opportunities, Mid-Cap Growth Equity and Technology Opportunities, entered into an Administration Agreement with the Manager, an indirect, wholly-owned subsidiary of BlackRock, to provide administrative services. For these services, the Manager receives an administration fee computed daily and payable monthly, based on a percentage of the average daily net assets of each Fund. The administration fee, which is shown as administration in the Statements of Operations, is paid at the annual rates below.

 

Average Daily Net Assets   Administration Fees  

First $500 million

    0.0425

$500 million - $1 billion

    0.0400  

$1 billion - $2 billion

    0.0375  

$2 billion - $4 billion

    0.0350  

$4 billion - $13 billion

    0.0325  

Greater than $13 billion

    0.0300  

In addition, the Manager charges each of the share classes an administration fee, which is shown as administration — class specific in the Statements of Operations, at an annual rate of 0.02% of the average daily net assets of each respective class.

For the six months ended November 30, 2022, the following table shows the class specific administration fees borne directly by each share class of each Fund:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Health Sciences Opportunities

  $  485,147      $  3,553      $  304,778      $  50,339      $ 42,904      $  25,285      $ 912,006  

Infrastructure Sustainable Opportunities

    10               10               860               880  

Mid-Cap Growth Equity

    634,532        7,700        180,314        22,277        447,637        9,176        1,301,636  

Technology Opportunities

    252,830        4,952        153,488        26,122        12,855        3,238        453,485  

Transfer Agent: Pursuant to written agreements, certain financial intermediaries, some of which may be affiliates, provide the Funds with sub-accounting, recordkeeping, sub-transfer agency and other administrative services with respect to servicing of underlying investor accounts. For these services, these entities receive an asset-based fee or an annual fee per shareholder account, which will vary depending on share class and/or net assets. For the six months ended November 30, 2022, the Funds paid the following amounts to affiliates of BlackRock in return for these services, which are included in transfer agent— class specific in the Statements of Operations:

 

Fund Name   Institutional      Total  

Capital Appreciation

  $ 50,727      $ 50,727  

The Manager maintains a call center that is responsible for providing certain shareholder services to the Funds. Shareholder services include responding to inquiries and processing purchases and sales based upon instructions from shareholders. For the six months ended November 30, 2022, each Fund reimbursed the Manager the following amounts for costs incurred in running the call center, which are included in transfer agent — class specific in the Statements of Operations:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Capital Appreciation

  $ 1,913      $      $ 48,143      $ 4,472      $ 1,974      $ 164      $ 56,666  

Health Sciences Opportunities

    13,728        153        65,288        13,538        1,220        1,062        94,989  

Mid-Cap Growth Equity

    15,722        315        50,631        5,920        5,704        658        78,950  

Technology Opportunities

    16,478        271        34,757        9,271        438        300        61,515  

For the six months ended November 30, 2022, the following table shows the class specific transfer agent fees borne directly by each share class of each Fund:

 

Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Capital Appreciation

  $ 341,915      $      $ 930,869      $ 41,337      $ 15,024      $ 25,106      $ 1,354,251  

Health Sciences Opportunities

    2,447,766        27,218        1,583,785        274,105        12,177        276,894        4,621,945  

Infrastructure Sustainable Opportunities

    42                             1               43  

Mid-Cap Growth Equity

    4,690,579        60,819        1,645,824        141,165        184,678        105,862        6,828,927  

Technology Opportunities

    1,638,859        26,264        1,000,961        154,498        8,146        36,723        2,865,451  

Other Fees: For the six months ended November 30, 2022, affiliates earned underwriting discounts, direct commissions and dealer concessions on sales of each Fund’s Investor A Shares as follows:

 

Fund Name   Amounts  

Capital Appreciation

  $ 17,001  

Health Sciences Opportunities

    39,868  

Mid-Cap Growth Equity

    27,112  

Technology Opportunities

    41,291  

 

 

 

78  

2 0 2 2  B L A C K O C K   E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

For the six months ended November 30, 2022, affiliates received CDSCs as follows:

 

Share Class   Capital
Appreciation
     Health
Sciences
Opportunities
     Mid-Cap
Growth
Equity
     Technology
Opportunities
 

Investor A

  $ 7,244      $ 5,473      $ 20,599      $ 48,938  

Investor C

    1,233        9,230        12,083        13,730  

Expense Limitations, Waivers, Reimbursements, and Recoupments: With respect to each Fund, the Manager voluntarily agreed to waive its investment advisory fees by the amount of investment advisory fees each Fund pays to the Manager indirectly through its investment in affiliated money market funds (the “affiliated money market fund waiver”) through June 30, 2024. The contractual agreement may be terminated upon 90 days’ notice by a majority of the directors who are not “interested persons” of the Corporation or the Trust, as defined in the 1940 Act (“Independent Directors”), or by a vote of a majority of the outstanding voting securities of a Fund. The amount of waivers and/or reimbursements of fees and expenses made pursuant to the expense limitation described below will be reduced by the amount of the affiliated money market fund waiver. These amounts are included in fees waived and/or reimbursed by the Manager in the Statements of Operations. For the six months ended November 30, 2022, the amounts waived were as follows:

 

Fund Name   Amounts Waived  

Capital Appreciation

  $ 23,527  

Health Sciences Opportunities

    62,966  

Infrastructure Sustainable Opportunities

    138  

Mid-Cap Growth Equity

    73,159  

Technology Opportunities

    13,212  

The Manager has contractually agreed to waive its investment advisory fee with respect to any portion of each Fund’s assets invested in affiliated equity and fixed-income mutual funds and affiliated exchange-traded funds that have a contractual management fee through June 30, 2024. The contractual agreement may be terminated upon 90 days’ notice by a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund. For the six months ended November 30, 2022, there were no fees waived and/or reimbursed by the Manager pursuant to this arrangement.

With respect to each Fund (except Health Sciences Opportunities), the Manager contractually agreed to waive and/or reimburse fees or expenses in order to limit expenses, excluding interest expense, dividend expense, tax expense, acquired fund fees and expenses, and certain other fund expenses, which constitute extraordinary expenses not incurred in the ordinary course of each Fund’s business (“expense limitation”). The expense limitations as a percentage of average daily net assets are as follows:

 

Share Class   Capital Appreciation     Infrastructure Sustainable Opportunities     Mid-Cap Growth Equity     Technology Opportunities  

Institutional

    N/A       1.00     0.80     0.92

Service

    N/A       N/A       1.05       1.17  

Investor A

    N/A       1.25       1.05       1.17  

Investor C

    1.94     N/A       1.80       1.92  

Class K

    0.72       0.95       0.75       0.87  

Class R

    N/A       N/A       1.30       1.42  

The Manager has agreed not to reduce or discontinue the contractual expense limitations through June 30, 2024 (or June 30, 2033 with respect to Capital Appreciation), unless approved by the Board, including a majority of the Independent Directors, or by a vote of a majority of the outstanding voting securities of a Fund.

For the six months ended November 30, 2022, Infrastructure Sustainable Opportunities waived and/or reimbursed the Manager investment advisory fees of $136,046, which is included in fees waived and/or reimbursed by the Manager in the Statements of Operations.

In addition, these amounts waived and/or reimbursed by the Manager are included in administration fees waived by the Manager — class specific and transfer agent fees waived and/or reimbursed by the Manager — class specific, respectively, in the Statements of Operations. For the six months ended November 30, 2022, class specific expense waivers and/or reimbursements are as follows:

 

     Administration Fees Waived by the Manager - Class Specific  
Fund Name   Institutional      Service      Investor A      Investor C      Class K      Class R      Total  

Infrastructure Sustainable Opportunities

  $ 5      $      $      $      $ 852      $      $ 857  

Mid-Cap Growth Equity

    634,532        7,700        180,314        17,495               9,176        849,217  

Technolog90ry Opportunities

    252,830        4,320        153,488        26,122        2,089        3,238        442,087  

 

     Transfer Agent Fees Waived and/or Reimbursed by  the Manager - Class Specific  
Fund Name   Institutional      Service      Investor A      Investor C      Class R      Total  

Infrastructure Sustainable Opportunities

  $ 26      $      $      $      $      $ 26  

Mid-Cap Growth Equity

    699,785        12,318        509,931        4,358        47,912        1,274,304  

Technology Opportunities

    603,635        6,522        369,964        45,019        23,357        1,048,497  

With respect to the contractual expense limitation of Infrastructure Sustainable Opportunities, if during the Fund’s fiscal year the operating expenses of a share class, that at any time during the prior two fiscal years received a waiver and/or reimbursement from the Manager, are less than the current expense limitation for that share class, the Manager is entitled to be reimbursed by such share class up to the lesser of: (a) the amount of fees waived and/or expenses reimbursed during those prior two fiscal years

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  79


Notes to Financial Statements  (unaudited) (continued)

 

under the agreement and (b) an amount not to exceed either the current expense limitation of that share class or the expense limitation of the share class in effect at the time that the share class received the applicable waiver and/or reimbursement, provided that:

  (1)

the Fund, of which the share class is a part, has more than $50 million in assets for the fiscal year, and

  (2)

the Manager or an affiliate continues to serve as the Fund’s investment adviser or administrator.

This repayment applies only to the contractual expense limitation on net expenses and does not apply to the contractual investment advisory fee waiver described above or any voluntary waivers that may be in effect from time to time. Effective September 30, 2028 the repayment arrangement between the Fund and the Manager pursuant to which the Fund may be required to repay amounts waived and/or reimbursed under the Fund’s contractual caps on net expenses was terminated.

As of November 30, 2022, the fund level and class specific waivers and/or reimbursements subject to possible future recoupment under the expense limitation agreement are as follows:

 

             Expiring May 31,  
Fund Name/Fund Level/Share Class   2024      2025  

Infrastructure Sustainable Opportunities

    

Fund Level

  $  198,233      $  136,046  

Institutional

    153        31  

Investor A

    151         

Class K

    1,479        852  

Securities Lending: The U.S. Securities and Exchange Commission (“SEC”) has issued an exemptive order which permits BIM, an affiliate of the Manager, to serve as securities lending agent for the Fund, subject to applicable conditions. As securities lending agent, BIM bears all operational costs directly related to securities lending. The Fund are responsible for expenses in connection with the investment of cash collateral received for securities on loan (the “collateral investment expenses”). The cash collateral is invested in a private investment company Money Market Series, managed by the Manager or its affiliates. However, BIM has agreed to cap the collateral investment expenses of the Money Market Series to an annual rate of 0.04%. The investment adviser to the Money Market Series will not charge any advisory fees with respect to shares purchased by the Fund. The Money Market Series may, under certain circumstances, impose a liquidity fee of up to 2% of the value withdrawn or temporarily restrict withdrawals for up to 10 business days during a 90 day period, in the event that the private investment company’s weekly liquid assets fall below certain thresholds. The Money Market Series seeks current income consistent with maintaining liquidity and preserving capital. Although the Money Market Series is not registered under the 1940 Act, its investments may follow the parameters of investments by a money market fund that is subject to Rule 2a-7 under the 1940 Act.

Securities lending income is equal to the total of income earned from the reinvestment of cash collateral, net of fees and other payments to and from borrowers of securities, and less the collateral investment expenses. Each Fund retains a portion of securities lending income and remits a remaining portion to BIM as compensation for its services as securities lending agent.

Pursuant to the current securities lending agreement, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities retain 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses. Pursuant to the current securities lending agreement, Infrastructure Sustainable Opportunities retains 82% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

In addition, commencing the business day following the date that the aggregate securities lending income earned across the BlackRock Multi-Asset Complex in a calendar year exceeds a specified threshold, Capital Appreciation, Health Sciences Opportunities, Mid-Cap Growth Equity and Technology Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 81% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses. Infrastructure Sustainable Opportunities, pursuant to the securities lending agreement, will retain for the remainder of that calendar year securities lending income in an amount equal to 85% of securities lending income (which excludes collateral investment expenses), and this amount retained can never be less than 70% of the total of securities lending income plus the collateral investment expenses.

The share of securities lending income earned by each Fund is shown as securities lending income — affiliated — net in the Statements of Operations. For the six months ended November 30, 2022, each Fund paid BIM the following amounts for securities lending agent services:

 

Fund Name   Amounts  

Capital Appreciation

  $ 7,061  

Health Sciences Opportunities

    165,841  

Infrastructure Sustainable Opportunities

    25  

Mid-Cap Growth Equity

    131,158  

Technology Opportunities

    111,599  

Interfund Lending: In accordance with an exemptive order (the “Order”) from the SEC, Capital Appreciation and Infrastructure Sustainable Opportunities may participate in a joint lending and borrowing facility for temporary purposes (the “Interfund Lending Program”), subject to compliance with the terms and conditions of the Order, and to the extent permitted by Capital Appreciation’s and Infrastructure Sustainable Opportunities’s investment policies and restrictions. Capital Appreciation is currently permitted to borrow under the Interfund Lending Program. In addition, Infrastructure Sustainable Opportunities is currently permitted to borrow and lend under the Interfund Lending Program.

 

 

80  

2 0 2 2  B L A C K O C K   E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

A lending BlackRock fund may lend in aggregate up to 15% of its net assets but may not lend more than 5% of its net assets to any one borrowing fund through the Interfund Lending Program. A borrowing BlackRock fund may not borrow through the Interfund Lending Program or from any other source more than 33 1/3% of its total assets (or any lower threshold provided for by the fund’s investment restrictions). If a borrowing BlackRock fund’s total outstanding borrowings exceed 10% of its total assets, each of its outstanding interfund loans will be subject to collateralization of at least 102% of the outstanding principal value of the loan. All interfund loans are for temporary or emergency purposes and the interest rate to be charged will be the average of the highest current overnight repurchase agreement rate available to a lending fund and the bank loan rate, as calculated according to a formula established by the Board.

During the six months ended November 30, 2022, Capital Appreciation and Infrastructure Sustainable Opportunities did not participate in the Interfund Lending Program.

Directors and Officers: Certain directors and/or officers of the Corporation and the Trust are directors and/or officers of BlackRock or its affiliates. The Fund reimburse the Manager for a portion of the compensation paid to the Corporation’s/Trust’s Chief Compliance Officer, which is included in Directors and Officer in the Statements of Operations.

 

7.

PURCHASES AND SALES

For the six months ended November 30, 2022, purchases and sales of investments, excluding short-term securities, were as follows:

 

Fund Name   Purchases      Sales  

Capital Appreciation

  $  925,927,932      $  1,167,721,089  

Health Sciences Opportunities

    1,191,112,246        1,514,200,462  

Infrastructure Sustainable Opportunities

    4,243,153        4,860,720  

Mid-Cap Growth Equity

    2,717,818,255        3,553,057,733  

Technology Opportunities

    811,973,672        1,289,720,519  

 

8.

INCOME TAX INFORMATION

It is each Fund’s policy to comply with the requirements of the Internal Revenue Code of 1986, as amended, applicable to regulated investment companies, and to distribute substantially all of its taxable income to its shareholders. Therefore, no U.S. federal income tax provision is required.

Each Fund files U.S. federal and various state and local tax returns. No income tax returns are currently under examination. The statute of limitations on each Fund’s U.S. federal tax returns generally remains open for a period of three years after they are filed. The statutes of limitations on each Fund’s state and local tax returns may remain open for an additional year depending upon the jurisdiction.

Management has analyzed tax laws and regulations and their application to the Funds as of November 30, 2022, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Fund’s financial statements.

As of November 30, 2022, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

 

Fund Name   Tax Cost      Gross
Unrealized
Appreciation
     Gross
Unrealized
Depreciation
    Net Unrealized
Appreciation
(Depreciation)
 

Capital Appreciation

  $ 1,975,763,673      $  1,130,391,751      $ (138,127,803 )   $ 992,263,948  

Health Sciences Opportunities

    6,170,526,528        3,798,950,835        (334,424,805     3,464,526,030  

Infrastructure Sustainable Opportunities

    9,349,532        291,374        (926,928     (635,554

Mid-Cap Growth Equity

    11,062,126,936        3,125,210,479        (907,176,332     2,218,034,147  

Technology Opportunities

    3,247,294,815        1,214,700,724        (170,264,847     1,044,435,877  

 

9.

BANK BORROWINGS

The Corporation and the Trust, on behalf of the Funds, along with certain other funds managed by the Manager and its affiliates (“Participating Funds”), is a party to a 364-day, $2.50 billion credit agreement with a group of lenders. Under this agreement, the Funds may borrow to fund shareholder redemptions. Excluding commitments designated for certain individual funds, the Participating Funds, including the Funds, can borrow up to an aggregate commitment amount of $1.75 billion at any time outstanding, subject to asset coverage and other limitations as specified in the agreement. The credit agreement has the following terms: a fee of 0.10% per annum on unused commitment amounts and interest at a rate equal to the higher of (a) Overnight Bank Funding Rate (“OBFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.80% per annum, (b) the Fed Funds rate (but, in any event, not less than 0.00%) in effect from time to time plus 0.80% per annum on amounts borrowed or (c) the sum of (x) Daily Simple Secured Overnight Financing Rate (“SOFR”) (but, in any event, not less than 0.00%) on the date the loan is made plus 0.10% and (y) 0.80% per annum. The agreement expires in April 2023 unless extended or renewed. These fees were allocated among such funds based upon portions of the aggregate commitment available to them and relative net assets of Participating Funds. During the six months ended November 30, 2022, the Funds did not borrow under the credit agreement.

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  81


Notes to Financial Statements  (unaudited) (continued)

 

10.

PRINCIPAL RISKS

In the normal course of business, the Funds invest in securities or other instruments and may enter into certain transactions, and such activities subject each Fund to various risks, including among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate and price fluctuations. Local, regional or global events such as war, acts of terrorism, the spread of infectious illness or other public health issues, recessions, or other events could have a significant impact on the Funds and their investments. Each Fund’s prospectus provides details of the risks to which each Fund is subject.

The Funds may be exposed to additional risks when reinvesting cash collateral in money market funds that do not seek to maintain a stable NAV per share of $1.00, which may be subject to redemption gates or liquidity fees under certain circumstances.

Infectious Illness Risk: An outbreak of an infectious illness, such as the COVID-19 pandemic, may adversely impact the economies of many nations and the global economy and may impact individual issuers and capital markets in ways that cannot be foreseen. An infectious illness outbreak may result in, among other things, closed international borders, prolonged quarantines, supply chain disruptions, market volatility or disruptions and other significant economic, social and political impacts.

Valuation Risk: The market values of equities, such as common stocks and preferred securities or equity related investments, such as futures and options, may decline due to general market conditions which are not specifically related to a particular company. They may also decline due to factors which affect a particular industry or industries. A Fund may invest in illiquid investments. An illiquid investment is any investment that a Fund reasonably expects cannot be sold or disposed of in current market conditions in seven calendar days or less without the sale or disposition significantly changing the market value of the investment. A Fund may experience difficulty in selling illiquid investments in a timely manner at the price that it believes the investments are worth. Prices may fluctuate widely over short or extended periods in response to company, market or economic news. Markets also tend to move in cycles, with periods of rising and falling prices. This volatility may cause each Fund’s NAV to experience significant increases or decreases over short periods of time. If there is a general decline in the securities and other markets, the NAV of a Fund may lose value, regardless of the individual results of the securities and other instruments in which a Fund invests.

The price a Fund could receive upon the sale of any particular portfolio investment may differ from a Fund’s valuation of the investment, particularly for securities that trade in thin or volatile markets or that are valued using a fair valuation technique or a price provided by an independent pricing service. Changes to significant unobservable inputs and assumptions (i.e., publicly traded company multiples, growth rate, time to exit) due to the lack of observable inputs may significantly impact the resulting fair value and therefore a Fund’s results of operations. As a result, the price received upon the sale of an investment may be less than the value ascribed by a Fund, and a Fund could realize a greater than expected loss or lesser than expected gain upon the sale of the investment. A Fund’s ability to value its investments may also be impacted by technological issues and/or errors by pricing services or other third-party service providers.

Counterparty Credit Risk: The Funds may be exposed to counterparty credit risk, or the risk that an entity may fail to or be unable to perform on its commitments related to unsettled or open transactions, including making timely interest and/or principal payments or otherwise honoring its obligations. The Funds manage counterparty credit risk by entering into transactions only with counterparties that the Manager believes have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose the Funds to market, issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of the Funds’ exposure to market, issuer and counterparty credit risks with respect to these financial assets is approximately their value recorded in the Statements of Assets and Liabilities, less any collateral held by the Funds.

A derivative contract may suffer a mark-to-market loss if the value of the contract decreases due to an unfavorable change in the market rates or values of the underlying instrument. Losses can also occur if the counterparty does not perform under the contract.

With exchange-traded options purchased and exchange-traded futures, there is less counterparty credit risk to the Funds since the exchange or clearinghouse, as counterparty to such instruments, guarantees against a possible default. The clearinghouse stands between the buyer and the seller of the contract; therefore, credit risk is limited to failure of the clearinghouse. While offset rights may exist under applicable law, a Fund does not have a contractual right of offset against a clearing broker or clearinghouse in the event of a default (including the bankruptcy or insolvency). Additionally, credit risk exists in exchange-traded futures with respect to initial and variation margin that is held in a clearing broker’s customer accounts. While clearing brokers are required to segregate customer margin from their own assets, in the event that a clearing broker becomes insolvent or goes into bankruptcy and at that time there is a shortfall in the aggregate amount of margin held by the clearing broker for all its clients, typically the shortfall would be allocated on a pro rata basis across all the clearing broker’s customers, potentially resulting in losses to the Funds.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within the Fund’s portfolio are disclosed in its Schedule of Investments.

Certain Funds invest a significant portion of their assets in securities within a single or limited number of market sectors. When a fund concentrates its investments in this manner, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the Fund and could affect the income from, or the value or liquidity of, the Fund’s portfolio. Investment percentages in specific sectors are presented in the Schedules of Investments.

Significant Shareholder Redemption Risk: Certain shareholders may own or manage a substantial amount of fund shares and/or hold their fund investments for a limited period of time. Large redemptions of fund shares by these shareholders may force a fund to sell portfolio securities, which may negatively impact the fund’s NAV, increase the fund’s brokerage costs, and/or accelerate the realization of taxable income/gains and cause the fund to make additional taxable distributions to shareholders.

LIBOR Transition Risk: The United Kingdom’s Financial Conduct Authority announced a phase out of the London Interbank Offered Rate (“LIBOR”). Although many LIBOR rates ceased to be published or no longer are representative of the underlying market they seek to measure after December 31, 2021, a selection of widely used USD LIBOR rates will continue to be published through June 2023 in order to assist with the transition. The Funds may be exposed to financial instruments tied to LIBOR to determine

 

 

82  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

payment obligations, financing terms, hedging strategies or investment value. The transition process away from LIBOR might lead to increased volatility and illiquidity in markets for, and reduce the effectiveness of new hedges placed against instruments whose terms currently include LIBOR. The ultimate effect of the LIBOR transition process on the Funds is uncertain.

 

11.

CAPITAL SHARE TRANSACTIONS

Transactions in capital shares for each class were as follows:

 

     Six Months Ended 11/30/22     Year Ended 05/31/22  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Capital Appreciation

       

Institutional

       

Shares sold

    3,785,921     $ 105,436,758       9,077,631     $ 365,178,278  

Shares issued in reinvestment of distributions

    1,544,991       42,626,290       2,208,629       96,052,412  

Shares redeemed

 

    (11,067,030)       (305,932,856)       (6,557,549)       (268,772,260)  
    (5,736,118   $ (157,869,808     4,728,711     $ 192,458,430  

Investor A

       

Shares sold and automatic conversion of shares

    2,174,558     $ 54,569,717       6,420,981     $ 239,225,888  

Shares issued in reinvestment of distributions

    4,104,484       99,656,876       6,684,788       259,138,163  

Shares redeemed

    (6,192,983)       (154,197,540)       (12,580,937)       (465,390,868)  
    86,059     $ 29,053       524,832     $ 32,973,183  

Investor C

       

Shares sold

    161,878     $ 2,327,703       417,400     $ 9,523,681  

Shares issued in reinvestment of distributions

    321,777       4,466,262       559,182       13,320,882  

Shares redeemed and automatic conversion of shares

    (513,764)       (7,525,291)       (987,837)       (22,223,382)  
    (30,109   $ (731,326     (11,255   $ 621,181  

Class K

       

Shares sold

    1,676,925     $ 48,395,299       2,650,053     $ 110,099,487  

Shares issued in reinvestment of distributions

    1,152,500       32,143,212       2,255,335       99,168,670  

Shares redeemed

    (1,590,824)       (45,603,888)       (4,243,421)       (179,618,463)  
    1,238,601     $ 34,934,623       661,967     $ 29,649,694  

Class R

       

Shares sold

    80,518     $ 1,490,858       257,323     $ 7,134,270  

Shares issued in reinvestment of distributions

    109,522       1,922,110       197,158       5,739,257  

Shares redeemed

    (131,233)       (2,415,774)       (521,347)       (14,052,755)  
    58,807     $ 997,194       (66,866   $ (1,179,228
    (4,382,760   $ (122,640,264     5,837,389     $ 254,523,260  

Health Sciences Opportunities

       

Institutional

       

Shares sold

    6,231,373     $ 421,120,686       13,550,039     $ 1,054,458,394  

Shares issued in reinvestment of distributions

    4,821,154       316,846,246       5,984,415       466,096,116  

Shares redeemed

    (11,021,522)       (740,283,371)       (22,567,955)       (1,745,432,325)  
    31,005     $ (2,316,439     (3,033,501   $ (224,877,815

Service

       

Shares sold

    34,621     $ 2,214,581       49,458     $ 3,664,984  

Shares issued in reinvestment of distributions

    39,889       2,470,297       51,296       3,778,993  

Shares redeemed

    (53,821)       (3,408,363)       (127,959)       (9,488,827)  
    20,689     $ 1,276,515       (27,205   $ (2,044,850

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  83


Notes to Financial Statements  (unaudited) (continued)

 

     Six Months Ended 11/30/22     Year Ended 05/31/22  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Health Sciences Opportunities (continued)

       

Investor A

       

Shares sold and automatic conversion of shares

    2,239,742     $ 142,462,117       5,392,110     $ 397,992,758  

Shares issued in reinvestment of distributions

    3,418,712       210,626,864       3,792,616       278,689,830  

Shares redeemed

 

    (4,286,267)       (271,833,933)       (7,954,173)       (581,723,514)  
    1,372,187     $ 81,255,048       1,230,553     $ 94,959,074  

Investor C

       

Shares sold

    247,187     $ 13,050,749       836,719     $ 53,237,828  

Shares issued in reinvestment of distributions

    832,560       42,677,038       1,004,187       62,580,022  

Shares redeemed and automatic conversion of shares

 

    (1,473,291)       (77,283,298)       (3,233,983)       (201,419,358)  
    (393,544   $ (21,555,511     (1,393,077   $ (85,601,508

Class K

       

Shares sold

    735,140     $ 49,881,566       1,698,513     $ 133,270,886  

Shares issued in reinvestment of distributions

    445,360       29,309,125       561,988       43,729,235  

Shares redeemed

 

    (745,167)       (50,119,610)       (1,876,019)       (144,869,125)  
    435,333     $ 29,071,081       384,482     $ 32,130,996  

Class R

       

Shares sold

    107,923     $ 6,639,311       359,301     $ 26,082,993  

Shares issued in reinvestment of distributions

    304,184       18,187,142       357,082       25,476,530  

Shares redeemed

    (306,380)       (18,901,412)       (572,860)       (40,780,069)  
    105,727     $ 5,925,041       143,523     $ 10,779,454  
    1,571,397     $93,655,735     (2,695,225)     $(174,654,649)  

Infrastructure Sustainable Opportunities

       

Institutional

       

Shares sold

    137     $ 1,200       11,003     $ 110,051 (a)  

Shares issued in reinvestment of distributions

    27       231             2 (a)  

Shares redeemed

 

                (320)       (3,269)(a)  
    164     $ 1,431       10,683     $ 106,784  

Investor A

       

Shares sold

    598     $ 5,500       10,952     $ 109,812 (a)  

Shares issued in reinvestment of distributions

    33       284              

Shares redeemed

 

    (44)       (399)              
    587     $ 5,385       10,952     $ 109,812  

Class K

       

Shares sold

    101     $ 865       980,348     $ 9,803,544 (a)  

Shares issued in reinvestment of distributions

 

    13       113              
    114     $978     980,348     $9,803,544  
    865     $7,794     1,001,983     $10,020,140  

Mid-Cap Growth Equity

       

Institutional

       

Shares sold

    27,254,787     $ 862,511,205       84,092,051     $ 3,672,781,183  

Shares issued in reinvestment of distributions

                9,954,734       462,557,816  

Shares redeemed

 

    (57,975,205)       (1,806,204,614)       (79,453,974)       (3,261,438,913)  
    (30,720,418   $ (943,693,409     14,592,811     $ 873,900,086  

 

 

84  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Notes to Financial Statements  (unaudited) (continued)

 

     Six Months Ended 11/30/22     Year Ended 05/31/22  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Mid-Cap Growth Equity (continued)

       

Service

       

Shares sold

    212,035     $ 5,901,104       854,941     $ 34,641,736  

Shares issued in reinvestment of distributions

                146,401       6,102,842  

Shares redeemed

 

    (324,983)       (9,210,429)       (771,097)       (29,078,865)  
    (112,948   $ (3,309,325     230,245     $ 11,665,713  

Investor A

       

Shares sold and automatic conversion of shares

    4,509,357     $ 122,664,749       16,857,882     $ 647,069,791  

Shares issued in reinvestment of distributions

                3,734,682       148,274,848  

Shares redeemed

    (8,691,164)       (230,711,907)       (17,401,969)       (628,539,903)  
    (4,181,807   $ (108,047,158     3,190,595     $ 166,804,736  

Investor C

       

Shares sold

    307,063     $ 6,199,824       1,829,067     $ 53,618,549  

Shares issued in reinvestment of distributions

                850,190       25,522,539  

Shares redeemed and automatic conversion of shares

    (1,485,295)       (29,680,459)       (2,880,629)       (78,703,717)  
    (1,178,232   $ (23,480,635     (201,372   $ 437,371  

Class K

       

Shares sold

    28,170,985     $ 880,976,278       75,010,864     $ 3,289,871,678  

Shares issued in reinvestment of distributions

                4,431,881       206,797,826  

Shares redeemed

    (20,918,779)       (660,524,075)       (26,364,924)       (1,103,248,628)  
    7,252,206     $ 220,452,203       53,077,821     $ 2,393,420,876  

Class R

       

Shares sold

    410,695     $ 10,846,348       1,783,479     $ 68,929,237  

Shares issued in reinvestment of distributions

                161,778       6,297,421  

Shares redeemed

    (384,485)       (9,971,275)       (1,059,950)       (37,561,892)  
    26,210     $ 875,073       885,307     $ 37,664,766  
    (28,914,989   $ (857,203,251     71,775,407     $ 3,483,893,548  

Technology Opportunities

       

Institutional

       

Shares sold

    9,933,081     $ 415,319,004       28,834,284     $ 1,778,526,131  

Shares issued in reinvestment of distributions

                5,074,418       339,300,116  

Shares redeemed

    (19,451,891)       (806,821,259)       (45,442,662)       (2,648,038,246)  
    (9,518,810   $ (391,502,255     (11,533,960   $ (530,211,999

Service

       

Shares sold

    96,111     $ 3,729,328       499,665     $ 29,601,143  

Shares issued in reinvestment of distributions

                98,949       6,194,905  

Shares redeemed

    (208,711)       (8,205,779)       (666,323)       (39,672,879)  
    (112,600   $ (4,476,451     (67,709   $ (3,876,831

Investor A

       

Shares sold and automatic conversion of shares

    2,694,591     $ 104,676,459       10,281,016     $ 602,060,939  

Shares issued in reinvestment of distributions

                3,054,990       186,654,164  

Shares redeemed

    (5,088,313)       (191,949,561)       (14,692,026)       (808,237,783)  
    (2,393,722   $ (87,273,102     (1,356,020   $ (19,522,680

Investor C

       

Shares sold

    343,802     $ 10,587,261       1,380,731     $ 64,636,301  

Shares issued in reinvestment of distributions

                764,535       37,880,552  

Shares redeemed and automatic conversion of shares

    (997,469)       (30,029,742)       (2,113,452)       (92,040,047)  
    (653,667   $ (19,442,481     31,814     $ 10,476,806  

 

 

O T E S   T O  I N A N C I A L  T A T E M E N T S

  85


Notes to Financial Statements  (unaudited) (continued)

 

     Six Months Ended 11/30/22     Year Ended 05/31/22  
Fund Name/Share Class   Shares     Amount     Shares     Amount  

Technology Opportunities (continued)

       

Class K

       

Shares sold

    783,905     $ 33,710,845       3,720,630     $ 244,270,015  

Shares issued in reinvestment of distributions

                207,785       13,921,146  

Shares redeemed

    (822,084     (34,714,237     (2,822,714     (151,390,233
 

 

 

   

 

 

   

 

 

   

 

 

 
    (38,179   $ (1,003,392     1,105,701     $ 106,800,928  
 

 

 

   

 

 

   

 

 

   

 

 

 

Class R

       

Shares sold

    97,256     $ 3,738,846       320,513     $ 17,676,525  

Shares issued in reinvestment of distributions

                61,453       3,776,895  

Shares redeemed

    (114,167     (4,297,820     (377,386     (20,691,562
 

 

 

   

 

 

   

 

 

   

 

 

 
    (16,911   $ (558,974     4,580     $ 761,858  
 

 

 

   

 

 

   

 

 

   

 

 

 
    (12,733,889   $ (504,256,655     (11,815,594   $ (435,571,918
 

 

 

   

 

 

   

 

 

   

 

 

 

(a) For the period from September 30, 2021 (commencement of operations) to May 31, 2022.

As of November 30, 2022, shares owned by BlackRock Financial Management, Inc., an affiliate of the Funds, were as follows:

 

Share Class   Infrastructure
Sustainable
Opportunities
     Technology
Opportunities
 

Institutional

    10,000         

Investor A

    10,000         

Class K

    980,000        8,673  

 

12.

SUBSEQUENT EVENTS

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

 

 

86  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Statement Regarding Liquidity Risk Management Program

 

In compliance with Rule 22e-4 under the Investment Company Act of 1940, as amended (the “Liquidity Rule”), BlackRock Capital Appreciation Fund, Inc. (the “Corporation”) and BlackRock FundsSM (the “Trust”) has adopted and implemented a liquidity risk management program (the “Program”) for BlackRock Capital Appreciation Fund, Inc., BlackRock Health Sciences Opportunities Portfolio, BlackRock Infrastructure Sustainable Opportunities Fund, BlackRock Mid-Cap Growth Equity Portfolio and BlackRock Technology Opportunities Fund (the “Funds”), which is reasonably designed to assess and manage each Fund’s liquidity risk.

The Board of Directors (the “Board”) of the Corporation and the Board of Trustees (the “Board”) of the Trust, on behalf of the Funds, met on November 8-9, 2022 (the “Meeting”) to review the Program. The Board previously appointed BlackRock Advisors, LLC or BlackRock Fund Advisors (“BlackRock”), each an investment adviser to certain BlackRock funds, as the program administrator for each Fund’s Program, as applicable. BlackRock also previously delegated oversight of the Program to the 40 Act Liquidity Risk Management Committee (the “Committee”). At the Meeting, the Committee, on behalf of BlackRock, provided the Board with a report that addressed the operation of the Program and assessed its adequacy and effectiveness of implementation, including the management of each Fund’s Highly Liquid Investment Minimum (“HLIM”) where applicable, and any material changes to the Program (the “Report”). The Report covered the period from October 1, 2021 through September 30, 2022 (the “Program Reporting Period”).

The Report described the Program’s liquidity classification methodology for categorizing each Fund’s investments (including derivative transactions) into one of four liquidity buckets. It also referenced the methodology used by BlackRock to establish each Fund’s HLIM and noted that the Committee reviews and ratifies the HLIM assigned to each Fund no less frequently than annually. The Report also discussed notable events affecting liquidity over the Program Reporting Period, including the imposition of capital controls in certain countries.

The Report noted that the Program complied with the key factors for consideration under the Liquidity Rule for assessing, managing and periodically reviewing each Fund’s liquidity risk, as follows:

 

  a)

The Fund’s investment strategy and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed whether each Fund’s strategy is appropriate for an open-end fund structure with a focus on funds with more significant and consistent holdings of less liquid and illiquid assets. The Committee also factored a fund’s concentration in an issuer into the liquidity classification methodology by taking issuer position sizes into account. Where a fund participated in borrowings for investment purposes (such as tender option bonds or reverse repurchase agreements), such borrowings were factored into the Program’s calculation of a fund’s liquidity bucketing. A fund’s derivative exposure was also considered in such calculation.

 

  b)

Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions. During the Program Reporting Period, the Committee reviewed historical redemption activity and used this information as a component to establish each Fund’s reasonably anticipated trading size utilized for liquidity classifications. Each Fund has adopted an in-kind redemption policy which may be utilized to meet larger redemption requests. The Committee may also take into consideration a fund’s shareholder ownership concentration (which, depending on product type and distribution channel, may or may not be available), a fund’s distribution channels, and the degree of certainty associated with a fund’s short-term and long-term cash flow projections.

 

  c)

Holdings of cash and cash equivalents, as well as borrowing arrangements. The Committee considered the terms of the credit facility committed to each Fund, the financial health of the institution providing the facility and the fact that the credit facility is shared among multiple funds (including that a portion of the aggregate commitment amount is specifically designated for BlackRock Floating Rate Income Portfolio, a series of BlackRock Funds V, and BlackRock Floating Rate Loan ETF, a series of BlackRock ETF Trust II). The Committee also considered other types of borrowing available to the Funds, such as the ability to use reverse repurchase agreements and interfund lending, as applicable.

There were no material changes to the Program during the Program Reporting Period other than the enhancement of certain model components in the Program’s classification methodology. The Report provided to the Board stated that the Committee concluded that based on the operation of the functions, as described in the Report, the Program is operating as intended and is effective in implementing the requirements of the Liquidity Rule.

 

 

T A T E M E N T  E G A R D I N G   I Q U I D I T Y  I S K  A N A G E M E N T  R O G R A M

  87


Additional Information

 

General Information

Quarterly performance, semi-annual and annual reports, current net asset value and other information regarding the Funds may be found on BlackRock’s website, which can be accessed at blackrock.com. Any reference to BlackRock’s website in this report is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock’s website in this report.

Householding

The Funds will mail only one copy of shareholder documents, including prospectuses, annual and semi-annual reports, Rule 30e-3 notices and proxy statements, to shareholders with multiple accounts at the same address. This practice is commonly called “householding” and is intended to reduce expenses and eliminate duplicate mailings of shareholder documents. Mailings of your shareholder documents may be householded indefinitely unless you instruct us otherwise. If you do not want the mailing of these documents to be combined with those for other members of your household, please call the Funds at (800) 441-7762.

Availability of Quarterly Schedule of Investments

The Funds file their complete schedules of portfolio holdings with the SEC for the first and third quarters of each fiscal year as an exhibit to their reports on Form N-PORT. The Funds’ Forms N-PORT are available on the SEC’s website at sec.gov. Additionally, each Fund makes its portfolio holdings for the first and third quarters of each fiscal year available at blackrock.com/fundreports.

Availability of Proxy Voting Policies, Procedures and Voting Records

A description of the policies and procedures that the Funds use to determine how to vote proxies relating to portfolio securities and information about how the Funds voted proxies relating to securities held in the Funds’ portfolios during the most recent 12-month period ended June 30 is available without charge, upon request (1) by calling (800) 441-7762; (2) on the BlackRock website at blackrock.com; and (3) on the SEC’s website at sec.gov.

BlackRock’s Mutual Fund Family

BlackRock offers a diverse lineup of open-end mutual funds crossing all investment styles and managed by experts in equity, fixed-income and tax-exempt investing. Visit blackrock.com for more information.

Shareholder Privileges

Account Information

Call us at (800) 441-7762 from 8:00AM to 6:00 PM ET on any business day to get information about your account balances, recent transactions and share prices. You can also visit blackrock.com for more information.

Automatic Investment Plans

Investor class shareholders who want to invest regularly can arrange to have $50 or more automatically deducted from their checking or savings account and invested in any of the BlackRock funds.

Systematic Withdrawal Plans

Investor class shareholders can establish a systematic withdrawal plan and receive periodic payments of $50 or more from their BlackRock funds, as long as their account balance is at least $10,000.

Retirement Plans

Shareholders may make investments in conjunction with Traditional, Rollover, Roth, Coverdell, Simple IRAs, SEP IRAs and 403(b) Plans.

BlackRock Privacy Principles

BlackRock is committed to maintaining the privacy of its current and former fund investors and individual clients (collectively, “Clients”) and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information BlackRock collects, how we protect that information and why in certain cases we share such information with select parties.

If you are located in a jurisdiction where specific laws, rules or regulations require BlackRock to provide you with additional or different privacy-related rights beyond what is set forth below, then BlackRock will comply with those specific laws, rules or regulations.

BlackRock obtains or verifies personal non-public information from and about you from different sources, including the following: (i) information we receive from you or, if applicable, your financial intermediary, on applications, forms or other documents; (ii) information about your transactions with us, our affiliates, or others; (iii) information we receive from a consumer reporting agency; and (iv) from visits to our websites.

 

 

88  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


Additional Information  (continued)

 

BlackRock does not sell or disclose to non-affiliated third parties any non-public personal information about its Clients, except as permitted by law or as is necessary to respond to regulatory requests or to service Client accounts. These non-affiliated third parties are required to protect the confidentiality and security of this information and to use it only for its intended purpose.

We may share information with our affiliates to service your account or to provide you with information about other BlackRock products or services that may be of interest to you. In addition, BlackRock restricts access to non-public personal information about its Clients to those BlackRock employees with a legitimate business need for the information. BlackRock maintains physical, electronic and procedural safeguards that are designed to protect the non-public personal information of its Clients, including procedures relating to the proper storage and disposal of such information.

Fund and Service Providers

 

Investment Adviser and Administrator

BlackRock Advisors, LLC

Wilmington, DE 19809

Sub-Advisers(a)

BlackRock International Limited

Edinburgh, EH3 8BL

United Kingdom

BlackRock (Singapore) Limited

079912 Singapore

Accounting Agent and Transfer Agent

BNY Mellon Investment Servicing (US) Inc.

Wilmington, DE 19809

Custodian

The Bank of New York Mellon

New York, NY 10286

Independent Registered Public Accounting Firm

Deloitte & Touche LLP

Boston, MA 02116

Distributor

BlackRock Investments, LLC

New York, NY 10022

Legal Counsel

Sidley Austin LLP

New York, NY 10019

Address of the Corporation/Trust

100 Bellevue Parkway

Wilmington, DE 19809

 

 

(a) 

For BlackRock Infrastructure Sustainable Opportunities Fund.

 

 

D D I T I O N A L  N F O R M A T I O  N

  89


Glossary of Terms Used in this Report

 

Currency Abbreviation

 

CHF    Swiss Franc
EUR    Euro
GBP    British Pound
USD    United States Dollar

Portfolio Abbreviation

 

ADR    American Depositary Receipt
NVS    Non-Voting Shares

 

 

90  

2 0 2 2   B L A C K O C K  E M I - A N N U A L  E P O R T   T O  H A R E H O L D E R S


 

Want to know more?

blackrock.com | 800-441-7762

This report is intended for current holders. It is not authorized for use as an offer of sale or a solicitation of an offer to buy shares of the Funds unless preceded or accompanied by the Funds’ current prospectus. Past performance results shown in this report should not be considered a representation of future performance. Investment returns and principal value of shares will fluctuate so that shares, when redeemed, may be worth more or less than their original cost. Statements and other information herein are as dated and are subject to change.

GROPPS-11/22-SAR

 

 

LOGO   

LOGO


(b) Not Applicable

 

Item 2 –

Code of Ethics – Not Applicable to this semi-annual report

 

Item 3 –

Audit Committee Financial Expert – Not Applicable to this semi-annual report

 

Item 4 –

Principal Accountant Fees and Services – Not Applicable to this semi-annual report

 

Item 5 –

Audit Committee of Listed Registrant – Not Applicable

 

Item 6 –

Investments

(a) The registrant’s Schedule of Investments is included as part of the Report to Stockholders filed under Item 1(a) of this Form.

(b) Not Applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.

 

Item 7 –

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies – Not Applicable

 

Item 8 –

Portfolio Managers of Closed-End Management Investment Companies – Not Applicable

 

Item 9 –

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers – Not Applicable

 

Item 10 –

Submission of Matters to a Vote of Security Holders –There have been no material changes to these procedures.

 

Item 11 –

Controls and Procedures

(a) The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 12 –

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies – Not Applicable

 

Item 13 –

Exhibits attached hereto

(a)(1) Code of Ethics – Not Applicable to this semi-annual report

(a)(2) Section 302 Certifications are attached

(a)(3) Any written solicitation to purchase securities under Rule 23c-1 – Not Applicable


(a)(4) Change in Registrant’s independent public accountant – Not Applicable

(b) Section 906 Certifications are attached


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

BlackRock FundsSM

 

  By:     

/s/ John M. Perlowski                            

       John M. Perlowski
       Chief Executive Officer (principal executive officer) of
       BlackRock FundsSM
  Date: January 20, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

  By:     

/s/ John M. Perlowski                            

       John M. Perlowski
       Chief Executive Officer (principal executive officer) of
       BlackRock FundsSM
  Date: January 20, 2023
  By:     

/s/ Trent Walker                            

       Trent Walker
       Chief Financial Officer (principal financial officer) of
       BlackRock FundsSM
  Date: January 20, 2023

ATTACHMENTS / EXHIBITS

CERTIFICATION PURSUANT TO SECTION 302

CERTIFICATION PURSUANT TO SECTION 906



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings